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The Agency for Toxic Substances and Disease Registry (ATSDR) has a unique mandate under the
Superfund laws to assess the presence and nature of health hazards at specific Superfund sites, to help
prevent or reduce further exposure and the illnesses that result from such exposures, and to expand the
knowledge base about health effects from exposure to hazardous substances. As part of its mandate, 
ATSDR has completed several epidemiological studies to determine if Marines, Navy personnel and
civilians residing and working on U.S. Marine Corps Base Camp Lejeune were at increased risk for
certain health effects as a result of exposure to water contaminated with volatile organic compounds
(VOCS). These studies, two retrospective cohort mortality studies of Marines/Navy personnel and of
civilian workers, and a case-control study of male breast cancer among Marines (Bove et al. 2014a, 
Bove et al. 2014b, Ruckart et al. 2015), used data from extensive water modeling (Maslia et al. 2007,
2013) to reconstruct monthly levels of contaminants in the drinking water. These contaminants included 
trichloroethylene (TCE), tetrachloroethylene (PCE), benzene, 1,2-dichloroethylene (DCE) and vinyl
chloride. The two cohort studies found elevated risks for several cancers, including cancers of the
kidney, rectum, prostate, lung, leukemias and multiple myeloma, when compared to similar unexposed 
cohorts from U.S. Marine Corps Base Camp Pendleton.  Parkinson disease was elevated among civilian
workers at Camp Lejeune but could not be evaluated in the study of Marines/Navy personnel due to
small numbers. Findings from the case-control study suggested possible associations between male
breast cancer and being stationed at Camp Lejeune and cumulative exposure to the contaminated 
drinking water but the study was limited by the small number of cases in the higher exposure categories.  
ATSDR integrated the findings from its Camp Lejeune studies with findings from studies of other
populations exposed occupationally or environmentally to the chemicals detected in the drinking water
at Camp Lejeune: trichloroethylene (TCE), tetrachloroethylene (also known as perchloroethylene or
PCE), vinyl chloride and benzene.  The purpose was to assess the strength of the evidence supporting
causality of adverse health effects from exposures to the drinking water contaminants at Camp Lejeune.
This report represents ATSDR’s assessment of the state of evidence at this time.
For this assessment, ATSDR did not conduct any new meta-analyses. Instead, ATSDR reviewed the
scientific literature on these contaminants and placed high weight on assessments conducted by other
agencies mandated to evaluate the health effects of these chemicals: i.e., the U.S. Environmental
Protection Agency (EPA 2011, 2012), the National Toxicology Program (NTP 2015) and the 
International Agency for Research on Cancer (IARC 100F, 2012; 106, 2014).  High weight was also
given to meta-analyses conducted by EPA (Scott and Jinot 2011) and other researchers. This report
summarizes the evidence for 16 diseases for which there was at least some epidemiological evidence for
an association with either TCE or PCE, the primary contaminants in the drinking water systems at Camp 
Lejeune.  The report also assesses the evidence linking these diseases with vinyl chloride and benzene.  
Two additional diseases, lung cancer and cervical cancer, are not included in this report.  ATSDR






    
 
    
  
    
 





    
    
    
    
    
     
    
     
  
    
    
   
    
   
    







     
     
   
Background
The Hadnot Point treatment plant provided drinking water to the main portion of the base at Camp 
Lejeune, including most of the barracks and workplaces. Samples of the Hadnot Point distribution 
system were conducted by the base in May and July 1982, December 1984, and throughout 1985. 
During the 1982 sampling, measured levels of TCE and PCE in the distribution system of Hadnot Point
were as high as 1,400 ppb and 100 ppb, respectively. Vinyl chloride and benzene were also detected in
the Hadnot Point distribution system during sampling conducted on or after December 1984.  The 
Tarawa Terrace treatment plant provided drinking water to the Tarawa Terrace housing area at the base.  
Samples of the Tarawa Terrace distribution system were conducted by the base in May and July 1982, 
and February 1985 onward. During the July 1982 distribution system sampling, PCE was measured as
high as 104 ppb and reached a maximum of 215 ppb during the February 1985 sampling. 
The current U.S. maximum contaminant levels (MCLs) for TCE and PCE are 5 ppb. The MCLs for
vinyl chloride and benzene are 2 ppb and 5 ppb, respectively. The MCLs for TCE, vinyl chloride and 
benzene were in effect as of 1989, and the MCL for PCE was in effect as of 1992. Historical 
reconstruction modeling of the drinking water contamination indicated that TCE and PCE levels above
their current MCLs were likely present in the distribution systems since the 1950s.  The highly
contaminated supply wells serving these systems were shut down by February 1985. For the
retrospective cohort study of Marines and Navy personnel at Camp Lejeune, the relevant exposure 
period was 1975 – January 1985.  The estimated monthly average contaminant concentrations in the
Hadnot Point and Tarawa Terrace systems during this period are shown in tables in the appendix of this
report.  In the Hadnot Point system, the median monthly estimated average concentrations of TCE, PCE, 
vinyl chloride and benzene was 366 ppb, 15 ppb, 22 ppb and 5 ppb, respectively. In the Tarawa Terrace
system, the median monthly estimated average concentrations of PCE, TCE and vinyl chloride were 85 
ppb, 4 ppb and 6 ppb.  The median number of months a marine or Navy personnel was stationed at the
base was 18 months.
A marine in training at Camp Lejeune consumes an estimated 6 liters of water per day for three days per 
week and 3 liters per day the rest of the week (ATSDR 2016). Under warm weather conditions, a
marine may consume between 1 and 2 quarts of water per hour and shower twice a day (Bove et al.
2014a). It is likely that during training, the water supplied in the field came from the Hadnot Point water
system with both measured and estimated levels of TCE and PCE substantially higher than their MCLs.
Methods
Description of the candidate list of diseases
The selection of diseases for assessment was initially based on a previous review of the literature that 
was included in a feasibility assessment for the mortality studies at Camp Lejeune (Bove and Ruckart
2008). That literature review identified a list of diseases for which there was at least limited or
suggestive evidence of an association with exposures to TCE or PCE.  Limited or suggestive evidence













   
  
 
    
   
   
 







    
     
   
   
 
     
   
   
 
  
      
     
 
 
   
   
 
  
risk or the odds ratio is greater than 1.0) was observed in at least one epidemiological study of high 
quality (i.e., the effect of biases on the study’s findings was probably low and the precision of the effect
estimate was adequate, e.g., the width of the 95% confidence interval as measured by the ratio of the 
upper to lower limit is ≤ 3) but there were inconsistencies in the results across studies and there was
substantial doubt that the body of evidence is strong enough to rule out the effect of biases.  This
definition of limited/suggestive evidence is similar to that used by the Institute of Medicine (IOM, now
renamed the Health And Medicine Division of the National Academies of Sciences, Engineering, and 
Medicine) (IOM 2008).  The list of diseases included cancers of the kidney, liver, cervix, bladder, lung, 
breast, pancreas, esophagus, non-Hodgkin lymphoma, Hodgkin disease, leukemias, multiple myeloma, 
and several non-cancers including scleroderma, Parkinson disease, liver disease, kidney disease, 
generalized skin disorder, lupus, and spontaneous abortion.
After review of the assessments of TCE and PCE by EPA (EPA 2011, 2012; Chiu et al. 2013; Guyton et
al. 2014), IARC (IARC 106, 2014) and NTP (NTP 2015), ATSDR added cancers of the brain and 
prostate and cardiac congenital malformations to its list of diseases with some association with either
TCE or PCE exposure. Finally, the list was expanded to include rectal cancer and kidney diseases based 
on the findings from the Camp Lejeune mortality studies and studies of PCE-contaminated drinking
water at Cape Cod MA (Paulu et al. 1999).  For this assessment, ATSDR decided to focus on sixteen of
these diseases: cancers of the kidney, hematopoietic system (leukemias, non-Hodgkin lymphoma, and 
multiple myeloma), liver, pancreas, prostate, breast, bladder, esophagus, rectum and brain, and 
Parkinson disease, kidney disease, scleroderma and cardiac congenital malformations.  In future
assessments, ATSDR will evaluate the remaining list of diseases as well as add new diseases to the list if
future research indicates an association with TCE or PCE exposure.
Literature search
Reviews of epidemiological studies involving TCE and PCE exposure have been conducted by EPA
(2011), IARC (2014) and NTP (2015).  In addition, meta-analyses have recently been conducted by NCI
researchers (Karami et al. 2012, Karami et al. 2013), EPA (EPA 2011, summarized in Scott and Jinot
2011), and an IARC workgroup (Vlaanderen et al. 2014) for TCE and kidney cancer, hematopoietic
cancers and liver cancer, and PCE and bladder cancer.  ATSDR utilized these reviews and meta-
analyses to identify epidemiological studies for TCE and PCE.  Meta-analyses of benzene and
hematopoietic cancers (Khalade et al. 2010, Vlaanderen et al. 2011, 2012) were used to identify
epidemiological studies for benzene. For vinyl chloride, we reviewed the IARC monograph 100F (2012)
that evaluated vinyl chloride to identify epidemiological studies involving vinyl chloride exposure. 
In addition, literature searches using PubMed were conducted to identify epidemiological studies
conducted after each of the meta-analyses and reviews were completed.  The keywords used in the
search were the combination of each of the contaminants and each of the diseases being assessed. An
additional search was conducted using the keyword “chlorinated solvents” in combination with each of
the diseases being assessed. The PubMed search identified epidemiological studies published through 
September 4, 2015.  Subsequently a PubMed search was conducted to identify epidemiological studies
published through August 12, 2016. All meta-analyses that evaluated epidemiological studies were 
identified either from the reports by IARC, EPA and NTP or by the literature search and are included in 









   
     
   
  





   
   
  
 






   
   
    
  
   
  
  
     
   
    




were conducted were identified by the literature search and included in this assessment.
Epidemiological studies that evaluated exposure-response relationships, whether included in a meta-
analysis or not, were included in this assessment. Also identified by the literature search and considered 
in this assessment were published articles that reviewed the epidemiological evidence for the chemicals
and diseases assessed in this document. 
A literature search was not conducted for animal studies.  Instead, information from animal studies, and 
information on possible disease mechanisms, were obtained from a review of the EPA, IARC and NTP
reports and published articles that reviewed the epidemiological evidence.  Information on animal
studies and mechanism were also obtained from the epidemiological studies identified via the literature
search or that were included in the meta-analyses.
Classification of Evidence
Several classification systems have been develop to reflect the strength of the evidence for a causal
relationship between an exposure and a particular health effect (IOM 2012).  The IARC, EPA and NTP
have established classification systems for exposures that may pose a cancer hazard.  The Institute of
Medicine has adopted classification systems to evaluate non-cancer endpoints as well as cancers. These 
classification systems were developed under different mandates and therefore differ in their approach to 
the evidence (IOM 2012).  For example, the IARC system separately evaluates and rates the human, 
animal, and mechanistic/other data before integrating these three types of evidence into one overall
classification.  On the other hand, the IOM reports on Agent Orange did not separately evaluate and then 
integrate these three types of evidence into one overall classification. Instead, IOM based the assessment
of evidence on the epidemiological studies and used toxicological and mechanistic information to assess
biological plausibility (IOM 2008). Although classification schemes and methods differ across these
agencies, these differences do not necessarily result in different conclusions concerning the evidence for
causality.
Because the focus of ATSDR’s assessment was primarily on the epidemiological evidence, and non-
cancers as well as cancers were assessed, the approach used by the IOM to assess evidence for causation
was most appropriate. However, the IOM used a different classification scheme for its Agent Orange 
reports than for its Gulf War reports (IOM 2008). Moreover, the Gulf War classification scheme has
changed the definition of its categories (while retaining the names of the categories) over time.
The classification scheme adopted for this report is the one recommended by an IOM panel that
reviewed the VA’s presumptive disability decision-making process for veterans (IOM 2008).  This
scheme makes clear when the evidence for causality is “at least as likely as not” or at the level of
“equipoise and above.” ATSDR adopted this scheme because of its focus on the epidemiological
evidence for causation (i.e., there is no category for evidence of a statistical association).  Additionally,
the scheme is one that is already in use by the U.S. Department of Veterans Affairs (VA) in its decision-
making concerning compensation for service-related disability compensation claims. The issue of








    





   
   
 
    
  
 
                                                 
  
    
	 
1. Sufficient: The evidence is sufficient to conclude that a causal relationship exists. 
 
2. Equipoise and Above1: The evidence is sufficient to conclude that a causal relationship is at least as 
likely as not, but not sufficient to conclude that a causal relationship exists. 
 
3. Below Equipoise: The evidence is not sufficient to conclude that a causal relationship is at least as 
likely as not, or is not sufficient to make a scientifically informed judgment. 
 
4. Against: The evidence suggests the lack of a causal relationship. 
The IOM panel anticipated that if the evidence for causation was categorized as “sufficient” or as
“equipoise and above,” then the VA would consider a presumptive service connection based on the
causal evidence. If the evidence for causation was categorized as “below equipoise,” then the VA might
reconsider the evidence at a later date as more research becomes available. This approach would be in
agreement with VA policy to give the benefit of the doubt to the veteran (IOM 2008).
Classification scheme categories 
Sufficient evidence for causation: the evidence is sufficient to conclude that a causal relationship exists. 
This category would be met, for example, if:  
 
1. 	 There is sufficient evidence from human studies in which chance and biases (including 
 
confounding) can be ruled out with reasonable confidence, or 
 
 
2. 	 There is less than sufficient evidence from human studies but sufficient evidence in animal 
studies and strong evidence that the agent acts through a relevant mechanism in humans.  
 
Sufficient evidence from human studies can be provided by a meta-analysis and/or by several studies 
considered to have high utility. 
 
 Considerations in assessing the evidence include several of Hill’s viewpoints: (1) temporal relationship, 
(2) consistent positive associations (e.g., risk ratio or odds ratio greater than 1.1), (3) magnitude of the 
effect estimate (e.g., risk ratio, odds ratio), (4) exposure-response relationship, and (5) biological 
plausibility (Hill 1965). 
Equipoise and above evidence for causation: The evidence is sufficient to conclude that a causal
relationship is at least as likely as not, but not sufficient to conclude that a causal relationship exists.
This category would be met, for example, if:
1. The degree of evidence from human studies is less than sufficient but there is supplementary
evidence from animal studies and/or mechanistic studies that supports causality, or
1 In an earlier draft of this document, the category “Modest evidence for causation” was created and used to characterize 



















   
 






   
 
     
   
   







     
     






2. A meta-analysis does not provide convincing evidence (e.g., the summary risk estimate is close
to the null value of 1.0, i.e., ≤1.1), or if the meta-analysis observes a non-monotonic exposure-
response relationship) but there is at least one epidemiological study considered to be of high 
utility occurring after the meta-analysis has been conducted, in which an association between the 
exposure and increased risk of the disease of interest has been found and in which chance and 
biases can be ruled out with reasonable confidence.
3. A meta-analysis has not been conducted, but there is at least one epidemiological study
considered to be of high utility in which an association between the exposure and increased risk 
of the disease of interest has been found and in which chance and biases can be ruled out with 
reasonable confidence.
Below Equipoise evidence for causation: The evidence is not sufficient to conclude that a causal
relationship is at least as likely as not, or is not sufficient to make a scientifically informed judgment.
This is a rather broad category that encompasses:
• evidence sufficient to conclude an association exists but where there is some doubt that biases
can be ruled out and the animal and mechanistic evidence is weak, or
• evidence for an association that is so limited that there is substantial doubt that biases can be
ruled out, or
• insufficient evidence to determine whether an association exists.
Evidence against a causal relationship: The evidence suggests the lack of a causal relationship.
ATSDR’s Methods Used to Assess the Strength of the Evidence for Causation
Comprehensive assessments of the evidence for causation for TCE, PCE, vinyl chloride and benzene
have been conducted by IARC (IARC 97, 2008; 100F, 2012; 106, 2014), EPA (EPA 2011, 2012), and 
NTP (NTP 2015).  ATSDR placed high weight on these assessments in reaching its conclusions
concerning the evidence of causation for these chemicals and the diseases evaluated in these reports.
ATSDR also placed high weight on the results of recent meta-analyses that were conducted by EPA
(Scott and Jinot 2011) and other researchers (e.g., Karami et al. 2012, 2013; Vlaanderen et al. 2011, 
2012, 2014). Meta-analyses were valuable for evaluating occupational studies.  Many of these studies
lacked precision in their effect estimates, in particular, when exposure-response trends were evaluated,
due to small numbers of exposed with the disease of interest.  Moreover, some of the meta-analyses
were able to reduce the inconsistencies in findings across studies by taking into account study
differences in exposure levels and in the quality of exposure assessments. Some of the meta-analyses
also evaluated whether confounding bias, publication bias and between-study heterogeneity was a 
concern. Also given high weight were studies considered to be of high or moderate utility by NTP in its
evaluation of TCE and kidney cancer, non-Hodgkin lymphoma and liver cancer (NTP 2015).  These










   
    
  
  
    
      
   
  
 
     
 
   
 
   
   
   




     
   
  
 




   
   
   







Epidemiological studies that were published after a meta-analysis was completed were included in the 
tables and evaluated in the assessment.  Also assessed and included in the tables were all studies that 
evaluated exposure-response trends even if they were included in a meta-analysis. For these studies, the 
assessment focused on the results of the exposure-response analyses. Although not included in the
tables, the assessment also considered information from animal studies and mechanistic information that 
was reported in the EPA, IARC and NTP reports, epidemiological studies, and epidemiological review
articles.
In its assessment of each contaminant and disease, ATSDR highlighted epidemiological findings (i.e., 
effect estimates such as risk ratios, odds ratios, standardized mortality ratios and standardized incidence
ratios) that:
1. Represented the risks to those most likely to have been exposed (and possibly less affected by
exposure misclassification bias), such as effect estimates in the higher cumulative exposure or 
exposure intensity categories, higher probability of exposure categories, and higher duration of
exposure categories, based on semi-quantitative or quantitative exposure assessments;
2. Minimally affected by healthy worker effect biases; and
3. Minimally affected by confounding bias due to smoking or other risk factors. 
Also highlighted were findings from the evaluation of disease subgroupings (e.g., leukemia types) and 
findings from the evaluation of effect modification (e.g., analysis of possible susceptible populations
such as those with a genetic polymorphism affecting a key metabolic pathway for the chemical under
evaluation). For cancers with a high probability of survival, findings based on incidence data were 
highlighted because mortality data has several limitations including: (1) cancers may be missed if the
exposure causes a less fatal form of the disease or if the cancer is not an underlying or contributing
cause of death; and (2) cancer information provided by cancer registries (e.g., histological information 
and identification of primary and metastatic sites) has greater accuracy compared to the information
available from the death certificate, therefore disease misclassification should be reduced for findings
based on incidence data. 
In the disease-specific tables, 95% confidence intervals were provided in order solely to indicate the
level of precision or uncertainty in the effect estimates. An effect estimate (e.g., risk ratio, odds ratio, or
standardized mortality ratio) was considered to have good precision (or less uncertainty) if the ratio of
the upper limit to lower limit of its 95% confidence interval was ≤ 2.  
In our assessment, we did not use confidence intervals to determine whether a finding was “statistically
significant” nor did we use significance testing to assess the evidence for causality (Rothman et al.
2008).  There are several limitations to the use of statistical significance testing (Rothman et al. 2008,
Goodman 2008, Stang et al 2010).  Moreover, a finding that does not achieve statistical significance
nonetheless can provide important evidence for a causal association, while a finding that achieves
statistical significance can often lack scientific and public health significance. Because of the limitations
of statistical significance testing, it was not used to assess the epidemiological evidence. Instead, 










   
 
      
   
 
  
   
  
















    









     
 
 
Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and 
standardized mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although 
the relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  
When considering the magnitude of the effect estimate, an effect estimate was considered “near the null
value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of biases, in particular
exposure misclassification, healthy worker effect, and confounding. 
1. Impact of Bias
Biases impact the validity of a study. Therefore, a consideration in the assessment of the evidence for
causation was the impact of key biases on the findings of the studies. The key limitation of all the
studies was exposure misclassification. The impact of exposure misclassification bias would likely be
to bias dichotomous comparisons (e.g., exposed vs unexposed) towards the null if an effect of the
exposure is truly present, and to distort exposure-response trends (e.g., the curve may flatten or attenuate
at high exposure levels). It is possible for exposure misclassification bias to be “differential” (i.e., the 
bias is associated both with exposure and disease status).  If differential, dichotomous comparisons can 
be biased toward or away from the null. For example, if exposures are assessed retrospectively (e.g.,
when cases and controls are interviewed about their past exposures), it is possible for exposure
misclassification bias to be differential.  However, differential exposure misclassification is not likely
for studies that assess exposures via job-exposure matrices (JEMs), plant record reviews, exposure
biomonitoring, or that historically reconstruct exposures via modeling.  
The vast majority of the epidemiological studies that evaluated the health effects of TCE, PCE or vinyl 
chloride were occupational studies. Some of the occupational studies used semi-quantitative JEMs
specific to a plant or industry to assess exposures. The JEMs were developed based on plant records, 
literature data, expert judgment from industrial hygienists, and/or exposure measurements (e.g., 
biomonitoring or work area sampling).  Some studies used generic JEMs that linked a wide range of
occupations and industries to exposure metrics for exposures of interest. All JEMs may introduce
exposure misclassification bias because they assume that workers with the same job during a specific 
time period will have similar exposures. However, generic JEMs are likely to result in much greater
exposure misclassification bias than industry-specific or plant-specific JEMs.  Occupational studies that
did not use JEMs based their exposure assessments on reviews of work history information (e.g. 
obtained via interview or from plant records) by experts in industrial hygiene. The quality of expert-
assessed exposure levels depends on the amount and accuracy of the available information for the jobs
being assessed. A few studies based their assessment of TCE exposure on urine trichloroacetic acid
(TCA) measurements. However, urine TCA is not specific to TCE exposure and measures recent
exposures that may not reflect exposures occurring in the past.  Drinking water studies included in this
review based their exposure assessments on modeled historical estimates of contaminant levels in the
drinking water serving residences or workplaces. Information on the amount of water consumed by 
individuals was either limited (due to likely inaccuracies in the recall of past consumption habits) or
unavailable.
Another important bias is due to the Healthy worker/veteran effect. This bias likely occurred in 
studies that compared incidence or mortality rates in worker or veteran cohorts with rates in the general
population (Checkoway et al. 2004, McLaughlin et al. 2008, Kirkeleit et al. 2013). Such a bias would 
tend to produce underestimates of the effect of exposure, and in many situations, reduce measures of












      





    
 
   
  
  
   
   
 
   
  
 









   
cohort studies or bias in the selection of cases or controls in case-control studies were generally minimal
for most of the studies evaluated in this assessment.
2. Confounding assessment
Another issue for most of the studies is possible confounding due to co-exposures to other workplace or
environmental chemicals.  For example, dry cleaning workers employed before the early 1960s were
likely exposed to other solvents besides PCE.  Dry cleaning workers also used solvents for spot removal
although these exposures would be considerably lower than exposures to the primary solvent. Workers
in aircraft manufacturing or maintenance may have been exposed to TCE, PCE and other solvents.  In 
the Camp Lejeune studies (Bove et al. 2014a, b) and the NJ drinking water studies (Cohn et al. 1994, 
Bove et al. 1995), both TCE and PCE appeared together as drinking water contaminants. However, the
possibility of confounding occurs only if the co-exposure independently increases the risk of the disease
under evaluation in addition to being correlated with the exposure of interest.
An additional concern was the possibility of confounding by non-occupational and non-environmental
risk factors for the diseases under evaluation, such as smoking and alcohol consumption.  However, for 
appreciable confounding (e.g., a change in the effect estimate by >20%) by smoking or any other risk 
factor to occur, at least two requirements must be met: (1) the risk factor must have an association with 
the outcome of interest at least as strong as the exposure of interest, and (2) the risk factor must also 
have a strong association with the exposure of interest.  For the latter requirement to be met, the
prevalence of the risk factor must be very different in the compared groups.  This might occur for 
example when a worker (or veteran) cohort is compared to the general population. However, the
prevalence of risk factors (other than the exposure of interest) should be similar when comparisons are
made either internal to a cohort or between similar cohorts (e.g., similar workforces or similar military
personnel), and therefore confounding would be expected to be minimal for these comparisons.  
In general, substantial confounding due to smoking or any other risk factor is rare in occupational and 
environmental epidemiology.  Even for studies of an occupational or environmental exposure and lung
cancer, a summary measure (e.g., RR, OR) adjusted for smoking rarely differs by more than 20% from
the unadjusted summary measure (Blair et al. 2007).  In any case, the amount of bias due to confounding
will not be greater than the weaker of these two associations: (1) between the exposure of interest and 
the confounder; (2) between the confounder and the disease of interest (Smith and Kriebel 2010).
Many of the studies included in the meta-analyses or listed in the tables did have information on 
smoking and were able to adjust for smoking if confounding was present. Most of the studies that did 
not have information on smoking were able to indirectly assess whether confounding due to smoking
affected the results by evaluating whether a smoking-related disease that was not known to be associated 
with the exposure of interest was elevated in the study.  Another indirect approach to evaluate possible
confounding due to smoking would be to evaluate all smoking-related diseases in the study for which 
the risk from smoking is known (or expected to be) much larger than the risk from the exposure of
interest. If appreciable confounding due to smoking were present, one would expect that all these 





































Many of the studies evaluated, or adjusted for, risk factors in addition to smoking such as alcohol
consumption and socioeconomic status. The appendix lists the studies included in the tables, whether or
not they evaluate smoking as a possible confounder, and any additional potential confounders. 
Assumptions on Duration of Exposure
One objective of this report was to evaluate whether there was sufficient information in the scientific
literature to determine a minimum duration at Camp Lejeune, or a minimum level of exposure,
necessary to increase the risk of one or more of the diseases being assessed. The 2012 Honoring
America’s Veterans and Caring for Camp Lejeune Families Act established a minimum duration at 
Camp Lejeune of 30 days in order to be eligible for health benefits under the Act. It is unclear how the
minimum duration was established for this legislation. However, the evidence from the epidemiological
studies included in this assessment is not sufficient to contradict this minimum duration. Moreover the
results from the Camp Lejeune mortality studies suggest that a 30 day minimum duration requirement 
may be appropriate since elevated risks for some of the diseases evaluated were observed for exposure
durations of 1-3 months.  These results should not be surprising given that the levels of TCE, PCE and 
vinyl chloride measured or estimated in the drinking water systems at Camp Lejeune considerably
exceeded their respective MCLs. 
The studies evaluated in this report provide very limited information concerning the level or duration of
exposure associated with an increased risk of a cancer or other disease.  For example, those studies that
evaluated cumulative exposure or exposure duration often used wide categorizations (e.g., duration of
exposure > 0 to 5 years).  An additional interpretative difficulty is the possible inverse relationship 
between duration and exposure intensity, e.g., high exposure intensities may require only a short
duration of exposure whereas low exposure intensities may require longer exposure durations.  Although 
cumulative exposure is a useful metric, it obscures this interplay between duration and intensity.  
Specifying a minimum duration of exposure also presupposes that there is a known threshold amount of
exposure below which there is no excess risk.  However, there is no compelling evidence that such 
thresholds exist for these contaminants and the cancers and other diseases evaluated in this report.
For cardiac birth defects, it is possible that very short durations of exposure to the mother may be
sufficient if the exposure occurs during the relevant vulnerability period for cardiac defects, i.e., 3-9 
months gestation.  In-utero exposures have been associated with increased risk of childhood leukemia
(Costas et al. 2002).
Given that sufficient evidence for a threshold is lacking, ATSDR recognizes that a decision to establish 






















    








An overall summary table is provided that lists each disease and ATSDR’s assessment of the evidence 
of causality for each chemical. In addition, a table for each disease was created followed by a narrative 
that includes the assessment of the evidence for each chemical and ATSDR’s conclusions.  Each
disease-specific table first lists the results from meta-analyses that have been conducted. Next, the table
lists the results from epidemiological studies that: (1) were not included in meta-analyses because they
appeared after the meta-analyses were conducted; and/or (2) contained information on exposure-
response trends (e.g., cumulative exposure, exposure duration, employment duration, exposure intensity, 
probability of exposure, or exposure biomarker); and/or (3) are included because no meta-analysis has
been conducted to date.  The studies in most of the tables are grouped in the following manner: cohort
studies of TCE and PCE exposures at industrial facilities, case-control studies of occupational exposures
to TCE and PCE, studies of dry cleaning workers, vinyl chloride worker studies, benzene worker
studies, and drinking water studies including the studies conducted at Camp Lejeune. (For some diseases
there are too few studies of each category to group in this manner. For these tables, cohort studies are
grouped together, then case-control studies, and then the drinking water studies.) Following each table, a
summary of the conclusions for that disease from the reviews by EPA, IARC and NTP, if available, are 
provided, followed by ATSDR’s assessment.
ATSDR’s assessment includes a brief discussion of the meta-analyses and key studies.  Animal study
information from the reviews by IARC, EPA and/or NTP are also provided.  If available, mechanistic
information from animal or human studies specific to the disease and chemical under evaluation are also 
presented. A summary statement of the evidence is then provided.
In an appendix, a table is provided listing each study and information concerning possible confounding








    
    
 
 
     
 
    
 
 
    
   
 
 
        
     
     
        
     
   
 
   
     
        
     
   
     
      
     
     
     
      
     
     
 
  
     
     
     

 Overall Summary of the Evidence*
Disease Chemicals Meta-analysis Citations ATSDR Conclusions
Kidney Cancer TCE Kelsh 2010; Scott (EPA) 2011;
Karami (NCI) 2012
Sufficient evidence for causation
PCE Below equipoise evidence for causation
Non-Hodgkin 
Lymphoma
TCE Kelsh 2010; Scott (EPA) 2011;
Karami (NCI) 2013
Sufficient evidence for causation. 
PCE Equipoise and above evidence for causation
Benzene Steinmaus 2008; Kane 2010;
Vlaanderen 2011
Sufficient evidence for causation
Multiple Myeloma TCE Alexander 2006; Karami (NCI) 2013 Equipoise and above evidence for causation
PCE Below equipoise evidence for causation
Benzene Infante 2006; Vlaanderen 2011 Equipoise and above evidence for causation
Leukemias TCE Alexander 2006; Karami (NCI) 2013 Equipoise and above evidence for causation for all types of leukemia 
PCE Below equipoise evidence for causation
Benzene Khalade 2010; Vlaanderen 2011;
Vlaanderen 2012
Sufficient evidence for causation for all types of leukemia
Vinyl chloride Boffetta 2003 Below equipoise evidence for causation
Liver Cancer TCE Alexander 2007; Scott (EPA) 2011 Equipoise and above evidence for causation
PCE Below equipoise evidence for causation
Vinyl chloride Boffetta 2003 Sufficient evidence for causation
Benzene Below equipoise evidence for causation
Pancreatic Cancer TCE Ojajarvi 2001, 2007 Below equipoise evidence for causation
PCE Ojajarvi 2001, 2007 Below equipoise evidence for causation
Benzene Below equipoise evidence for causation
Vinyl chloride Ojajarvi 2001, 2007 Below equipoise evidence for causation
Prostate Cancer TCE Morgan 1998 Below equipoise evidence for causation
PCE Below equipoise evidence for causation
Vinyl chloride Below equipoise evidence for causation
Breast Cancer (male 
& female)
TCE Below equipoise evidence for causation
PCE Below equipoise evidence for causation






   
      
   
     
     
      
     
      
     
     
     
     
      
     
     
     
     
 
 
    
     
     
    






Disease Chemicals Meta-analysis Citations ATSDR Conclusions
Bladder Cancer TCE Below equipoise evidence for causation
PCE Vlaanderen (IARC) 2014 Sufficient evidence for causation
Vinyl chloride Below equipoise evidence for causation
Benzene Below equipoise evidence for causation
Parkinson Disease TCE Equipoise and above evidence for causation
PCE Below equipoise evidence for causation
Kidney Diseases TCE Equipoise and above evidence for causation for end-stage renal disease
PCE Equipoise and above evidence for causation for end-stage renal disease
Esophageal Cancer TCE Below equipoise evidence for causation
PCE Below equipoise evidence for causation
Benzene Below equipoise evidence for causation
Rectal Cancer TCE Below equipoise evidence for causation
PCE Below equipoise evidence for causation
Brain/CNS Cancers TCE Below equipoise evidence for causation
PCE Below equipoise evidence for causation
Vinyl chloride Boffetta 2003 Below equipoise evidence for causation
Systemic Sclerosis/
Scleroderma
TCE Cooper 2009; Zhao 2016 Equipoise and above evidence for causation
PCE Zhao 2016 Below equipoise evidence for causation
Benzene Zhao 2016 Below equipoise evidence for causation
Cardiac Defects TCE Sufficient evidence for causation
PCE Below equipoise evidence for causation


















    
 
 
    
 
   
 
 
   
 
   
 
 





    
                   
 
                      
 
  
           
               






      









    
                                                         
                          
                             





























   
     
      
           
     
       
      
             
Individual Tables
Kidney Cancer
Reference, type of 








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Kelsh 2010 TCE Not sRR=1.42 (1.13, 1.77) – 23 studies; “Shortest” duration: RR=1.50 “Low” cumulative exposure:
meta-analysis reported
“More likely exposed”: sRR=1.34 
(0.96, 2.36) – 7 studies RR=1.29 (0.68, 2.47) – 3 studies
(1.07, 1.67) – 8 cohort studies “Longest” duration: RR=1.24 “High” cumulative exposure:
(0.69, 2.23) – 7 studies RR=1.39 (0.75, 2.59) – 3 studies




sRR=1.27 (1.13, 1.43) – 15 studies; (11 incidence (I), 4 mortality M))
─
High cumulative exposure, summary
RR=1.64 (1.31, 2.04) – 10 studies
Karami 2012
meta-analysis
TCE 478 (?)** sRR=1.32 (1.17, 1.50) – 18 studies (9 cohort – 4 I, 5 M; 9 case-control – 8 
I, 1 M)  ─
─
Cohort Studies:




PCE (blood PCE) 2 SIR=1.82 (0.22, 6.56)




TCE (job title, plant 
air monitoring &
Urine TCA data)
76 Duration of employment (yr)  (SIR)  # cases
Men  Women
<1:      0.8 (0.5, 1.4)   14    1.1 (0.1, 3.8)  2
1-4.9:  1.2 (0.8, 1.7)  25   1.2 (0.2, 3.4)  3
≥5: 1.6 (1.1, 2.3) 29   1.5 (0.3, 4.3)  3
Zhao 2005¶ Aerospace Cumulative Exposure (RR)
















16 Cumulative Exposure (unit-yr) 
HR
0-5:   1.9 (0.6, 6.0) – 10 cases
5-25: 0.3 (0.0, 2.8) – 1 case
>25:  1.2 (0.3, 4.3) – 5 cases
Exposure intensity (HR) # cases
Low, intermittent: 1.6 (0.5, 4.8) 15
Low, continuous: 1.8 (0.6, 5.6) 11
Peak, infrequent:   1.0 (0.2, 5.7) 2























                                                                       
                                        
                                      













   
 
   
   








     
   
  

































                                                      
                                     
                                    
                                    
 
                                    
                                    
                                    
 
 








    
   
     




Reference, type of 








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Lipworth 2011+++ Aircraft Any exposure: Duration of exposure (yr) (RR) # cases
Mortality Manufacturing 13 SMR=0.80 (0.43, 1.37) TCE PCE
5,830 (PCE) PCE (JEM) <1:   0.84 (0.48, 1.47)  18 1.26 (0.65, 2.45)   11
1960-2008 1-4:  1.10 (0.59, 2.04)   14 1.00 (0.50, 2.00)   10








TCE (urine TCA) 32
19
SIR=1.01 (0.70, 1.42)
20 yr lag: SIR=1.11 (0.67, 1.73)
Urine TCA (mg/L): (RR)
<5: referent
5-25: 1.1 (0.5, 2.7) – 11 cases
25-50: 0.8 (0.2, 3.0) – 3 cases
>50:  2.0 (0.8, 5.2) – 9 cases
Silver 2014 Microelectronics 56 Cumulative exposure (5 exposure-yr)
Mortality firm TCE (JEM) HR=1.24 (0.87, 1.77)
34,494 PCE (JEM) HR=0.15 (0.01, 4.04)
1969-2009
Buhagen 2016 Train maintenance 13 SIR=1.7 (1.0, 3.0)
Incidence TCE
997 males (union employment
1960-2010 list)
Case-Control Studies:
Pesch 2000+ Questionnaire and Cumulative exposure (percentiles) Odds ratios
Incidence JTEM M  F Males:   Females








60th: 1.1 (0.8, 1.5) 0.8 (0.4, 1.9)
90th: 1.3 (0.8, 2.1) 1.8 (0.6, 5.0)
30th: 1.2 (0.9, 1.7) 2.2 (0.9, 5.2)
60th: 1.1 (0.7, 1.5) 1.5 (0.6, 3.8)
90th: 1.3 (0.7, 2.3) 2.0 (0.5, 7.8)
Charbotel 2006+ TCE (occupational 37 Ever exposed, OR=1.64 (0.95, 2.84) Cumulative dose: (ORs)
Incidence questionnaire & Low: 1.6 (0.8, 3.5) – 12 cases
86 cases JTEM) Med: 1.2 (0.5, 2.8) – 9 cases


























    
 
  
   
 
    
   
   
 
   
   































































   
  
  






                        
         









     
Reference, type of 








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Moore 2010++ TCE (occupational 29 High confidence, any exposure: <1,080 hours, OR=1.22 (0.48, <1.6 ppm-years: OR=1.77 (0.64,
Incidence questionnaire & OR=2.05 (1.13, 3.73) 3.12) – 9 cases; 4.80) – 9 cases;
1,097 cases JTEM) ≥1.6 ppm-years: OR=2.23 (1.07,
1,476 controls ≥1,080 hours, OR=2.86 (1.31, 4.64) – 20 cases
NTP: High Utility 6.23) – 20 cases
<0.076 ppm intensity: OR=1.73 
(0.75,  4.02) – 13 cases;
≥0.076 ppm intensity: OR=2.41 (1.05,
5.56) – 16 cases
Vlaanderen 2013
Incidence
Tertiles of cumulative exposure: >90th percentile cumulative 
exposure: (HRs)
76,130 cases TCE (JEM) 1,217 1. HR=1.01 (0.95, 1.07) TCE: 0.86 (0.75, 0.98) 251 cases
380,650 controls 1,556 2. HR=1.02 (0.97, 1.08) PCE: 0.81 (0.65, 1.01)   88 cases
1961-2005 1,372 3. HR=1.00 (0.95, 1.07)
>90th percentile, intensity x freq. exp.
PCE (JEM) 375 1. HR=1.11 (0.99, 1.24) TCE: 1.00 (0.90, 1.30) 387 cases
333 2. HR=0.96 (0.86, 1.08) PCE: 1.01 (0.82, 1.25) 103 cases
314 3. HR=0.94 (0.83, 1.06)
Benzene (JEM) 1359 1. HR=1.00 (0.94, 1.06)
1435 2. HR=1.00 (0.95, 1.06)
1560 3. HR=1.06 (1.00, 1.12)
Christensen 2013# TCE 5 Any exposure: OR=1.0 (0.3, 2.9) ─ ─
Incidence 2 “substantial”:  OR=0.7 (0.1, 3.2)
177 cases PCE 2 Any exposure: OR=1.6 (0.3, 9.4)
533 controls 2 “substantial”:  OR=3.1 (0.4, 24)
Dry Cleaning Workers Studies
Blair 2003 Dry Cleaning 8 SMR=1.0 (0.4, 2.0) Exposure intensity  # cases
Mortality Little/no: SMR=0.3 (0.0, 1.6) 1 
5,369 Med/high: SMR=1.5 (0.6, 3.1) 7
1948-1993
























   
   


















































        
       
      
     
 
           
   


















     
  
    
  
                 
          















Reference, type of 








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Calvert 2011 Dry Cleaning 5 SMR=1.14 (0.37, 2.67) All







3 SMR=1.04 (0.21, 3.04) PCE plus
Selden 2011 Dry Cleaning and Any exposure
Incidence Laundry Workers: 29 All: SIR=1.04 (0.69, 1.49)
9,440 (plant survey, work 10 Men: SIR=1.06 (0.51, 1.94)
1985-2006 history) 19 Women: SIR=1.03 (0.62, 1.60)
Drinking water studies:










42 Exposure duration (months)
1-3: OR=1.3 (0.4, 4.5) 3  cases
4-6: OR=1.2 (0.3, 5.5) 2  cases
Cumulative Exposure (HR)  # cases
TCE
Low:  1.5 (0.6, 3.6) 11   




vs. Camp Pendleton HR=1.35 (0.84, 2.16) >12: OR=1.7 (0.8, 3.6) 20  cases High: 1.5 (0.6, 3.6)  11
Bove 2014b (Camp VOC contaminated 7 5 of 7 deaths had any residential All 7 deaths had residential 
Lejeune Civilian drinking water exposure duration >12  months cumulative exposures above the 





vs. Camp Pendleton HR=1.92 (0.58, 6.34)
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
** One included study did not report the number of exposed cases.  The rest of the included studies reported a total of 478 exposed cases.
ø Included in the table for information on PCE.
¶ Included in the EPA meta-analysis
+ Included in the EPA, Karami et al. 2012, and Kelsh et al. 2010 meta-analyses




     
   
  
   
















+++ Included in the Karami et al. 2012 meta-analysis. Note: only the PCE findings for Lipworth et al. 2011 are included in the table because 
no meta-analyses have been conducted for PCE and kidney cancer.  There was no exposure-response information for PCE or TCE in the
Lipworth et al. study.
# Exposure assessment based on interviews and expert assessment
¥ There were only 2 deaths due to kidney cancer among the 3,725 women workers.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
JTEM: job-task exposure matrix
Urine-TCA: Urine levels of the TCE metabolite, trichloroacetic acid
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)




   
 





     
 
 














   
    
  




   





    
  
Summary of EPA, IARC and NTP reviews of TCE and kidney cancer
EPA Toxicological Review of TCE (EPA 2011, p. 4-632): “...TCE is characterized as carcinogenic to
humans by all routes of exposure. This conclusion is based on convincing evidence of a causal association 
between TCE exposure in humans and kidney cancer. The kidney cancer association cannot be reasonably
attributed to chance, bias, or confounding.”
IARC (IARC 2014, p. 189): “There is sufficient evidence in humans for the carcinogenicity of
trichloroethylene. Trichloroethylene causes cancer of the kidney.
NTP Monograph on TCE (NTP 2015, p. 177-178): “Epidemiological studies have demonstrated a
causal relationship between trichloroethylene exposure and kidney cancer based on consistent evidence
of increased risk across studies with different study designs, in different geographical areas, and in 
different occupational settings; evidence of increasing cancer risk with increasing level or duration of
exposure; and statistically significant increased risks of kidney cancer across studies combined in two 
meta-analyses. Overall, increased risks of kidney cancer were found among individuals with the highest
exposure in the most informative studies (i.e., studies with higher levels of exposure to trichloroethylene
and better assessments of exposure and disease….” “… biases or confounding by known or suspected
occupational co-exposures, smoking, or other lifestyle factors are unlikely to explain the positive findings
across studies…” “Toxicokinetic and mechanistic data in both humans and animals provide credible
evidence for the biological plausibility of the proposed mechanisms of trichloroethylene’s carcinogenicity in 
humans.”
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA, NTP and IARC as well as meta-analyses. High weight was also given to a study that was
considered of moderate or high utility by the NTP, evaluated a susceptible subpopulation, or provided 
mechanistic information.  Our assessment of the epidemiological evidence considered some of the
viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk 
ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4) exposure-response
relationship (although the relationship could be non-linear or non-monotonic), and (5) biological
plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect estimate was
considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of
biases, in particular exposure misclassification, healthy worker effect, and confounding.
TCE
The three meta-analyses that have been conducted consistently observed an elevated summary RR in the 1.3­
1.4 range, and higher cumulative exposures were observed to increase the risk of kidney cancer. The EPA
(Scott and Jinot 2011) and Karami et al. 2012 meta-analyses reported that there was no between-study





    
      
     
    
  
   




    




     
  
  
    
 
 
    
      
     
    
  
   
    









that confounding by smoking and other risk factors would have a minimal impact on the meta-analysis
results. NTP (2015) in its assessment stated that the increased risks found across the epidemiological
studies were unlikely to be explained by biases. IARC (2014) and EPA (2011) have determined that
there is sufficient evidence in humans that TCE causes kidney cancer. NTP (2015) noted that increased
risks were observed in studies with higher levels of exposure and better exposure assessments. The NTP
concluded: “Epidemiological studies have demonstrated a causal relationship between trichloroethylene
exposure and kidney cancer based on consistent evidence of increased risk across studies with different study
designs, in different geographical areas, and in different settings; evidence of increasing cancer risk with
increasing level or duration of exposure; and meta-analyses showing statistically significantly increased
cancer risk across studies.”
Since the meta-analyses were conducted, two Camp Lejeune studies and five other recent studies have 
been published. Of these recent studies, Hansen et al. 2013 had the best study design with: (1) a large 
pooled cohort, (2) evaluation of cancer incidence, (3) documented exposure based on TCE metabolite
biomonitoring, (4) minimal confounding by smoking especially for the internal (urinary TCA) analysis, 
and (5) an analysis of exposure-response trend. This study observed an elevated risk among those with 
the highest levels of urine TCA (RR=2.0; 95% CI: 0.8, 5.2). However, this study was limited by the low
exposures among most of its workers, the reliance on a few urine TCA measurements to assess 
exposures and the small numbers of exposed cases in the exposure-response analysis. Two recent studies
that did not observe an increased risk for kidney cancer, Vlaanderen et al. 2013 and Christensen et al.
2013, had severe limitations. The Vlaanderen et al. study used a generic JEM that the authors admitted 
was likely to introduce considerable exposure misclassification. Moreover, only a small percentage of
the study population received high exposures to either TCE or PCE. The Christensen et al. study had 
very few exposed cases.  Two other recent studies, Silver et al. 2014 and Buhagen et al. 2016, and the
two Camp Lejeune studies (Bove et al. 2014 a,b) observed increased risks of kidney cancer.
One study included in both the NCI and EPA meta-analyses, Moore et al. 2010, was of particular importance
since it not only evaluated exposure-response trends but also the interaction between TCE exposure and 
genotypes for the GSTT1 and renal-CCBL1enzymes.  These enzymes are highly active in the kidney and 
involved in the bioactivation of TCE (via GSH-conjugation pathway). This study was considered of “high 
utility” by the NTP (2015) review of TCE and ATSDR concurs. In addition to observing exposure-response
trends for TCE exposure and kidney cancer, the study also found that those exposed to TCE with at least one
intact GSTT1 allele had elevated risks for kidney cancer, but those with a functionally inactive GSTT1 
enzyme (i.e., with two deleted alleles, the null genotype) had no elevated risk. Findings for the interaction 
between TCE exposure and minor alleles for the renal-CCBL1 enzyme supported the findings for the GSTT1 
enzyme. The findings of this study are in agreement with the hypothesized mechanism for TCE-induced 
kidney cancer and therefore provide strong evidence for causality. 
Animal and mechanistic information: “The mode of action for trichloroethylene-induced kidney
cancer is not completely understood but the available data provide support for a mutagenic and cytotoxic
mode of action mediated by GSH-conjugation-derived metabolites. There is experimental evidence that
GSH metabolites (particularly DCVC) are genotoxic and nephrotoxic and are both formed in and 






    
     
    
     
   
 
   
      
   
 
   
   





       
     
     
    
 
   
   






Trichloroethylene, 2015, p. 106.) Exposure to TCE via inhalation or stomach tube has been observed to 
cause kidney cancer in rats (NTP 2015). 
Exposure-Response: The Moore et al. 2010 study and the Raaschou-Nielsen 2003 study found increased 
risk with increasing duration of exposure.  The Moore et al. 2010 study also suggested that an elevated
risk could occur with a short duration of exposure (OR=1.2, 95% CI: 0.5, 3.1 for ≤6 month exposure
duration). The Camp Lejeune mortality study of Marines/Navy personnel (Bove et al. 2014a) found an 
elevated risk among those with exposure ≤3 months to the drinking water contaminants including TCE
(RR=1.3, 95% CI: 0.4, 4.5), although higher risks were observed with exposure durations >6 months. 
Both the Scott and Jinot 2011 and the Kelsh et al. 2010 meta-analyses found an increased risk with 
higher cumulative exposures.  In the Camp Lejeune study of Marines and Navy personnel (Bove et al.
2014a), there was a monotonic trend for cumulative exposure when all the contaminant levels were
summed, but not for TCE or the other contaminants when analyzed separately.
Conclusion: ATSDR concurs with the evaluations made by IARC, EPA and NTP. Based on the overall
consistent findings of increased risks of kidney cancer from exposures to TCE and the supporting
mechanistic information, there is sufficient evidence for causation for TCE and kidney cancer.
PCE
No meta-analyses have been conducted for PCE and kidney cancer. The epidemiological studies have 
not consistently observed an increased risk.  Increased risks were found in the Camp Lejeune studies
(Bove et al. 2014 a, b) and the Cape Cod drinking water study (Aschengrau et al. 1993) as well as the
Pesch et al. 2000 and the Christensen et al. 2013 studies. No increased risks were observed in the
Lipworth et al. 2011, Vlaanderen et al. 2013, and Silver et al. 2014 studies.  A major limitation of
several of the studies was the small number of exposed cases. In one bioassay, PCE exposure via
inhalation resulted in an increase in the combined incidence of benign and malignant tubular-cell kidney
tumors in male rats (Guyton et al. 2014).
Conclusion: ATSDR concludes that there is below equipoise evidence for causation for PCE and




   













   
      
                     
              
  
 
   
  
                      









           




                
       
 
     
     
   
 
    





   
 
   
   
  
      
   












   
   
           
       
      















                
    





 Non-Hodgkin Lymphoma (NHL)
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Mandel 2006 TCE (All workers) 429 sRR =1.29 (1.00, 1.66) 8 studies <5 yrs exp.: sRR=1.47 (1.08, 2.0) low intensity: sRR=2.33 (1.29, 3.91)
Meta-analysis (4 I, 4 M) ≥5 yrs exp.: sRR=1.60 (1.20, 2.10) high intensity: sRR=2.11 (0.76, 5.84)
“more likely
exposed”
137 sRR =1.59 (1.21, 2.08) 7 studies
(4 I, 3 M)
Scott 2011 TCE Not Summary RRs/ORs:  # studies: higher TCE exposure, summary
Meta-analysis reported All: 1.23 (1.07, 1.42) 17 (13 incidence (I), 4 mortality (M)) RRs/ORs:
(EPA) Cohort: 1.33 (1.13, 1.58)   9 (5 I, 4 M)
Case-control: 1.11 (0.89, 1.38)  8 (8 I)
All studies: 1.43 (1.13, 1.82)
Cohort: 1.60 (1.24, 2.08)








TCA (21 exposed 
cases)
Summary RRs/ORs: # studies:
All: 1.32 (1.14, 1.54)  19
Cohort: 1.52 (1.29, 1.79)  10 (6 I, 4 M)
Case-control: 1.14 (0.93, 1.40) 9 (9 I)
RR=2.15 (1.34, 3.45)  3 (3 I)
Cohort studies:
“low”: RR=1.30 (0.92, 1.84)
“high”: RR=1.56 (1.02, 2.40)
Case-control studies:
“low”: OR=1.46 (0.78, 2.73)
“high”: OR=1.18 (0.60, 2.34)
Cohort studies:
“low intensity”: RR=1.68 (1.14, 2.46)
“high intensity”: RR=1.27 (0.83, 1.96)
Case-control studies:
“low intensity”: RR=1.06 (0.79, 1.42)
“high intensity”: RR=1.42 (0.86, 2.33)
Steinmaus 2008 Benzene 228 (?)∆ sRR=1.22 (1.03, 1.46) 22 studies (6 cohort studies, 4 mortality and 2 incidence; 16 case-control studies)
Meta-analysis 133 sRR=1.49 (1.15, 1.92) 13 high exposure studies
23 sRR=2.12 (1.11, 4.02) 6 high exposure studies that did not use self-reported data
133 sRR=1.53 (1.19, 1.96) 13 high exposure studies adjusted for healthy worker effect





sRR=1.11 (0.94, 1.30) 24 studies (6 cohort, 16 case-control, 1 cancer registry study, 1 death certificate study)
Vlaanderen 2011 Benzene 647 Quantitative & qualitative exposure assessment: mRR=1.00 (0.89, 1.13) 33 cohort studiesα (6 incidence, 27 mortality)
Meta-analysis 106 Quantitative to some industrial hygiene sampling: mRR=1.03 (0.70, 1.51)   8 cohort studiesα (2 incidence, 6 mortality)
69 Quantitative or semi-quantitative estimates:           mRR=1.04 (0.63, 1.72)   7 cohort studiesα (1 incidence, 6 mortality)
50 Quantitative exposure assessment:      mRR=1.27 (0.90, 1.79)  6 cohort studies (1 incidence, 5 mortality)
Cohort Studies:
Anttila 1995Ѱ PCE (blood PCE Any exposure: TCE exposure:
Incidence levels) 3 SIR=3.76 (0.77, 11.0) Urine TCA (µmol/L) # cases
3,089 TCE workers <100: SIR=2.01 (0.65, 4.69) 5


































      
        
         


































    











              
 
  
        
  
                                    
        
        
         
  
                                   
      
       
            

















   
 
                              
 
    
 















    
 
















Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Raaschou-Nielsen TCE (job title, plant 96 Any exposure: High exposure group: ─
2003 £ air monitoring & 83 Men:      SIR=1.2 (1.0, 1.5) SIR=1.5 (1.2, 2.0)  65 
Incidence Urine TCA data) 13 Women: SIR=1.4 (0.7, 2.3) Duration of employment (years):
40,049 1–4.9: SIR=1.5 (1.1, 2.1)  35
1964-1997 TCE (20 year 31 Men:      SIR=1.3 (0.9, 1.9) ≥5:       SIR=1.6 (1.1, 2.2) 30





46 Any TCE exposure:
HR=1.36 (0.77, 2.39)
Cumulative exposure score (unit-yr)
Men  (HR)  #  Women (HR)
Men: HR    # cases
Low, intermittent:1.5 (0.7, 3.3) 25




9 Women: HR=1.18 (0.49, 2.85) 0-5:  1.8 (0.8, 4.2) 18    1.5 (0.5, 4.7) 4
5-25:1.2 (0.4, 3.2)  7 0
>25: 1.5 (0.6, 3.7) 12    1.3 (0.5, 3.8) 5
Peak, infrequent:  1.9 (0.7, 5.2) 7
Peak, frequent:     1.6 (0.7, 3.7)  16
Women HR # cases
Low, Intermittent:  1.4 (0.5, 4.0)  5
Low, Continuous:   1.0 (0.2, 4.7) 2
Peak, Infrequent: 3.5 (1.0, 12) 3
Peak, Frequent: 1.3 (0.5, 3.5)    6
PCE (JEM) 5 HR=2.32 (0.75, 7.15)  males
2 HR=2.35 (0.52, 10.7)  females
Lipworth 2011+ Aircraft Any exposure: Years exposed (RR, # exposed cases): ─
Mortality manufacturing TCE PCE
5,443 (TCE) TCE (JEM) 50 SMR=1.31 (0.97, 1.73) <1:  0.8 (0.5, 1.5) 18   1.3 (0.7, 2.5) 11
5,830 (PCE) PCE (JEM) 36 SMR=1.43 (1.00, 1.98) 1-4: 1.1 (0.6, 2.0) 14   1.0 (0.5, 2.0) 10
1960-2008 >4:  1.0 (0.6, 1.9) 15   1.0 (0.5, 2.0) 12
Hansen 2013 TCE (urine TCA) 32 Men: SIR= 1.55 (1.06, 2.20) Urine TCA (mg/L)







38 All: SIR=1.26 (0.89, 1.73) >25-50: RR=1.56 (0.63, 3.81) 8 cases
>50: RR=0.66 (0.21, 2.03) 4 cases
Bahr 2011 TCE 23 Exposure Level
Mortality (Qualitative JEM) 12 2: SRR=1.31 (0.47, 3.65)






















































    
  
 
    
  
 
    
  
   
 
              
              
 
              
              
 
              

















                       
                
                
                  
 
                               
    
        
 
                   
                    
                                                
  
   
                      
                      
                         
  
                                     
            
               
 
                         
            
            
 


















                                          
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Silver 2014 Microelectronics 98 Cumulative exposure, 5 exposure­ ─ ─
Mortality plant (JEM) years:
34,494 TCE HR=0.87 (0.57, 1.35)
1969-2009 PCE HR=1.25 (0.90, 1.73)
Case-Control Studies:
Miligi 2006® TCE Medium/high exposure intensity Exposure intensity: OR               # cases
Incidence PCE Duration of exposure (OR): TCE
1,135 cases: Benzene TCE Very low/low: 0.8 (0.5, 1.3) 35
NHL and chronic ≤15 years: 1.1 (0.6, 2.1) 22 cases Medium/high: 1.2 (0.7, 2.0) 35
lymphocytic >15 years: 1.0 (0.5, 2.6)   12 cases PCE
leukemia CLL) PCE
≤15 years: 1.3 (0.5, 3.3) 10 cases
Very low/low: 0.6 (0.3, 1.2) 18
Medium/high: 1.2 (0.6, 2.5) 14
1,246 controls >15 years: not estimated.   3 cases
Benzene
≤15 years: 1.2 (0.7, 2.0) 39 cases
>15 years: 2.9 (0.9, 9.0)   14 cases
Benzene
Very low/low: 0.6 (0.4, 0.9) 49
Medium/high: 1.6 (1.0, 2.4) 58
Seidler 2007¶ Cumulative exposure (percentiles): Cumulative exposure (percentiles)
Incidence B-cell NHL (N=550) # cases T-cell NHL (N=33) # cases all NHL cases (B-cell & T-cell)   # cases




>50-90%: OR=0.8 (0.5, 1.3) 27    OR=1.1(0.2, 5.1)  2
>90%:      OR=2.3 (1.0, 5.3) 17    OR=4.7 (0.8, 26) 2
>0-50%: OR=0.9 (0.4, 2.0) 12     (1 case in each exposure stratum)
>50-90%: OR=1.0 (0.5, 2.3) 12
>90%: OR=3.2 (0.6, 16.7)  5
>0-50%: OR=0.9 (0.6, 1.4) 41        OR=1.2 (0.3, 4.4) 3
>50-90%: OR=1.0 (0.6, 1.5) 39     OR=1.7 (0.5, 6.1) 3
>90%: OR=1.0 (0.4, 2.3) 11     ― (1 case)
>50-90%: OR=0.7 (0.5, 1.2) 32 
>90%:      OR=2.3 (2.1, 4.8) 21 
>0-50%:   OR=1.1 (0.5, 2.3) 16 
>50-90%: OR=1.0 (0.5, 2.2) 14
>90%:       OR=3.4 (0.7, 17) 6
>0-50%:   OR=0.9 (0.6, 1.3) 53 
>50-90%: OR=1.0 (0.7, 1.5) 47
>90%:      OR=0.8 (0.4, 1.9) 12
Christensen 2013 TCE 7 “any”exposure: OR=1.3 (0.5, 3.4) ─ ─
Incidence 3 “substantial”: OR= 0.9 (0.2, 3.4)
215 cases PCE 3 “any”exposure: OR=2.2 (0.5, 10)



































































    
 
    
       
       
       
          
  
                 
           
              
   
        
        
     










    
                                                           
       
       
        
 
   
   
  
   
   




















       
     
     
      
      
 
Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Cocco 2013 Probability of  TCE 335 Odds ratio (NHL, all types): High probability of exposure # cases High probability of exposure and
Incidence exposure 109 Low:  1.0 (0.8, 1.3) 1-14 yrs:   OR=0.7 (0.4, 1.5) 15 Intensity level (ppm) # cases




50 High: 1.4 (0.9, 2.1) 30-39 yrs: OR=2.8 (1.0, 7.8) 15
40+ yrs:    OR=3.3 (0.3, 33) 3
% work time exposed:
≤5%: OR=1.6 (0.8, 3.2) 22
6-30%:  OR=1.2 (0.6, 2.4) 20
>30%:   OR=1.3 (0.4, 3.7) 8
5-75: OR=1.3 (0.8, 2.2) 33
>75:  OR=2.2 (0.7, 6.7) 9
90 Diffuse large B-cell lymphoma:
28 Low:   0.8 (0.5, 1.2)
51 Med:   0.8 (0.6, 1.1)
11 High:  0.9 (0.5, 1.8)
59 Follicular lymphoma:
13 Low: 0.9 (0.5, 1.5)
37 Med: 1.3 (0.9, 1.8)
9 High:1.6 (0.7, 3.4)
70 Chronic lymphocytic leukemia:
23 Low:  1.1 (0.7, 1.8)
36 Med: 0.9 (0.6, 1.2)
11 High: 1.8 (0.9, 3.6)
Vlaanderen 2013 JEM Cumulative exposure tertiles, HR,  #exposed cases: >90th percentile cumulative exposure:
Incidence Exposure tertiles TCE # cases PCE # cases Benzene # cases TCE: HR=0.95 (0.84, 1.06) 353 cases
69,254 cases (unexposed as 1: 1.01 (0.95, 1.07) 1,213 1.06 (0.94, 1.19) 346     0.99 (0.93, 1.06) 1,259 PCE: HR=1.04 (0.84, 1.29) 102 cases
346,270 controls referent) 2: 0.93 (0.88, 1.00) 1,183 1.04 (0.93, 1.17) 337     1.01 (0.95, 1.07) 1,289 >90th percentile, intensity x freq exposed
1961-2005 3: 0.97 (0.91, 1.03) 1,211 0.95 (0.84, 1.08) 292     0.97 (0.91, 1.04) 1,212 TCE: HR=0.96 (0.84, 1.09) 269 cases
PCE: HR=1.23 (1.00, 1.52) 113 cases





Dry Cleaning 12 Any exposure
SMR=0.9 (0.5, 1.6)
Lynge 2006 Dry Cleaning Unexposed as referent: Duration of employment (RR)
Incidence 42 RR=0.95 (0.65, 1.41) 0-1 yr:   1.35 (0.44, 4.14) 5 cases
187 cases 2-4 yrs:  0.61 (0.17, 2.21)   3 cases
939 controls 5-9 yrs:  0.92 (0.49, 1.72) 14 cases
1970-2001 ≥10 yrs: 0.66 (0.36, 1.22) 15 cases




















   
























































     
  
     
 













     
      
     
 
            
      















Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Calvert 2011 Dry Cleaning 11 SMR=1.57 (0.78, 2.81) All







5 SMR=1.10 (0.36, 2.56) PCE plus
Selden 2011 Dry Cleaning: Any exposure Employment duration (years) (RRs)
Incidence PCE subcohort (plant 33 All: SIR=1.42 (0.98, 2.00) <1:  3.3 (1.6, 6.0) 10 cases
6,356 survey, work history) 15 Men: SIR=2.02 (1.13, 3.34) 1-4: 1.0 (0.4, 2.1)   7 cases





Dry Cleaning 97 OR=1.02 (0.75, 1.38)
‘t Mannetje 2015 Dry cleaning Not a dry cleaner is referent:
Incidence Ever employed 97 OR=0.92 (0.70, 1.20)
10,046 cases
12,025 controls >10 years
1988-2004 employment OR=1.29 (0.74, 2.23)
Benzene Workers Studies:
Wang 2008 Benzene (JEM) 120 OR=1.1 (0.9, 1.5) Avg. Exposure Intensity:
Incidence Low:           OR=1.0 (0.7, 1.4)   80 cases
601 cases Med-High: OR=1.5 (0.9, 2.4) 40 cases
717 controls Med-High intensity & exp. probability:
1996-2000 OR=1.4 (0.8, 2.4) 30 cases
Orsi 2010 Benzene (JEM) 94 OR=1.0 (0.7, 1.5) Definite exp. /Duration of exposure: Average Intensity/definite exposure:




6 “pure benzene”: OR=3.0 (0.8, 11) 5-15 yrs: OR=0.8 (0.4, 1.4) 17 cases
>15 yrs:  OR=1.3 (0.8, 2.3) 26 cases
Medium: OR=0.9 (0.6, 1.5) 40 cases
High: OR=2.6 (0.6, 11)   4 cases
Linet 2015 Benzene Any exposure:
Incidence 30 RR=3.9 (1.5, 13.2)
73,789 exposed 19 Male: RR=3.6 (1.2, 15)























                                                          
    
     











   
 
 
   
   
   
 
     








    
 
 
    
    





















     
  
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information









1.49 (0.90, 2.48) B-cell NHL
Duration exposed (yrs), B-cell NHL
# cases
>0–5.49:   RR=1.44 (0.77, 2.67) 22
5.5–12.9:  RR=1.52 (0.81, 2.84) 19
≥13:       RR=1.54 (0.82, 2.90) 20
Cum. exposure, tertiles, B-cell NHL
1st:   RR=1.44 (0.77, 2.69) 21 cases
2nd: RR=1.44 (0.76, 2.73) 19 cases
3rd: RR= 1.62 (0.87, 3.01) 21 cases
Bassig 2015 Benzene (JEM) 24 Any exposure: Exposure Duration (years) Cumulative Exposure (tertiles)
Incidence RR=1.87 (1.19, 2.96) 1-11:    RR=1.44 (0.63, 3.31)  6 cases 1st    RR=0.93 (0.29, 2.96) 3 cases
73,087 12-21:  RR=2.10 (1.01, 4.35)  8 cases 2nd  RR=2.22 (1.12, 4.44) 9 cases
1996-2009 >21:     RR=2.07 (1.07, 4.01) 10 cases 3rd    RR=2.16 (1.17, 3.98) 12 cases
Vinyl Chloride Workers Studies:
Carreón 2014 Vinyl chloride 11 Any exposure: Duration of employment (SRR) Vinyl chloride exposure duration (SRR)
Mortality SMR=2.38 (1.19, 4.26) 0.16-<1.1 yrs: 3.6 (0.6, 22) 4 cases >0-<6 yrs: 0.5 (0.1, 2.6) 4 cases
1,874 1.1-<15 yrs:    1.5 (0.2, 14) 2 cases ≥6 yrs:       0.4 (0.1, 2.2)  4 cases






































   
 
   
   
   
   
     
   
     





   
   
   
     
     
   
     
     
                                                                                                 
                                                                   
                                               
                                               
                                          
                                               
                                               
                                                        
                                               
                                               
                                                                      
                                               
                                               
                                                                   
                                               
                                               
                                          
                                               
                                               
                                                        
                                               
                                               
                                                                      
                                               










Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Drinking Water Studies:
Cohn 1994 M  F Males Females
Incidence TCE-contaminated 841 817 Total NHL:
75 towns in NJ municipal drinking 272 226 0.1-5 ppb: RR=1.28 (1.10, 1.48) RR=1.02 (0.87, 1.20)
1979-1987 water (sample data) 78 87 >5 ppb:     RR=1.20 (0.94, 1.52) RR=1.36 (1.08, 1.70)
841 cases, male 216 186 Intermediate Grade: NHL: diffuse large cell/reticulosarcoma:
817 cases, female 67 48 0.1-5 ppb: RR=1.25 (0.93, 1.69) RR=0.95 (0.68, 1.34)
26 24 >5 ppb:     RR=1.59 (1.04, 2.43) RR=1.66 (1.07, 2.59)
34 35 High Grade NHL (total):
12 9 0.1-5 ppb: RR=1.54 (0.74, 3.20) RR=1.04 (0.48, 2.30)
4 6 >5 ppb:     RR=1.72 (0.58, 5.08) RR=2.43 (0.97, 6.05)
24 27 High Grade NHL: non-Burkitt's:
9 6 0.1-5 ppb: RR=1.73 (0.73, 4.11) RR=0.92 (0.36, 2.37)
3 6 >5 ppb:     RR=1.92 (0.54, 6.81) RR=3.17 (1.23, 8.18)
PCE-contaminated 841 817 Total NHL:
municipal drinking 235 187 0.1-5 ppb: RR=1.25 (1.07, 1.46) RR=0.95 (0.81, 1.13)
water (sample data) 119 121 >5 ppb:     RR=1.10 (0.90, 1.35) RR=1.08 (0.89, 1.32)
216 186 Intermediate Grade: NHL: diffuse large cell/reticulosarcoma:
61 39 0.1-5 ppb: RR=1.23 (0.91, 1.67) RR=0.86 (0.60, 1.24)
26 31 >5 ppb:     RR=0.91 (0.60, 1.39) RR=1.21 (0.82, 1.80)
34 35 High Grade NHL (total):
9 5 0.1-5 ppb: RR=1.11 (0.51, 2.41) RR=0.71 (0.26, 1.89)
2 11 >5 ppb:     RR=0.41 (0.09, 1.76) RR=2.66 (1.27, 5.60)
24 27 High Grade NHL: non-Burkitt's:
7 3 0.1-5 ppb: RR=1.26 (0.51, 3.09) RR=0.53 (0.15, 1.82)





















































     
  
 
     
       
 
        
 
      
    
      
 












































RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information





























5 SMR=0.60 (0.19, 1.40)
HR=0.83 (0.26, 2.67)
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
** One included study did not report the number of exposed cases.  The rest of the included studies reported a total of 532 exposed cases.
∆ Two of the included studies did not report the number of exposed cases.  The rest of the included studies reported a total of 228 exposed 
cases.
α “Significant evidence for between study heterogeneity….” (quoted from Vlaanderen et al. 2011).
Ѱ Included in the Karami et al. 2013, EPA and Mandel et al. meta-analyses for TCE exposure.  Included in the table for PCE exposure
information.
£ Included in the Karami et al. 2013, EPA and Mandel et al. meta-analyses. Included in the table because of information on employment
duration and exposure lag time.
€ Included in the Karami et al. 2013 and EPA meta-analyses. Included in the table because of information on exposure intensity (men only;
there were small number of cases among women) and cumulative exposures. 
+ Included in the Karami et al. 2013 meta-analysis. Included in the table for PCE information and for exposure duration for both TCE and 
PCE.











    
 
                      
  
   
   
    
¶ Included in the Cocco 2013 study but provided additional information on PCE and benzene .
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR or mRR: summary risk ratio or meta-analysis risk ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)
Urine TCA: urine levels of trichloroacetic acid, a metabolite of TCE.




      
 
    





   
   
   










   
 
  
   
      
 
    
   
 
  





   
 
 
   
   
   
  
   
  
   
 
Summary of EPA, IARC and NTP reviews of TCE, PCE, or benzene and NHL:
EPA Toxicological Review of TCE (EPA 2011): “The human evidence of carcinogenicity from
epidemiologic studies of TCE exposure is strong for NHL but less convincing than for kidney cancer….”
“Associations observed in epidemiologic studies of lymphoma and TCE exposure suggest a causal relation 
between TCE exposure and NHL.”
IARC review of TCE (IARC 2014) concluded that there was a positive association between TCE and
NHL.  In particular, the cohort studies of biologically monitored workers in the Nordic countries “show
evidence of modestly increased risk for non-Hodgkin lymphoma” (p. 185). The meta-analyses were 
consistent in finding that TCE exposure increased the risk of NHL.  Higher risks were observed in the
cohort studies compared to the case-control studies.  This may be due to better exposure assessment in 
the cohort studies. 
NTP Monograph on TCE (NTP 2015): “Overall, there is some evidence of an association between
exposure to trichloroethylene and NHL based on findings of a modest increase in risk of NHL in several
studies with different study designs and in different populations, although the strength of the evidence 
varied.” (p. 132-33)”  
EPA Toxicological Review of PCE (EPA 2012): “The results from the collection of studies pertaining
to non-Hodgkin lymphoma indicate an elevated risk associated with tetrachloroethylene exposure. The
results from five cohort studies that used a relatively high quality exposure-assessment methodology
generally reported relative risks between 1.7 and 3.8 (Calvert et al. 2011; Seldén and Ahlborg, 2011;
Radican et al. 2008; Boice et al. 1999; Anttila et al. 1995) and support an association with 
tetrachloroethylene. The studies with tetrachloroethylene-specific exposure measures and exposure-
response analysis (based on intensity, duration, or cumulative exposure) (Seidler et al. 2007; Miligi et al.
2006; Boice et al. 1999) provide further support for an association, reporting higher non-Hodgkin 
lymphoma risks in the highest exposure category, with the strongest evidence from the large case-
control study in Germany, in which a relative risk of 3.4 (95% CI: 0.7, 17.3) was observed in the highest
cumulative exposure category (trend p-value = 0.12) (Seidler et al. 2007). Lynge et al. (2006)
distinguished dry cleaners from other workers but used an approach with greater potential for
misclassification because exposure was assigned only for jobs held in 1970. This study did not report an 
association between dry cleaners and non-Hodgkin lymphoma, nor did risk estimates increase with 
exposure duration. Effect estimates in studies with broader exposure assessments showed a more
variable pattern…. Confounding by lifestyle factors are unlikely explanations for the observed non-
Hodgkin lymphoma results because common behaviors, such as smoking and alcohol use, are not strong
risk factors for non-Hodgkin lymphoma…..”
IARC review of benzene (IARC 2012): In its review, IARC observed that a positive association existed
between exposure to benzene and non-Hodgkin lymphoma but concluded that there was limited
evidence in humans for a causal association of benzene with NHL.  However, IARC also concluded:
“…the biological plausibility of benzene as a cause of lymphoproliferative disorders has been 
strengthened in recent years. There are additional studies demonstrating that benzene produces
lymphomas in laboratory animals….” “Multiple studies show that it produces genotoxicity in the
lymphocytes of exposed humans. Accordingly, there is considerable support for the notion that it is





   
      
  





   




      
    
   
  
    
   
   
    
   
    
  












   
  
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA, NTP and IARC as well as the meta-analyses. High weight was also given to a study that was
considered of moderate or high utility by the NTP, evaluated NHL subgroupings, or provided 
mechanistic information.  Our assessment of the epidemiological evidence considered some of the
viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk
ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4) exposure-response
relationship (although the relationship could be non-linear or non-monotonic), and (5) biological
plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect estimate was
considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of
biases, in particular exposure misclassification, healthy worker effect, and confounding.
TCE
NTP (NTP 2015) found that TCE exposure increased the risks for NHL among all of the three studies
they considered of high or moderate utility for evaluation of NHL (Cocco et al. 2013, Hansen et al.
2013, Radican et al. 2008). NTP considered the pooled InterLymph analysis study by Cocco et al. 2013 
to be the most informative study because it evaluated NHL subtypes and conducted a good exposure
assessment. ATSDR agrees with NTP that this study is highly informative because of its evaluation of
NHL subtypes. This study found an increased risk of NHL (all types) among workers with high 
probability of exposure to TCE (OR=1.4, 95% CI: 0.9, 2.1) as well as increased risk for the NHL
subtypes, follicular lymphoma (OR=1.6, 95% CI: 0.7, 3.4) and chronic lymphocytic leukemia (OR=1.8, 
95% CI: 0.9, 3.6).  ATSDR concurs with EPA that the occupational epidemiological studies provide
strong evidence of causation for TCE and NHL. The meta-analyses by EPA (Scott and Jinot 2011) and 
Karami et al. 2013 summarize the findings from these studies and strengthen the evidence that TCE 
causes NHL. The strongest findings in these meta-analyses were contributed by the cohort studies.  
Karami et al. 2013 reported no between-study heterogeneity and no evidence of publication bias for the
cohort studies included in the meta-analysis.  The EPA meta-analysis reported low between-study 
heterogeneity in the analysis of higher TCE exposure.
Animal and mechanistic information for TCE: “Severe immune dysregulation, whether from
immunosuppression, inflammation, or autoimmune disease, is associated with an increased risk of NHL. 
Thus, it is biologically plausible that the mode of action of trichloroethylene-induced NHL could 
involve altered immunity. … Although few applicable studies were conducted in humans, the available
data provide evidence that trichloroethylene can alter the immune system based on some studies finding
an association between markers of immune modulation and other studies showing an association with 
autoimmune disease (e.g., systemic sclerosis). … However, the available data are insufficient to
demonstrate that immunomodulation is operant as a mode of action for trichloroethylene-induced NHL.” 
(NTP 2015, p. 148).  Evidence from animal studies indicates that TCE exposure causes
immunomodulation including autoimmune disease and immunosuppression. Both autoimmune disease
and immunosuppression are associated with NHL. Studies conducted of Chinese factory workers
exposed to TCE have observed alterations in immune function markers that have been associated with 
an increased risk of NHL, indicating that the associations observed between TCE and NHL are
biologically plausible (Bassig et al. 2013).  In a recent study of the cohort of Chinese factory workers, 




     
 
  
      
      
      
     
  
  
    
     
     
 




     
     
     
    
 
  
        
    
   
  
     
     
 
 
   
  
    
 
  
   
 
    
were observed for CD4+ T cells, CD8+ T cells B cells and NK cells (Bassig et al. 2016).  The study
concluded that these results provided evidence that TCE exposure can lead to immunosuppresssion, 
which is associated with an increased risk of NHL. 
Exposure-Response: An increased risk with longer duration of exposure was observed in the Mandel et
al. 2006 meta-analysis and for cohort studies in the Karami et al. 2013 meta-analysis. An increased risk
with longer exposure duration was also found in the Raaschou-Nielsen et al. 2003 and Cocco et al. 2013 
studies. An increased risk with higher TCE cumulative exposure was found in the Scott and Jinot 2011 
meta-analysis and the Cocco et al. 2013 study. Increased risk with higher exposure intensity was found 
in the Karami et al. 2013 meta-analysis for case-control studies but not cohort studies.  Two of the meta-
analyses of TCE suggest that “low intensity” exposures can also result in an elevated risk of NHL
(Mandel et al. 2006, Karami et al. 2013).
Conclusion: Based on the meta-analyses, the study of NHL subtypes (Cocco et al. 2013), and the
mechanistic evidence that TCE causes immunosuppression which is a risk factor for NHL, ATSDR
concludes that there is sufficient evidence for causation for TCE and NHL.
PCE
No meta-analyses have been conducted for PCE and NHL. The findings for PCE and NHL are mixed.
Among the dry cleaning worker studies, Calvert et al. 2011 and Selden et al. 2011 found elevated risks
for NHL, although virtually all the elevated risk in the latter study occurred among male workers. The 
study by ‘t Mannetje et al. 2015 observed no elevated risk for ever exposed but obtained an OR of 1.29 
(95% CI: 0.74, 2.23) for those with greater than 10 years of employment as a dry cleaning worker. The 
other dry cleaning worker studies (Blair et al. 2003; Morton et al. 2014) either found no elevation in risk
or a risk near the null; and one study found no elevation in risk except among those with ≤1 year of
employment and with unknown duration of employment (Lynge et al. 2006).  Four cohort studies
(Antilla et al. 1995, Radican et al. 2008, Lipworth et al. 2011, Silver et al. 2014) and two case-control
studies (Seidler et al. 2007, Christensen et al. 2013) of PCE exposed workers also found elevated risks
for NHL. In the Seidler et al. 2007 case-control study, only PCE exposed workers in the 90th percentile 
of cumulative exposure had elevated risks for NHL and the B-cell NHL subtype. The NJ drinking water
study (Cohn et al. 1994) found elevated risks for NHL and specific NHL grades, but only among
women.  Risks were not elevated in the Camp Lejeune mortality studies (Bove et al. 2014a, b). 
In its toxicological review of PCE, EPA concluded that the findings from the cohort studies of PCE
workers and two of the cohort studies of dry cleaning workers provided support for an association 
between PCE and NHL (EPA 2012). On the other hand, the IARC review of PCE stressed the lack of
consistent findings across studies and the small numbers of exposed cases in many of the studies (IARC
2014). The lack of consistent findings could be due to non-differential exposure misclassification bias.
The small number of exposed cases in some of the cohort studies that evaluated NHL mortality would 
be expected since NHL is highly survivable with a 5-year survival percentage of about 70%.  ATSDR
agrees with EPA’s conclusion that the findings from the positive cohort and case-control studies are
unlikely to be affected by confounding due to lifestyle factors, since these factors are not strong risk 
factors for NHL and are unlikely to be associated with PCE exposure status.  ATSDR concludes that the
epidemiological evidence for PCE and NHL, although weak, is sufficient to classify the causal








    
  
        
 
    
  
      
 
 




    
   
   
  
  
    
  
    
     
        
      
    
   
   
    
   
   
  
   
   
   
    
Conclusion: Based on the epidemiological evidence, ATSDR concludes that there is equipoise and
above evidence for causation for PCE and NHL.
Benzene
Three meta-analyses of benzene and NHL have been conducted.  The Steinmaus et al. 2008 meta-
analysis found an elevated summary risk ratio when 16 case-control and 6 cohort studies were evaluated.  
The summary risk ratio (sRR) increased from 1.22 (95% CI: 1.03, 1.46) to 2.12 (95% CI: 1.11, 4.02)
when the analyses were restricted to studies that did not use self-reported exposure information.  The
meta-analysis attempted to address the healthy worker bias effect that can arise when SMRs are 
calculated.  The approach involves replacing the SMR with the mortality odds ratio which is computed 
by comparing NHL (“cases”) to all other causes of death (“controls”) on their benzene exposures and
assuming that the healthy worker effect bias will be similar across cases and controls.  This approach 
resulted in a slight increase in the sRR for the 6 studies that did not use self-reported exposure
information, from an sRR of 2.12 (95% CI: 1.11, 4.02) to an sRR of 2.26 (95% CI: 1.29, 3.97).  
Two meta-analyses were published after the IARC workgroup met in 2009 (IARC 2012). The Kane 
2010 meta-analysis included two studies (cancer registry, death certificates) that should be considered
surveillance efforts that based their exposure assessments on the occupation listed on the cancer
registration or death certificate. The summary RR was 1.11 (95% CI: 0.94, 1.30) based on a total of 24 
studies. The Vlaanderen et al. 2011 meta-analysis found an elevated sRR only when the analysis was
restricted to the 6 cohort studies with quantitative exposure assessment (sRR=1.27, 95% CI: 0.90, 1.79).
Restricting the analyses to these 6 cohort studies removed the between-study heterogeneity that was
present when the analyses were not restricted to studies with quantitative exposure assessments.
The Vlaanderen et al 2011 meta-analysis was mostly based on mortality studies.  This was a limitation
since NHL is highly survivable with a 5-year survival percentage of about 70%.  The three large cohort
studies published after the Vlaanderen et al. 2011 meta-analysis evaluated NHL incidence.  These three 
cohort studies observed higher risks for benzene exposures and NHL than those observed in the
Vlaanderen et al. 2011 meta-analysis (Linet et al. 2015, Stenehjem et al. 2015, Bassig et al. 2015).  The
Stenehjem et al. 2015 study assessed exposures using a semi-quantitative JEM and observed monotonic
exposure-response trends for B-cell NHL and exposure duration and cumulative exposure. The Bassig
et al. 2015 study observed non-monotonic exposure-response trends. The Bassig study’s exposure
assessment was particularly comprehensive, using an industry JEM and an occupation JEM calibrated
with short-term area air benzene exposure measurements conducted in the Shanghai factories.
Animal and mechanistic information for Benzene: “…, there are at least two probable mechanisms by
which exposure to benzene could enhance the incidence of lymphoma, i.e. by inducing chromosome
rearrangements associated with NHL, and through immunosuppression leading to decreased
immunosurveillance. Benzene is well known to produce multiple cytogenetic abnormalities in
lymphocytes…. Further, benzene induces specific chromosomal changes associated with NHL in human 
lymphocytes….” (IARC 2012). Benzene has also produced lymphomas in animal studies (IARC 2012).




   
   
    
  
   
   
alterations in lymphoid cell types and B-cell activation markers indicative of immunosuppresssion that
could result in an increased risk of NHL (Bassig et al. 2016). 
Conclusion: Although IARC concluded that the human evidence for causation for benzene and NHL
was “limited”, three recent large cohort studies have found positive associations.  Based on the recent
epidemiological evidence and the supporting evidence from mechanistic and animal studies, ATSDR















    
 




      
  




   
 






   
     
         
     











                      
     
































   
  
   

















               
         
         
          
                
        
        
        
              
                                     
                   
       
      
      
                                       
       
      
       
    

 Multiple Myeloma
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information




TCE 62 sRR = 1.05 (0.80, 1.38)




TCE 148 sRR = 1.07 (0.86, 1.34) 8 cohort studies (4 incidence (I), 4 mortality (M)) & 












Quantitative & qualitative exposure assessment: mRR=1.12 (0.98, 1.27) 26 cohort studies
Quantitative to some industrial hygiene sampling: mRR=1.15 (0.74, 1.79)   9 cohort studies







TCE (urine TCA) Urine TCA (µmol/L) # cases
<100: SIR=1.48 (0.18, 5.35)  2





25 Any TCE exposure:
HR=1.35 (0.62, 2.93)
TCE cumulative exposure (unit-yrs):
Men (HR)     # cases
TCE exposure intensity
Men HR  # cases
14,455 19 HR=1.08 (0.43, 2.71), men >0-5:   0.7 (0.2, 2.3) 5 Low, intermittent: 1.0 (0.4, 2.7) 13 
1953-2000 6 HR=2.37 (0.67, 8.44), women >5-25: 1.6 (0.5, 4.7) 7 
>25:    1.2 (0.4, 3.5) 7 
Women (HR) # cases
>0-5:   2.2 (0.4, 12) 2 
>5-25: 2.8 (0.3, 25) 1
>25:    2.4 (0.5, 11) 3
Low, continuous:  1.2 (0.4, 3.4) 10
Peak, infrequent:   1.8 (0.5, 5.8)  5
Peak, frequent:      1.3 (0.5, 3.6) 10
Women HR # cases
Low, Intermittent:  4.3 (1.1, 16)  5
Low, Continuous:   1.7 (0.2, 15)  1
Peak, Infrequent:     3.2 (0.4, 29)  1
Peak, Frequent:        1.9 (0.4, 8.7)  3
PCE (JEM) 3 HR=1.7 (0.4, 6.9) men















































         
          
    
     
  






























                        
                    
                   
 




















   
 
  
       
      
 
       
       
      
 
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information












TCE (JEM) 23 SMR=1.21 (0.76, 1.81) <1:    0.70 (0.31, 1.58)   8 cases
1-4:   1.45 (0.68, 3.09) 10 cases
>4:    0.67 (0.25, 1.83)   5 cases
PCE (JEM) 14 SMR=1.07 (0.58, 1.79) PCE
<1:    0.87 (0.30, 2.51) 4 cases
1-4:   1.14 (0.46, 2.82) 6 cases
>4:    0.34 (0.08, 1.49)   2 cases
Hansen 2013 TCE (urine TCA was 4 Men: SIR= 0.47 (0.13, 1.20) ─ ─







8 All: SIR=0.65 (0.28, 1.27)
Silver 2014 Microelectronics 36 5 exposure-years, cumulative 
Mortality plant exposure: ─ ─
34,494 TCE (JEM) HR=1.18 (0.70, 1.99)
1969-2009 PCE (JEM) HR=0.04 (0.00, 59.7)
Buhagen 2016 Train maintenance 8 SIR=0.8 (0.4, 1.7)
Incidence TCE
997 males (union employment
1960-2010 list)
Case-control Studies
Seidler 2007¶ TCE 10 Cumulative exposure (ppm*yrs)
Incidence Benzene 13 TCE
75 cases >0-≤8.6:     OR=0.5 (0.2, 1.9)   3 cases
710 controls >8.6-≤130: OR=1.0 (0.4, 2.7) 6 cases
>130:       OR=0.7 (0.1, 5.5)   1 cases
Benzene
>0-≤8.6: OR=1.0 (0.4, 2.4)   6 cases
>8.6-≤130: OR=0.7 (0.2, 2.0) 4 cases
























                  
    
  
 
        
    
   
 
                                       
  
          
               
 
 
   
































    
 
   
   




    
   
   
    
 
  
    
  
   
  
 
   
   
   
    
  
 










                                                         
    
    
    
 
  
      
 
  
   
      

















    
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Costantini 2008 TCE 14 Medium/High intensity Exposure Intensity (ORs)
Incidence Exposure duration (yrs.)  (OR): TCE
263 cases Benzene 22 TCE Very low/Low: 1.5 (0.7, 3.5) 9 cases
1,100 controls ≤15: 0.5 (0.1, 2.3) 2 cases Medium/High:  0.9 (0.3, 2.4) 5 cases
1991-1993 >15: 1.3 (0.3, 5.9) 3 cases
Benzene              
≤15: 0.8 (0.3, 2.2) 9 cases
>15: 4.1 (0.8, 20) 5 cases
Benzene
Very low/Low: 0.6 (0.3, 1.5)  8 cases
Medium/High:  1.9 (0.9, 3.9) 14 cases
Gold 2011£ TCE (JEM) 66 All: OR=1.4 (0.9, 2.1) Likely exposed, exposure duration Likely exposed, cum. exp. quartile, 10yr
Incidence 43 Likely exposed: OR= 1.7 (1.0, 2.7) 1-4 yrs:   OR=0.9 (0.3, 2.4)   6 cases exposure lag
180 cases 5-7 yrs:   OR=1.3 (0.5, 3.6)   6 cases 1: OR=1.1 (0.4, 2.9)  6 cases
481 controls 8-24 yrs: OR=2.5 (1.2, 5.1) 20 cases 2: OR=1.6 (0.7, 3.5) 11 cases
2000-2002 >24 yrs:  OR=1.9 (0.8, 4.5) 11 cases 3: OR=1.4 (0.5, 3.8)  6 cases
4: OR=2.3 (1.1, 5.0) 18 cases
PCE (JEM) 29 All: OR=1.4 (0.9, 2.4) 1-4 yrs:   OR=0.9 (0.2, 3.5)   3 cases 1: OR=0.4 (0.0, 3.2)  1 case
16 Likely exposed: OR=1.5 (0.8, 2.9) 5-7 yrs:   OR=2.0 (0.4, 9.2)   3 cases
8-24 yrs: OR=1.3 (0.3, 4.6)   4 cases
>24 yrs:  OR=2.1 (0.7, 6.8) 6 cases
2: OR=0.5 (0.1, 4.7)  1 case
3: OR=1.7 (0.5, 6.5)  4 cases
4: OR=4.1 (1.4, 12) 10 cases
Vlaanderen 2013# JEM Cumulative exposure tertiles, HR, # cases: >90th percentile cumulative exposure:
Incidence Exposure tertiles TCE # cases PCE # cases Benzene # cases TCE: HR=1.01 (0.84, 1.22) 132 cases
35,534 cases (unexposed as 1: 0.93 (0.84, 1.03) 468     0.99 (0.83, 1.18) 149     1.01 (0.92, 1.11) 584 PCE: HR=1.15 (0.88, 1.51) 64 cases
177,670 controls referent) 2: 0.92 (0.84, 1.01) 574     0.93 (0.78, 1.12) 140     1.00 (0.92, 1.09) 663
1961-2005 3: 0.96 (0.88, 1.06) 541     0.98 (0.82, 1.17) 148     0.93 (0.85, 1.02) 577 >90th percentile, intensity x freq exposed
TCE: HR=1.03 (0.88, 1.22) 174 cases
PCE: HR=1.18 (0.87, 1.59) 53 cases





Dry cleaning 7 Any exposure:
SMR=0.8 (0.3, 1.6)
Selden 2011 Dry Cleaning & 11 SIR=0.79 (0.39, 1.41)
Incidence Laundry Workers

















































                           
 
 
    
 
      
        































































RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Benzene Workers Studies





(JEM) 19 Benzene >1ppm: OR=0.9 (0.5, 1.9)
Cocco 2010 Benzene 16 Ever/never exposed: ─ Low:         OR=0.7   4 cases
Incidence (questionnaires, OR=0.9 (0.5, 1.6) Medium:   OR=0.4     2 cases
176 cases workplace High:         OR=1.4   10 cases
1,589 controls inspections) (Confidence intervals were not provided.)
1998-2004
Stenehjem 2015 Benzene (offshore oil 13 Ever/never exposed: Years exposed   # cases Cumulative exposure (tertiles)
Incidence industry workers) RR = 1.64 (0.55, 4.89) >0–5.49: RR = 1.31 (0.32, 5.35)  4 1st:   RR=0.99 (0.22, 4.52)   3 cases
24,917 (JEM) 5.5–<13: RR = 2.05 (0.58, 7.24)  5 2nd:  RR=1.14 (0.26, 5.10) 3 cases
1999-2011 ≥ 13:     RR = 1.65 (0.42, 6.51)  4 3rd:   RR=3.25 (1.00, 10)    7 cases
Drinking Water Studies






17 Duration of exposure # cases
1–3 months:   OR=2.8 (0.7, 12)  3
4–12 months: OR=2.5 (0.7, 7.9)  5
Modeled TCE cumulative exposure 
(unexposed as referent):
Very low:     HR=1.3 (0.5, 3.6)






vs. Camp Pendleton HR = 1.68 (0.76, 3.72)






6 ─ Modeled TCE cumulative exposure:
(<median as referent):
≥median: HR=0.6 (0.1, 3.2)










   
 
      
 
  
     
 








   
 
                      
  
  
   
   
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of
work/job histories obtained from interviews or plant records unless otherwise noted.
€ Included in the Karami et al. 2013 meta-analysis. Included in the table because of information on TCE exposure intensity and cumulative
exposures, and information on PCE exposure.
¶ Not included in the meta-analyses of TCE or benzene.
£ Included in the Karami et al. 2013 meta-analysis. Included in the table because of information on exposure duration and cumulative
exposure.
# The Vlaanderen 2013 study did not provide findings for >90th percentile cumulative benzene exposure or >90th percentile intensity x
frequency exposure to benzene.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
mRR: meta-analysis risk ratio
sRR: summary risk ratio from the meta-analysis
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)
Urine TCA: urine levels of trichloroacetic acid, a metabolite of TCE.




    
  
 




   
      





   





   
      







    
   
   
     
       
   
 
  
    
   
Summary of EPA’s review of PCE and multiple myeloma
EPA Toxicological Review of PCE (EPA 2012): “For non-Hodgkin lymphoma and multiple myeloma,
the presence of higher relative risk estimates in studies with better exposure-assessment methodologies
and evidence of an exposure-response trend in one or more studies provide the basis for considering the
collection of studies as supportive of a role of tetrachloroethylene as a likely carcinogen.”
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA and IARC as well as the meta-analyses. High weight was also given to a study that provided 
mechanistic information.  Our assessment of the epidemiological evidence considered some of the
viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk
ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4) exposure-response
relationship (although the relationship could be non-linear or non-monotonic), and (5) biological
plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect estimate was
considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of
biases, in particular exposure misclassification, healthy worker effect, and confounding. 
TCE
The meta-analyses indicate that TCE exposures are associated with risks near the null. However,
elevated risks for multiple myeloma incidence were observed for TCE in a large case-control study that
evaluated cumulative exposure and duration of exposure (Gold et al. 2011). Odds ratios of 1.7 (95% CI:
1.0, 2.7) and 2.3 (95% CI: 1.1, 5.0) were observed for those likely exposed to TCE and those with TCE
cumulative exposure in the top quartile, respectively (Gold et al. 2011).  Odds ratios of 2.5 (95% CI: 1.2, 
5.1) and 1.9 (95%CI: 0.8, 4.5) were observed for those likely exposed to TCE for 8 – 24 years and for
>24 years, respectively (Gold et al 2011).  To minimize exposure misclassification bias in this study, 
occupation-specific and industry-specific JEMs based on extensive information on chlorinated solvent
use in industry were applied to each individual’s detailed work histories (Gold et al. 2011).
In one cohort study, elevated mortality risks for multiple myeloma were observed mostly for female 
workers although the number of exposed cases was small (Radican et al. 2008). Other cohort studies
observed relative risks of about 1.20 (Lipworth et al. 2011, Silver et al. 2014) or a much higher risk 
based on very few exposed cases (Anttila et al. 1995).  Three cohort studies found no elevation in risk 
(Hansen et al. 2013, Buhagen et al. 2016 and Seidler et al. 2007) but were based on small number of
exposed cases.  One large case-control study observed no elevation in risk (Vlaanderen et al. 2013).  
However, the authors of this study acknowledged that the exposure assessment likely resulted in 
considerable exposure misclassification bias due to reliance on census data to ascertain work history






   
 
   
   
        
   
 









    
   
     
     
 
     
 
   
   
  









      
  
  
The Camp Lejeune mortality studies found elevated risks for multiple myeloma mortality, which is
noteworthy given that multiple myeloma is a disease of older populations (median age=69 for diagnosis, 
and 75% are diagnosed after age 55) and the Camp Lejeune cohorts were relatively young at the end of
the studies: Marines/Navy personnel, median age=49, years, <3% aged 55 or older; and civilian 
workers, median age=58, over 70% under the age of 65 (Bove et al. 2014a, 2014b). For Marines and
Navy personnel at Camp Lejeune, the exposure-response analyses were limited by small numbers of
exposed cases but elevated risks were observed with increasing cumulative exposure and for exposure
durations of 1-3 and 4-12 months but not for a duration of more than a year (Bove et al. 2014a).
Animal and mechanistic Information: Evidence from animal data indicates that TCE causes
autoimmune disorders (Chiu et al. 2013). In humans, TCE has been associated with systemic sclerosis
(see section on systemic sclerosis later in this report). In a recent meta-analysis (McShane et al. 2014), 
any autoimmune condition was associated with subsequent risk of multiple myeloma (pooled RR=1.13, 
95% CI: 1.04, 1.22). Systemic sclerosis had a pooled RR of 1.28 (0.66, 2.48) for multiple myeloma
based on 3 studies. A much stronger association was observed between systemic sclerosis and 
subsequent risk of Monoclonal Gammopathy of Undetermined Significance (MGUS), a precursor to 
multiple myeloma, with a pooled RR of 4.87 (2.49, 9.54) based on two studies.  In one of these two
studies, based on patients identified in the U.S. Veterans Affairs (VA) Patient Treatment File (inpatient 
discharge data from VA hospitals) from 1969 to 1996, the RRs for systemic sclerosis and multiple
myeloma and MGUS were 2.41 (1.08, 5.36) and 4.21 (1.89, 9.38), respectively (Brown et al. 2008). In 
general, systemic sclerosis is associated with hematopoietic cancers including NHL and leukemia 
(Onishi et al. 2013; Zhang et al. 2013). One hypothesis is that chronic stimulation of the immune system
may lead to multiple myeloma. Another hypothesis is that the dysfunctional immune system found in
autoimmune diseases may allow malignant clones to exist, escape and persist (McShane et al. 2014).
Premature aging of the immune system associated with autoimmune diseases could reduce the ability to
distinguish “self” and “foreign” antigens.
Conclusion: ATSDR concludes that the epidemiological evidence for TCE and multiple myeloma is
insufficient by itself to reach equipoise.  However, there is mechanistic information that provides
support for a causal association. Evidence from animal studies indicates that TCE exposure causes
immunomodulation including autoimmune disease. In human studies, TCE has been associated with the
autoimmune disease, systemic sclerosis.  Autoimmune disorders, including systemic sclerosis are
associated with multiple myeloma. Combining the epidemiological and mechanistic evidence, ATSDR
concludes that there is equipoise and above evidence for causation for TCE and multiple myeloma. 
PCE
No meta-analyses have been conducted that evaluated PCE exposure and multiple myeloma. In one
large case-control study, an elevated risk for multiple myeloma was observed among those most likely
exposed to PCE (OR=1.5, 95% CI: 0.8, 2.9).  Although no elevation in risk was observed in the first two 





   
      
   
 
   





   
  




   








    
  
 
had ORs of 1.7 (95% CI: 0.5, 6.5) and 4.1 (95% CI: 1.4, 12.0), respectively (Gold et al. 2011).  Elevated 
ORs were also observed among those with exposure durations ≥5 years although the trend was not
monotonic. A cohort mortality study observed elevated risks among men and women but it was based on 
≤3 exposed cases (Radican et al. 2008). Another mortality cohort study observed an SMR near the null, 
with an elevated risk for those with 1-4 years of exposure but no elevation in risk among those exposed 
for more than four years (Lipworth et al. 2011).  A third mortality cohort study did not observe an 
elevated risk (Silver et al. 2014). Two cohort studies of dry cleaning workers, one evaluating mortality
(Blair et al. 2003) and the other evaluating incidence (Selden et al. 2011) observed no elevation in risk. 
ATSDR concludes that the epidemiological evidence is mixed and inadequate to determine whether a 
causal association exists for PCE and multiple myeloma. There is also a lack of animal or mechanistic 
information.
Conclusion: ATSDR concludes that there is insufficient information to determine whether a causal
association exists for PCE and multiple myeloma.  Therefore ATSDR concludes that there is below
equipoise evidence for causation for PCE and multiple myeloma.
Benzene
The IARC (IARC 2012, Monograph 100F) concluded that a positive association was observed for 
benzene exposure and multiple myeloma. The Infante et al. 2006 meta-analysis supports this conclusion. 
The IARC review was completed before the Vlaanderen et al. 2011 meta-analysis and the recent study
of Norwegian offshore oil industry workers (Stenehjem et al. 2015) which provided additional evidence
for an association between benzene exposure and multiple myeloma.  The latter study found an 
exposure-response trend for cumulative exposure although based on a small number of exposed cases
(Stenehjem et al. 2015).  There was also a non-monotonic trend for exposure duration in this study. The 
meta-analysis by Vlaanderen et al 2011 observed a summary risk ratio of 1.12 (95% CI: 0.98, 1.27)
based on 26 cohort studies, however the summary risk ratio increased to 1.48 (95% CI: 0.96, 2.27) when 
the analysis was restricted to cohort studies with quantitative exposure assessments.
Conclusion: ATSDR concludes that there is equipoise and above evidence for causation for benzene 
and multiple myeloma based on the results of the meta-analyses and the recent study of Norwegian 












       
 
 
      
  






   





   
          
        




       
        
          
 
       
         
          
 
       
        














   
 
 
   
   
   
 
       
   
      
                             
 
       
       
      
                           
 
       
        
       




Reference, type of Exposure** # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information




Vinyl chloride 53 Summary SMR=0.91 (0.69, 1.21) 2 multi-center cohort mortality studies
Alexander 2006
Meta-analysis
TCE 131 (?)*** sRR = 1.11 (0.93, 1.32) 7 studies






sRR = 1.10 (0.94, 1.28)
9 cohort studies (3 incidence, 6 mortality); 1 case-control study (mortality)
CLL/SLL: summary RR=1.19 (0.73, 1.96) 5 studies (2 cohort mortality studies; 3 case-control incidence studies)
Khalade 2010 Benzene Not Leukemia: sRR = 1.40 (1.23, 1.57) 15 studies (12 cohort, 3 case-control) Cumulative exposure (sRR)       # cases
Meta-analysis reported AML:     sRR = 1.38 (1.15, 1.64) 8 studies
CML:     sRR = 1.05 (0.83, 1.34) 6 studies
CLL:      sRR = 1.31 (1.09, 1.57) 10 studies
Leukemia
<40 ppm-yrs:    1.64 (1.13, 2.39) 66
40-99 ppm-yrs: 1.90 (1.26, 2.89) 44
≥100 ppm-yrs: 2.62 (1.57, 4.39) 33
AML
<40 ppm-yrs:    1.94 (0.95, 3.95) 18
40-99 ppm-yrs: 2.32 (0.91, 5.94) 8
≥100 ppm-yrs: 3.20 (1.09, 9.45) 12
CLL
<40 ppm-yrs:    1.83 (0.75, 4.48) 13
40-99 ppm-yrs: 1.67 (0.86, 3.24) 15
≥100 ppm-yrs: 3.50 (0.90, 13.2) 9
Vlaanderen 2011 Benzene 217 AML
Meta-analysis 217 Quantitative & qualitative exposure assessment: mRR=1.68 (1.35, 2.10)  21 studies
108 Quantitative to some industrial hygiene sampling: mRR=1.73 (1.26, 2.38)  10 studies
95 Quantitative or semi-quantitative estimates:           mRR=1.82 (1.25, 2.66) 9 studies
71 Quantitative exposure assessment: mRR=2.32 (1.55, 3.47)   6 studies (2 incidence, 4 mortality)
47 ALL
47 Quantitative & qualitative exposure assessment: mRR=1.44 (1.03, 2.02)  17 studies
11 Quantitative to some industrial hygiene sampling: mRR=1.26 (0.50, 3.16) 4 studies
11 Quantitative or semi-quantitative estimates:           mRR=1.26 (0.50, 3.16) 4 studies
5 Quantitative exposure assessment:      mRR=2.80 (0.27, 29.2) 1 incidence study
111 CLL
111 Quantitative & qualitative exposure assessment: mRR=1.14 (0.78, 1.67)   18 studies
61 Quantitative to some industrial hygiene sampling: mRR=1.38 (0.71, 2.69) 8 studies
53 Quantitative or semi-quantitative estimates:           mRR=1.54 (0.72, 3.31) 7 studies













    
   
   
   
   
 
       
       
       









                   
     









   
                      
            
          
                    
            
         
                       
            
                                 
                     
       
      



























   
 
  
   













                                                                                      
                               
                               
 
                           
                                                 
 
Reference, type of Exposure** # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Vlaanderen 2012 Benzene 76 CML
Meta-analysis 76 Quantitative & qualitative exposure assessment: mRR=1.23 (0.93, 1.63)   17 studies
29 Quantitative to some industrial hygiene sampling: mRR=1.44 (0.82, 2.53) 6 studies
29 Quantitative or semi-quantitative estimates:           mRR=1.44 (0.82, 2.53) 6 studies






TCE (urine TCA) Urine TCA (µmol/L) # cases
<100: SIR=0.39 (0.01, 2.19)  1









Men (HR) # cases
>0-5:   0.9 (0.4, 2.0) 11
>5-25: 0.5 (0.2, 1.6) 4
>25: 0.9 (0.4, 2.1) 9
Women (HR)    # cases
>0-5:  0.4 (0.1, 2.7) 1
>5-25: ―  0
>25: 0.5 (0.1, 2.2)  2
Men  HR  # cases
Low, intermittent: 1.0 (0.4, 2.7) 13
Low, continuous:  1.2 (0.4, 3.4) 10
Peak, infrequent:   1.8 (0.5, 5.8)  5
Peak, frequent:      1.3 (0.5, 3.6) 10
Bahr 2011€ TCE 20 Exposure Level
Mortality (Qualitative JEM) 5 2: SRR=0.73 (0.15, 3.45)
5,016 white males 15 3: SRR=1.89 (0.61, 5.86)
1953-2003
Hansen 2013 TCE (Urine TCA 23 SIR=1.06 (0.67, 1.60) ─ ─















Myeloid leukemia (179 cases)      (RR)       Lymphoid leukemia (225 cases)
# cases   # cases
Low:  1.02 (0.74, 1.39) 70 0.91 (0.68, 1.20)  85
High: 0.60 (0.24, 1.51)  5 0.76 (0.37, 1.59)  8
Low:  1.15 (0.78, 1.70) 39     1.06 (0.75, 1.50)  51


























                      
 



















   
   
   
      
 
   
         









                                                                       
                                                                                    
 
                             
                       
 
                                                 
                                                 
 
                      




























     
    
  
Reference, type of Exposure** # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information

















Seidler 2007¶ Cumulative exposure (ppm*yr) # cases
Incidence TCE 18 >0-≤8.6:     OR=1.1 (0.5, 2.4)      10
104 cases of CLL >8.6-≤130: OR=0.7 (0.3, 1.7)  6
710 controls >130:       OR=0.9 (0.2, 4.5)  2 
Benzene 24 >0-≤8.6:     OR=0.8 (0.4, 1.8)  8
>8.6-≤130: OR=1.6 (0.8, 3.2) 14 







Exposure intensity (OR)    # cases      Years of Exposure (OR) # cases
Leukemias   AML       CLL      CLL
TCE
1,278 controls Very low/Low: 1.0 (0.5, 1.8) 17    1.0 (0.4, 2.5) 6 1.2 (0.5, 2.7)  8  ≤15: 0.7 (0.1, 3.4)  2
1991-1993 Medium/High:  0.7 (0.4, 1.5) 11        1.1 (0.5, 2.9) 6   0.9 (0.3, 2.6)  4  >15: 1.2 (0.2, 6.2)  2
PCE
Very low/Low: 0.6 (0.2, 1.6)  6 -­ 2 --­ 3
Medium/High:  1.0 (0.4, 2.7)  7 -­ 2 --­ 1
Benzene
Very low/Low: 0.5 (0.3, 0.9) 16        0.3 (0.1, 1.0) 3   0.7 (0.3, 1.4) 11   ≤15: 1.8 (0.7, 4.6)  9
Medium/High:  1.3 (0.7, 2.3) 25        0.9 (0.4, 2.3) 6   1.8 (0.9, 3.9) 12   >15: 4.7 (0.8, 26)  3
Cocco 2013 TCE 70 Probability of Exposure (OR): High exp. prob./Duration      # cases High exp. prob./Intensity level (ppm)
Incidence (questionnaires, 23 Low:       1.1 (0.7, 1.8) 1-14 years:   OR=0.9 (0.3, 3.2)  3 ≤5:    OR=1.4 (0.3, 7.0) 2 cases
689 CLL cases workplace 36 Medium: 0.9 (0.6, 1.2) 15-29 years: OR=2.3 (0.6, 8.7)  3 5-75: OR=1.7 (0.7, 4.0) 7 cases
4,279 controls inspections) 11 High:       2.0 (1.0, 4.0) 30-39 years: OR=3.8 (1.0, 14)  4 >75:  OR=3.2 (0.6, 18)    2 cases























       
                                                                                
                                                                                                    
                                          
                          
                                  
 
                        
          
  







    
 























    
 
  






    
 
  














Reference, type of Exposure** # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure exposed exposure information
of subjects, follow- assessment) cases
up period
Talibov 2014# (JEM) Cumulative
Incidence TCE 645 exposure TCE (RR) (# cases) Benzene (RR) (# cases)
15,332 AML cases PCE 172 percent:        total  # Males # Females #      total Males # Females #
76,660 controls Benzene 808 <50th: 0.9 (0.8, 1.1) 302    0.9 (0.8, 1.1) 239 1.2 (0.7, 1.9) 63  1.0 (0.8, 1.2) 430   1.1 (0.9, 1.4) 350   0.9 (0.6, 1.2) 81
1961-2005 50-90th:  1.1 (0.9, 1.3) 275 1.1 (0.9, 1.3) 225 1.4 (0.9, 2.4) 50  0.9 (0.7, 1.1) 310   0.9 (0.7, 1.2) 264 1.1 (0.7, 1.7) 45
>90th: 1.1 (0.8, 1.5)   68 1.1 (0.8, 1.5) 49 1.5 (0.7, 3.3) 19  0.8 (0.6, 1.2)  68   0.8 (0.5, 1.1)  63 2.0 (0.6, 7.0)  5
PCE  total #
<50th: 1.1 (0.8, 1.4) 89
50-90th:   0.8 (0.6, 1.1)  67






Dry cleaning 12 Any exposure:
SMR=0.8 (0.4, 1.4)
─ ─
Selden 2011 Dry Cleaning & 11 Lymphoid leukemia:
Incidence Laundry Workers SIR=1.01 (0.51, 1.81)
9,440 (plant survey, 11 Myeloid leukemia:







Dry cleaning Any exposure:
CLL/SLL: OR=1.20 (0.66, 2.18)








































                                     
     
     
       
 
     
     
       
 
     
     
       
  
 
     
        
 
     
       
 
   
              
        
 
 
                                         
    
       
 
    
       
 
     










   
 
 
   
    
    
      
   
        











   
       
 
                                 
   
   
            
 
 
         
          
         
 
 
         
         

















Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Schnatter 2012 Benzene (work Average Exposure (ppm) Duration of employment (yrs)  # cases Cumulative exposure (tertiles, ppm-yrs)
Incidence & histories, plant AML # cases AML AML    # cases
Mortality monitoring data) .016-.081: OR=2.0 (0.9, 4.5)  15 15.6-28: OR=1.0 (0.5, 2.0) 16 0.348-2.93: OR=1.04 (0.50, 2.19)  19
60 AML cases & .081-.259: OR=1.4 (0.6, 3.3)  13 >28:  OR=1.7 (0.8, 3.9)    17 >2.93:       OR=1.39 (0.68, 2.85) 21
241 controls >.259:     OR=1.9 (0.9, 4.2)  16 CLL CLL
28 CML cases & CLL 15.6-28: OR=2.1 (1.1, 4.2) 36 0.348-2.93: OR=1.49 (0.81, 2.76)  32
122 controls .016-.081: OR=0.7 (0.4, 1.5)  15 >28:  OR=1.2 (0.6, 2.6)    26 >2.93:       OR=1.05 (0.56, 1.98) 24
80 CLL cases & .081-.259: OR=0.8 (0.4, 1.6)  19 CML CML
345 controls >.259:     OR=0.8 (0.4, 1.7)  15 15.6-28: OR=3.1 (0.9, 10.6) 14 0.348-2.93: OR=5.04 (1.45, 17.5) 16
1950-2006 CML
.016-.081: OR=1.8 (0.6, 5.0)  9
.081-.259: OR=2.2 (0.7, 6.9)  8
>.259:     OR=0.9 (0.3, 3.3)  4
>28:  OR=1.4 (0.4, 5.7) 8 >2.93:       OR=2.20 (0.63, 7.68)  8
Linet 2015 Benzene 61 Leukemias: RR = 2.8 (1.6, 5.5) ─ ─
Incidence Exposed vs 8 ALL: RR = 4.5 (0.8, 83.9)
73,789 exposed unexposed 13 CML: RR = 2.5 (0.8, 10.7)
35,504 unexposed 26 AML: RR = 2.1 (0.9, 5.2)
1972-1999 2 CLL:  RR − no cases unexposed
Stenehjem 2015 Benzene (offshore Any exposure: Years exposed (RR)       # cases Cumulative exposure (tertiles) (RR)
Incidence oil industry 8 AML: RR = 2.18 (0.47, 10) AML      CLL AML         # cases       CLL        # cases
24,917 workers) (JEM) 11 CLL: RR = 5.40 (0.70, 41) >0-5.49: 2.0 (0.3, 13) 3    7.6 (0.9, 63) 5 1: 1.4 (0.2, 11)  2  6.2 (0.7, 54)  4
1999-2011 5.5-<13: 3.4 (0.7, 17) 4    4.8 (0.5, 47) 3
≥ 13: 1.0 (0.1, 11) 1  4.0 (0.4, 39) 3
2: 0.9 (0.1, 9.3) 1 3.1 (0.3, 34)  2
3: 4.9 (0.9, 27)  5  6.7 (0.8, 60)  5
Average exposure (tertiles) (RR)
AML         # cases       CLL        # cases
1: 0.8 (0.1, 8.7) 1  2.9 (0.3, 31)  2
2: 2.5 (0.4, 15)  3  7.6 (0.9, 65)  5
3: 3.5 (0.6, 19)  4  5.9 (0.6, 56)  4
Vinyl Chloride Workers Study
Hsieh 2011 Polyvinyl chloride 8 SMR=2.62 (1.13, 5.16)
Mortality workers 6 SMR=3.93 (1.40, 8.54) during high

























































   
   
   
     
 
   
   
 
   
   
   
   




   
   
   
     
 
   
   
                                                                                                      
                                                         
                                                              
                                                         
                                                           
                                                         
                                                         
                                                          
                                                          
                                                         
                                                            
                                                         
                                                             
                                                             
                                                         
                                                         
 
                                                         
                                                              
                                                         
                                                           
                                                         
                                                         
                                                          
                                                          





Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Drinking Water Studies
Aschengrau 1993 PCE levels in Exposure (OR) ─ ─
Incidence drinking water 5 Any:  1.72 (0.50, 4.71)
34 cases (modeling) 2 Low:  0.84 (0.09, 3.48)
737 controls 3 High:  5.78 (0.98, 23)
1983-1986 High: adj OR=5.84 (1.37, 24.91)
Cohn 1994 Municipal M  F Males Females
Incidence Drinking water 663 527 Total leukemias
75 towns in NJ (sample data) 162 156 0.1-5 ppb: RR=0.85 (0.71, 1.02) RR=1.13 (0.93, 1.37)
1979-1987 TCE 63 56 >5 ppb:     RR=1.10 (0.84, 1.43)      RR=1.43 (1.07, 1.90)
663 cases, male 64 54 Acute lymphocytic leukemia
527 cases, female 16 22 0.1-5 ppb: RR=0.91 (0.53, 1.57)      RR=1.85 (1.03, 3.70)
3 7 >5 ppb:     RR=0.54 (0.17, 1.70)      RR=2.36 (1.03, 5.45)
205 149 Chronic lymphocytic leukemia
55 40 0.1-5 ppb: RR=1.01 (0.74, 1.39)      RR=0.99 (0.68, 1.44)
25 18 >5 ppb:     RR=1.49 (0.97, 2.30)      RR=1.57 (0.95, 2.60)
155 121 Acute myelogenous leukemia
37 40 0.1-5 ppb: RR=0.83 (0.58, 1.21)      RR=1.23 (0.84, 1.81)
15 7 >5 ppb:     RR=1.08 (0.63, 1.86) RR=0.75 (0.35, 1.63)
76 70 Chronic myelogenous leukemia
15 16 0.1-5 ppb: RR=0.63 (0.36, 1.11)      RR=0.83 (0.47, 1.48)
6 10 >5 ppb:     RR=0.82 (0.35, 1.91)      RR=1.79 (0.90, 3.55)
663 527 Total leukemias
150 127 0.1-5 ppb: RR=0.90 (0.75, 1.08) RR=1.05 (0.85, 1.29)
PCE 80 83 >5 ppb:     RR=0.84 (0.66, 1.06)      RR=1.20 (0.94, 1.52)
64 54 Acute lymphocytic leukemia
10 21 0.1-5 ppb: RR=0.55 (0.27, 1.12)      RR=1.89 (1.04, 3.44)
8 9 >5 ppb:     RR=0.81 (0.38, 1.72)      RR=1.58 (0.74, 3.36)
205 149 Chronic lymphocytic leukemia
48 37 0.1-5 ppb: RR=0.94 (0.68, 1.32)      RR=1.01 (0.69, 1.48)

































   
 
   
   
   
    
 
     
   






















    
   
                    
 
   
    
 






      
  
    
     
  



























Reference, type of 









RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
















66 SMR=0.78 (0.60, 0.99)
HR = 1.11 (0.75, 1.62)
Any exposure (months):
1-3:    OR=1.8 (0.8, 3.9)    9 cases
4-6:  OR=1.7 (0.7, 4.3)    6 cases
7-12:  OR=0.9 (0.4, 2.2)    6 cases
>12:   OR=0.9 (0.5, 1.6) 22 cases
TCE Cumulative exposure (HR)
Low:       2.0 (1.0, 4.0) 16 cases
Medium: 1.5 (0.7, 3.4)   11 cases
High:      1.8 ( 0.9, 3.9) 13 cases















12 SMR = 1.55 (0.80, 2.71)
HR = 1.59 (0.66, 3.84)
─ Cumulative exposure (HR)
TCE
Medium: 1.0 (0.1, 7.4)  2 cases
High:       1.8 (0.4, 9.3) 8 cases
PCE
Medium: 0.9 (0.1, 7.0)  2 cases
High:       1.7 (0.3, 8.5)  8 cases
* The results are for all leukemias combined unless otherwise noted.
** Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
*** One study was included that did not report the number of leukemia cases and whether the cases were incident or deaths.
**** One study did not report the number of leukemia cases.
€ Included in the Karami et al. 2013 meta-analysis.
¶ Included in the Cocco 2013 study but provided additional information on benzene as well as results for cumulative exposure to TCE.
β Included in the Khalade et al. 2010 meta-analysis of benzene and leukemias.
# The Talibov et al. 2014 study did not present separate results by gender for PCE cumulative exposure.
JEM: job-exposure matrix
Chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL)
ALL: Acute lymphocytic leukemia
CLL: Chronic lymphocytic leukemia
AML: Acute myelogenous leukemia










   
 
                      
  
  









SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
mRR: Meta-analysis summary risk ratio.
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)













   
   










       
   
 




     
 
    
      
   
   
  
   
   
     
    
   
    
   
 
 
Summary of IARC’s review of benzene and leukemias
IARC review of benzene (IARC 2012): “Benzene causes acute myeloid leukaemia/acute non­
lymphocytic leukaemia.  Also, a positive association has been observed between exposure to benzene
and acute lymphocytic leukaemia, chronic lymphocytic leukaemia, multiple myeloma, and non-Hodgkin 
lymphoma.”
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA, NTP and IARC as well as the meta-analyses. High weight was also given to a study that
evaluated leukemia types, pooled data from other studies, or provided mechanistic information.  Our
assessment of the epidemiological evidence considered some of the viewpoints associated with Hill: (1)
temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and standardized 
mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although the
relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  When 
considering the magnitude of the effect estimate, an effect estimate was considered “near the null value” 
if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of biases, in particular exposure
misclassification, healthy worker effect, and confounding. 
TCE: 
The meta-analyses (Alexander et al. 2006, Karami et al. 2013) are in agreement with a summary RR for
leukemias from TCE exposure of about 1.10. A case-control study primarily focused on benzene
exposure also evaluated TCE but was not included in the meta-analyses (Costantini et al. 2008).  In this
study TCE exposures were likely low even among those classified as having “medium/high” exposure
intensity. Among those classified as having “medium/high” exposure, no elevation was observed for all
leukemias or CLL, and an OR near the null was observed for AML. 
Subsequent to the Karami et al. 2013 meta-analysis, three cohort studies and two case-control studies
have been published.  Two cohort studies found elevated risks in the range of 1.2 and 1.3 (Hansen et al.
2013, Silver et al. 2014), although one of these studies found the elevation only among male workers
(Hansen et al. 2013). The Silver et al. 2014 focused on mortality from non-CLL leukemias that likely
were predominantly myeloid leukemias. No elevation was observed in the Saberi Hosnijeh et al. 2013 
cohort study although there were small numbers of cases in the high exposure group, a generic JEM was 
used which likely introduced considerable non-differential exposure misclassification, and there was
limited information on duration of employment, work history and exposure to particular chemicals.  A
pooled case-control study observed exposure-response trends for exposure duration and exposure
intensity among workers with high probability of TCE exposure and CLL, although the analyses were
based on small numbers of exposed cases (Cocco et al. 2013). A case-control study of AML observed
RRs for cumulative exposure near the null for males, and a monotonic trend for females with a RR of
1.5 (95% CI: 0.7, 3.3) at the >90th percentile of cumulative exposure (Talibov et al. 2014).  The study
was limited by an exposure assessment that relied on census data for occupation and a generic JEM





   
   





    
 
 
      
  
   
     
   
    
 






      
    
 
      
   
      




   
      
   
   
     
     




     
 
 
The New Jersey drinking water study (Cohn et al. 1994) observed elevated risks for CLL in both sexes, 
and elevated risks in females only for ALL and CML. For ALL, the elevated risk in females was
virtually all due to childhood ALL. The RR for AML in males was 1.08 and was not elevated in
females.  The Camp Lejeune mortality study of Marines and Navy personnel (Bove et al. 2014a)
observed elevated risks among those exposed for shorter durations (1-6 months) but not for longer
durations (>6 months).  Elevated risks were observed among those with any cumulative exposure
compared to unexposed, but the exposure-response trend was not monotonic.  The Camp Lejeune
mortality study of civilian workers (Bove et al. 2014b) observed a monotonic exposure-response trend 
for cumulative exposure based on small numbers of exposed cases. 
The above table lists studies that evaluated adult leukemias. However, although childhood leukemia was
not a focus of this assessment, for completeness, ATSDR notes the existence of two drinking water case-
control studies that evaluated TCE and childhood leukemia. In the Woburn MA study, TCE was the 
primary contaminant in the drinking water with measured levels as high as 267 ppb. Residential 
exposure to the contaminated drinking water during pregnancy resulted in an odds ratio of 8.3 (95% CI:
0.7, 95) for ALL which increased to 14.3 (95% CI: 0.9, 225) for those exposed to >50th percentile 
cumulative exposure (Costas et al. 2002).  In the Camp Lejeune study, residential TCE drinking water
exposure was not associated with the combined outcome, childhood leukemia and childhood NHL
(Ruckart et al. 2013).
Animal and mechanistic information
Evidence from animal data indicates that TCE causes autoimmune disorders (EPA 2011). In humans, 
TCE has been associated with systemic sclerosis (EPA 2011). In a pooled analysis, systemic sclerosis
was associated with leukemia based on 2 studies: SIR=2.75 (95% CI: 1.32, 5.73) (Onishi et al. 2013).  In 
general, there is human and animal evidence that TCE is associated with immunomodulation, 
autoimmunity and immune suppression, and that these immune disorders are associated with 
hematopoietic cancers such as leukemias (EPA 2011, NTP 2015). In a study of factory workers in China
exposed to TCE, declines in lymphoid cell types including B cells and CD4+ T cells were observed
(Bassig et al. 2016). This finding supports an association between TCE and the lymphoid leukemias, 
ALL and CLL. There is strong evidence that autoimmune disorders are associated with myeloid
leukemias and myelodysplastic syndromes as well as lymphoid leukemias (Anderson et al 2009, 
Kristinsson et al 2011, Gunnarsson et al 2016). 
Conclusion: ATSDR concludes that the epidemiological evidence for TCE and leukemia from the
occupational and drinking water studies is not strong but nevertheless sufficient to at least reach
equipoise. The meta-analyses indicated a risk of about 1.10. Although not consistent, positive findings in 
human studies have been observed for each leukemia type. The strongest findings were for CLL (Cocco
et al. 2013).  But elevated risks have also been observed for AML (Constantini et al. 2008, Talibov et al.
2014), ALL (Cohn et al. 1994) and CML (Cohn et al. 1994). In addition, the Silver et al 2014 study
observed an elevated risk for non-CLL leukemias which likely were predominantly myeloid leukemias.
Supporting evidence comes from human and animal studies indicating that TCE causes immune
disorders that have been linked to leukemias.  Moreover, a study of TCE exposure among factory
workers in China observed declines in lymphoid cell types, supporting an association with lymphoid 





    




     
   
    
     














    




     
    
  




     
   
   
   
 
  
   
  
Based on the epidemiological evidence, the link between TCE-associated immune disorders and 
leukemias, including myeloid as well as lymphoid leukemias, and the evidence that TCE affects
lymphoid cell types, ATSDR concludes that there is equipoise and above evidence for causation for 
TCE and all adult leukemias, including AML, ALL, CML and CLL.
PCE: 
No meta-analyses have been conducted for PCE and leukemias. A large cohort mortality study of dry 
cleaning workers did not observe an elevated risk (Blair et al. 2003). A second cohort study combined 
dry cleaning workers with laundry workers that were unlikely to be exposed to PCE and obtained SIRs
near the null (Selden et al. 2011).  Two case-control studies of dry cleaning workers observed elevated 
risks for CLL/SLL of about 1.2 (Morton et al. 2014, t’Mannetje et al. 2015). The Morton et al. 2014 
study obtained an OR of 1.10 (95% CI: 0.15, 8.12) for ALL.  A cohort mortality study observed a risk 
near the null for all leukemia (Silver et al. 2014). A case-control study observed no elevation in risk for
all leukemias (Costantini et al. 2008), and a case-control study of AML observed an RR near the null for
low cumulative exposure and no elevation at higher levels of exposure (Talibov et al. 2014).
PCE-contaminated drinking water and leukemia was evaluated in the Cape Cod study (Aschengrau et al.
1993). Any PCE exposure was associated with an elevated risk of 1.7 which increased to 5.8 for those
exposed above the 90th percentile. In the NJ drinking water study, elevated risks for ALL was observed 
only among females (Cohn et al. 1994). 
Animal information: Inhalation exposure to PCE was associated with mononuclear-cell leukemia in
rats of both sexes. EPA concluded that there was sufficient evidence for a causal association between
PCE and mononuclear-cell leukemia in rats (EPA 2012).  However, the relevance of this association to 
humans continues to be debated. Large granular lymphocyte (LGL) cells exist in humans that are similar
to the cells involved in mononuclear-cell leukemia in the rat. Disorders associated with LGL cells
include lymphoproliferative disorders such as NHL, Hodgkin lymphoma, multiple myeloma, hairy cell
leukemia, and B-cell lymphoproliferative disorders as well as autoimmune diseases such as lupus (EPA
2012).
Conclusion: Because of the limited number of epidemiological studies, the mixed results in the studies
of dry cleaning workers who most likely have the highest exposures to PCE, and the uncertainties
regarding the relevance of the finding of mononuclear-cell leukemia in the rat, ATSDR concludes that
there is below equipoise evidence for causation for PCE and leukemias.
Benzene: 
AML is known to be caused by benzene exposure (IARC 2012). IARC (IARC 2012) has concluded that
positive associations exist for ALL and CLL. The epidemiological evidence from the meta-analyses
(Khalade 2010, Vlaanderen 2011, 2012) indicates that benzene causes all types of leukemia. The 
Vlaanderen meta-analysis was not available for IARC’s review of benzene. This meta-analysis observed
no publication bias and, with the exception of CLL, no evidence of between-study heterogeneity when
the analyses were restricted to studies with quantitative exposure assessments.  The meta-analysis found 
elevated risks for benzene exposure and all 4 types of leukemia (Vlaanderen et al. 2011, 2012).  In the
meta-analysis conducted by Khalade et al. 2010, monotonic exposure-response trends were observed for










   
    
  
    




    
 
 













CLL was not monotonic but indicated an increased risk at the highest cumulative exposure level
(Khalade et al. 2010). A case-control study not included in the meta-analyses evaluated CLL and used a 
generic JEM to assign exposures (Orsi et al. 2010).  The authors stated that exposures to benzene were 
very low, and no elevation of risk was observed. 
Four cohort studies have been conducted since the publication of the Vlaanderen et al. 2011, 2012 
meta-analyses.  Saberi Hosnijeh et al. 2013 found an elevated risk for myeloid leukemia but not for
lymphoid leukemia. Schnatter et al. 2012 observed an increased risk of AML with increasing cumulative
exposure to benzene.  CML risks were higher in the lower exposure groups than in the high exposure
group and no clear pattern was observed for CLL.  The Linet et al. 2015 study found elevated risks for
ALL, CML and AML but could not evaluate CLL because there were no unexposed cases. Stenehjem et
al. 2015 observed elevated risks for AML and CLL but the exposure-response trends were not
monotonic.
In a study of factory workers in China exposed to benzene, declines were seen in both myeloid and 
lymphoid cell types (Bassig et al. 2016). These findings provide supporting evidence for associations
between benzene and all types of leukemia, myeloid and lymphoid.
Conclusion: Based on the results of the meta-analyses, the recent cohort studies and the finding that
occupational benzene exposure is associated with reductions in both lymphoid and myeloid cell types, 
ATSDR concludes that there is sufficient evidence for causation for benzene and all leukemia types, 
i.e., ALL, CLL, AML, and CML. 
Vinyl Chloride: A meta-analysis observed no elevation in risk (Boffetta 2003).  However a study of
polyvinyl chloride workers observed excess mortality, especially during the period of high exposures
(SMR=3.93, 95% CI: 1.40, 8.54) (Hsieh 2011).  Because of the conflicting findings between the latter
study and the meta-analysis, ATSDR concludes that there is below equipoise evidence for causation




























        









                    
       

















      
      














   
 
 
              
       
        
         

























                              
  
     
    
          
    
     
   













Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information






SMR=2.96 (2.00, 4.39) 6 studies
SMR=1.35 (1.04, 1.77) for liver cancers except angiosarcoma 4 studies
Alexander 2007
Meta-analysis







sRR = 1.29 (1.07, 1.56) 9 studies (8 cohort studies - 4 incidence, 4 mortality; 1 case-control – mortality)
sRR = 1.28 (0.93, 1.77) 8 cohort studies
Cohort Studies
Anttila 1995£ TCE (urine TCA) Urine TCA (µmol/L) # cases
Incidence <100: SIR=1.64 (0.20, 5.92)   2
3,089 TCE workers ≥100: SIR=2.74 (0.33, 9.88)  2
1967-1992
Raaschou-Nielsen TCE (job title, plant air Any exposure (SIR): Duration of employment (years), # cases:
2003£ monitoring & urine TCA 27 Men:      1.1 (0.7, 1.6) <1:     men, RR=1.3 (0.6, 2.5)  9            women, RR=2.8 (0.3, 10.0) 2
Incidence data) 7 Women: 2.8 (1.1, 5.8) 1-4.9: men, RR=1.0 (0.5, 1.9)  9            women, RR=4.1 (1.1, 10.5) 4













Cumulative exposure score (unit-yrs):
0-5:  HR=3.28 (0.37, 29.5) 4 cases
5-25: HR=0
>25:  HR=4.05 (0.45, 36.4)  4 cases
Exposure intensity HR  # cases
Low, intermittent: 3.8 (0.5, 30) 8
Low, continuous: 1.3 (0.1, 14) 2
Peak, infrequent: 6.4 (0.7, 62) 3
Peak, frequent: 2.1 (0.2, 20) 3





TCE (JEM) 24 SMR=0.89 (0.57, 1.33) TCE
<1:    0.67 (0.32, 1.42) 10 cases
1-4:   0.69 (0.28, 1.71) 6 cases
>4:    0.83 (0.36, 1.91)  8 cases
PCE (JEM) 19 SMR=0.93 (0.56, 1.45) PCE
<1:    0.71 (0.25, 2.02)   4 cases
1-4:   0.93 (0.38, 2.27) 6 cases
>4:    1.29 (0.60, 2.78) 10 cases
Bahr 2011 TCE (Qualitative JEM) Not Exposure Level
Mortality reported 2: SRR=0.34 (0.05, 2.07)






























   
   











































      
                                                           
              
           
           
 
   
      
   
   
































                                                        
                                   
              
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Hansen 2013 TCE (urine TCA) 36 Liver & biliary passages: Liver & biliary passages, 20 yr. lag: Liver & biliary passages:









5-25:   0.66 (0.31, 1.42)  12
25-50: 0.45 (0.13, 1.54)  5
>50:    0.63 (0.22, 1.68) 3
Silver 2014 Microelectronics plant 39Ѱ 5 exposure-yrs cumulative 
Mortality exposure:
34,494 TCE (JEM) HR=0.99 (0.50, 1.95)
1969-2009 PCE (JEM) HR=0.79 (0.27, 2.30)
Case-Control Study
Christensen 2013 TCE 1 “any”exposure: OR=1.1 (0.1, 11) ─ ─
Incidence 1 “substantial”: OR= 2.5 (0.3, 25)
48 cases
1,834 controls PCE 1 “any”exposure: OR=3.3 (0.2, 60)
1979-1985 1 “substantial”: OR=4.4 (0.2, 103)
Vlaanderen 2013 TCE (JEM) Cumulative exposure tertiles, HR, # cases >90th percentile cumulative exposure:
Incidence TCE # cases PCE # cases Benzene # cases TCE: HR=1.02 (0.82, 1.25) 106  cases
23,896 cases PCE (JEM) 1: 1.03 (0.91, 1.16) 340       0.91 (0.73, 1.14) 90 1.00 (0.89, 1.12) 373 PCE: HR=1.11 (0.79, 1.57) 40  cases
119,480 controls 2: 0.99 (0.90, 1.09) 508       1.18 (0.97, 1.44) 121  1.04 (0.94, 1.15) 497 >90th percentile, intensity x freq.
1961-2005 3: 1.00 (0.90, 1.11) 422       1.13 (0.92, 1.38) 114  1.14 (1.03, 1.26) 485 TCE: HR=1.08 (0.90, 1.30) 137 cases
PCE: HR=1.26 (0.88, 1.80) 38 cases
















Selden 2011 Dry Cleaning: Any exposure: Duration of employment (SIR) # cases
Incidence PCE sub-cohort (plant 8Ѱ Men: SIR=2.14 (0.92, 4.21) <1 year 1-4 years  >4 years
6,356 survey, work history) 10Ѱ Women: SIR=0.90 (0.43, 1.65) Men:       0.0  3.2 (0.7, 9.3) 3     2.1 (0.7, 4.8) 5
1985-2006 Women   1.7 (0.2, 6.0) 2     1.5 (0.5, 3.5) 5     0.5 (0.1, 1.3) 3
Page 58


















     
                   
                         
     
          
                               
  
                        
               
                                        
         




































































         
      







Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Vinyl Chloride Workers Studies




by air monitoring data)
2 Duration (yrs)
RR SMR        # cases 
0:  ―     1.1 (0.6, 1.8)   15
>0-5: 2.5 (0.4, ∞)    0.4 (0.0, 2.1)  1
5-9:   0.7 (0.0, ∞) 2.4 (0.1, 13)  1
10+:  ―  ―  0
Cumulative exposure (tertiles)
RR SMR      # cases
Unexposed: ― 1.1 (0.6, 1.8) 15
1:  ―  ―  0
2:      1.0 (0.0, 6.7) 0.9 (0.0, 4.8)  1
3:      0.4 (0.0, 2.6) 0.4 (0.0, 2.0) 1
Gennaro 2008 Vinyl chloride 7 Autoclave workers: RR=9.57 (3.71, 24.7)





5 PVC compound workers: RR=2.46 (0.94, 6.42)




workers 33 SMR=1.93 (1.37, 2.79) during 
high exposure period
Carreón 2014 Vinyl chloride 11Ѱ Any exposure: Duration of vinyl chloride exposure:
Mortality SMR=3.80 (1.89, 6.80) <7.4 years:        SMR=1.26 (0.26, 3.69)   3 cases
1,874 11Ѱ Exposed <1975: 7.4 - <16 years: SMR=3.94 (0.48, 14.2)   2 cases







Benzene 286 RR=1.2 (0.9, 1.4)
Drinking Water Studies












vs. Camp Pendleton 51Ѱ SMR=0.74 (0.55, 0.97)
HR = 1.42 (0.92, 2.20)
Any residential exposure  # cases:
1-3 months, OR=1.3 (0.5, 3.5) 5
4-6 months,   OR=1.5 (0.5, 4.4) 4
7-12 months, OR=1.2 (0.5, 2.9) 6
>12 months,  OR=1.0 (0.5, 1.8)  18
Modeled residential cumulative
exposure to TCE: (no exposure as
referent)
“very low”:        HR=1.30 (0.74, 2.29)































        
  
   









                      
  
  
   
 
 
Reference, type of 








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information












3Ѱ SMR=0.42 (0.09, 1.21)
HR=0.62 (0.16, 2.45)
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
** One study included in the meta-analysis did not report the number of exposed cases.
£ Included in the EPA (Scott and Jinot 2011) and Alexander et al. 2007 meta-analyses. Included in the table because of information on 
exposure-response relationships (urine-TCA levels, duration of employment).
€ Included in the EPA meta-analyses. Included in the table because of information on exposure intensity and cumulative exposures for men 
only. (There were no exposed primary liver cancer cases among women.)
Ѱ Liver/biliary/gall bladder cancers.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)




      
 
     
  
   
    
   
  
 
   
    
 
     
    




   
 
  

















    
   
    
   
 
  
    
Summary of NTP, EPA, and IARC reviews of TCE and vinyl chloride and liver cancer:
NTP Monograph on TCE (NTP 2015): “The epidemiological data suggest that trichloroethylene may
be associated with a modest increase in the risk of liver cancer, based primarily on the two meta-
analyses. However, the findings are inconsistent across studies, and there was little evidence for
exposure-response relationships in the individual studies or the meta-analyses. In addition, the role of
chance or confounding by one or more common occupational co-exposures or lifestyle factors cannot be 
completely ruled out.”
EPA Toxicological Review of TCE (EPA 2011): “The evidence is more limited for liver cancer mainly
because only cohort studies are available and most of these studies have small numbers of cases.”
IARC review of TCE (IARC 2014) concluded that a positive association was observed between TCE
exposure and liver cancer. However, IARC also noted: “Although some positive associations were observed
in cohort studies, the results were somewhat inconsistent.”
IARC review of vinyl chloride (IARC monograph 100F, 2012) concluded: “There is compelling
evidence that exposure to vinyl chloride is associated with angiosarcoma of the liver, and strong
evidence that it is associated with hepatocellular carcinoma. Together with the observation that vinyl
chloride increases the risk of liver cirrhosis, which is a known risk factor for hepatocellular carcinoma, 
the findings from two large multicentre cohort studies provide convincing evidence that vinyl chloride
causes hepatocellular carcinoma as well as angiosarcoma of the liver.” 
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA, NTP and IARC as well as the meta-analyses. High weight was also given to a study that was
considered of moderate utility by the NTP or pooled data from other studies.  Information on possible
mechanisms was also considered. Our assessment of the epidemiological evidence considered some of
the viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g.,
risk ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4) exposure-
response relationship (although the relationship could be non-linear or non-monotonic), and (5)
biological plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect 
estimate was considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered were
the effects of biases, in particular exposure misclassification, healthy worker effect, and confounding.
TCE: 
Both meta-analyses found elevated summary RRs for TCE exposure and liver cancer.  The EPA meta-
analysis observed no evidence of between-study heterogeneity or publication bias.  The summary RR for
any exposure and the high exposure group were essentially the same, about 1.30 (Scott and Jinot 2011).  
However, the exposure-response evaluation in the EPA meta-analysis was severely limited by small 
numbers of highly exposed cases in the included studies.
Six occupational studies (four cohort and two case-control) have been published since the EPA meta-





    
   
 
  





   
    
 
 
   
    
  
 
   
    
     
    








     
  
  
   
 
  









    
 
of “low utility” (Bahr et al. 2011; Silver et al. 2014; Christensen et al. 2013 and Vlaanderen et al. 2013).  
One study was considered to have “low/moderate utility” (Lipworth et al. 2011), and one study was
considered to have “moderate utility” (Hansen et al. 2013).  The Hansen et al. 2013 pooled analysis of
studies conducted in three Nordic countries obtained a RR for primary liver cancer of 1.93 (95% CI:
1.19, 2.95) that was similar for males and females. The RR increased with lag time when liver cancer
was combined with cancer of the biliary passages (RR=2.09, 95% CI: 1.34, 3.11).  The study evaluated
urine TCA levels and found no increase in risk with increasing level.  However, nearly half of the 
exposed cases were in the reference category with small numbers of cases in the higher urine-TCA 
levels. Other limitations were that a majority of the workers had only one or two urine-TCA 
measurements, and urine-TCA measures only recent TCE exposure (i.e., over the previous week). The 
study could not evaluate cumulative exposure or exposure duration. The Christensen et al. 2013 study
obtained an elevated OR for “substantial” TCE exposure based on one exposed case (OR=2.5, 95% CI:
0.3, 25.0).
The four other occupational studies published after the EPA meta-analysis did not observe elevated
risks, however each of these studies had serious limitations. The Lipworth et al. 2011 cohort study
provided no information on TCE exposure levels although it was likely that exposures were low and of
short duration since TCE use at the facility ended in 1966.  Over 40% of the exposed cases had less than 
1 year duration of exposure.  There was also evidence of healthy worker effect bias with the SMRs for
all cancers and liver cancer of 0.92 (95% CI: 0.96, 0.97) and 0.89 (95% CI: 0.57, 1.33), respectively. 
The Bahr et al. 2011 cohort study did not provide the total number of liver cancers, the number of
exposed liver cancers, or the levels of TCE exposure.  The authors acknowledged that strong healthy
worker effect biases were present as the SMRs for all causes of death and for liver cancer were 0.76
(95% CI: 0.72, 0.79) and 0.43 (95% CI: 0.10, 1.84).  Considerable exposure misclassification bias was
likely because a generic JEM was used to determine exposure assignment. Healthy worker effect bias
was also evident in the Silver et al. 2014 cohort study with an SMR for all cancers of 0.74 (95% CI:
0.71, 0.77) and the SMR for liver/biliary passages/gall bladder (calculated from data in the article) of
0.54 (95% CI: 0.39, 0.74).  The study did not report exposure levels or the number of exposed cases, and 
TCE exposure prevalence was expected to be low.  The exposure assessment was also limited by
missing data on work histories. Finally, the Vlaanderen et al. 2013 case-control study was limited by
low levels of TCE exposure and the use of a generic JEM that likely introduced considerable exposure
misclassification bias. The authors acknowledged that the JEM used in this study was so poor that it was
likely that a majority of those classified as exposed to TCE or PCE may have been unexposed to these
chemicals.
The Camp Lejeune mortality studies found an increased risk of liver cancer among Marines/Navy
personnel but not among civilian workers when compared to the Camp Pendleton cohorts (Bove et al.
2014a, b).
Mechanistic information: “Although species differences in sensitivity to the proposed modes of action 
are likely, no data suggest that trichloroethylene causes liver tumors in mice by mechanisms that are
irrelevant to humans. Most of the hypothesized modes of action for liver tumors have some experimental
support and are biologically plausible in humans and rodents.” (NTP 2015, page 176). “It is likely that
multiple mechanisms, potentially including immune dysregulation, epigenetic alterations, cytotoxicity
and secondary oxidative stress, alteration of proliferation and/or apoptosis, may contribute to 







   
  
     
    





    
   
      
      
     
   
 
    






   
   
   
       
  








    
   
   
 
Conclusion: The EPA meta-analysis observed an elevated risk for TCE and liver cancer with no 
evidence of publication bias or between-study heterogeneity.  However, the meta-analysis was limited in
its ability to evaluate exposure-response trends due to small numbers of highly exposed cases in the
included studies.  Several studies were conducted after the EPA meta-analysis but most had serious
limitations, including low exposures, and biases due to exposure misclassification and/or healthy worker
effect. ATSDR concludes that the epidemiological evidence by itself is sufficient to classify the causal 
association as at least equipoise. Combining the epidemiological evidence with the supporting evidence
from animal studies and plausible mechanistic information, ATSDR concludes that there is equipoise
and above evidence for causation for TCE and liver cancer.
No meta-analysis has been conducted for PCE exposures and liver cancer. A limited number of
epidemiological studies have evaluated PCE exposure and liver cancer.  Two studies of dry cleaning
workers did not find an elevated risk of liver cancer (Blair et al. 2003, Lynge et al. 2006). A third dry
cleaning study found an elevated risk only among male workers (Selden et al. 2011). Cohort studies of
workers exposed to PCE in other industries did not find an excess risk (Lipworth et al. 2011, Silver et al.
2014).  One case-control study found elevated risks in the range of 1.1-1.2 (Vlaanderen et al. 2013).
Conclusion: The epidemiological evidence for PCE and liver cancer is insufficient to determine
whether a positive association exists, given the conflicting and mostly negative findings in the dry
cleaning and other occupational studies.  Therefore, ATSDR concludes that there is below equipoise
evidence for causation for PCE and liver cancer.
Vinyl Chloride: 
The meta-analysis by Boffetta et al. 2003 indicated that vinyl chloride was associated not only with 
angiosarcoma of the liver but also hepatocellular carcinoma. Since the IARC review (IARC 2012),
which concluded that there was convincing evidence that vinyl chloride exposure causes hepatocellular
carcinoma as well as angiosarcoma of the liver, two recent studies, Hsieh et al. 2011 and Carreón et al.
2014, also found associations between occupational exposures to vinyl chloride and liver cancer. The 
Carreón et al. 2014, study also found an exposure-response trend for duration of exposure.  
ATSDR concurs with the IARC (2012) assessment and concludes that there is sufficient evidence for 
causation for vinyl chloride and hepatocellular carcinoma as well as angiosarcoma of the liver.
Benzene
Because only one study evaluated occupational benzene exposure and liver cancer, the epidemiological 
evidence is insufficient to determine whether a positive association exists for benzene and liver cancer.




























          
              
         
        
   
         























                     
          










                    
                   








   




























                    
                    
                  
                   
          
        
                           

 Pancreatic Cancer
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Ojajarvi 2001, 2007 Metal degreasing sRR=2.0 (1.2, 3.6) 6 studies       27 exposed cases
meta-analysis Dry-cleaning & Laundry
TCE
sRR=1.4 (1.1, 2.4) 7 studies (3 incidence, 4 mortality) 83 exposed cases




sRR=1.17 (0.71, 1.91) 4 studies (all mortality studies) 85 exposed cases
sRR=3.08 (0.63, 8.99) 1 study (cohort incidence study)   3 exposed cases
sRRѰ=2.2 (1.31, 3.68) 20 studies
Cohort Studies




TCE (urine TCA) 11 SIR=1.61 (0.81, 2.88) <100  SIR=1.61 (0.59, 3.50) 6
100 +  SIR=1.31 (0.27, 3.82) 3
1967-1992 PCE (blood PCE) 3 SIR=3.08 (0.63, 8.99)
Morgan 1998 Aerospace workers 11 Any exposure: ─ Exposure Intensity: (SMR)  # cases
Mortality TCE SMR=0.76 (0.38, 1.37) Low:   0.95 (0.31, 2.22) 5
4,733 High:  0.66 (0.24, 1.43)  6
1950-1993
Ritz 1999 Uranium Processing TCE Exposure duration (years)
Mortality (JEM)  TCE 17 <2:    Referent
3,814 1 2-10:  3.54 (0.45, 27.9)
1951-1989 0 >10     0
Raaschou-Nielsen TCE (job title, plant air Any exposure:











Cumulative intensity score # cases
Medium: RR=1.13 (0.58, 2.21) 15






















   
  
     
 
 
                     
      
      
  
               
      
 
       
  





                            
     
 
 
































    





















    
Reference, type of








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Radican 2008 TCE (JEM) 46 All:         HR=1.06 (0.61, 1.84) Cumulative exposure score (unit-yr) Exposure Intensity
Mortality (Aircraft maintenance) 39 Males: HR=0.91 (0.49, 1.68) Men (HR)  # cases Men (HR)      # cases
14,455 7 Females: HR=1.71 (0.57, 5.12) 0-5:   0.97 (0.48, 1.97) 17 Low, Intermittent: 0.86 (0.45, 1.64)   27
1953-2000 5-25: 0.74 (0.31, 1.76)  8
>25:  0.97 (0.46, 2.04)    14
Women (HR)   # cases
0-5:   2.06 (0.51, 8.26)  3
5-25:  0
>25:  1.96 (0.55, 6.97) 4
Low, Continuous: 0.88 (0.44, 1.77)   19
Peak, Infrequent:   1.18 (0.49, 2.80)  8
Peak, Frequent:      0.96 (0.48, 1.93)  18  
Women (HR)      # cases
Low, Intermittent:  1.53 (0.38, 6.13) 3
Low, Continuous:  0
Peak, Infrequent:  0
Peak, Frequent:      1.59 (0.45, 5.65) 4
Lipworth 2011 Aircraft manufacturing Any exposure: ─ ─




PCE (JEM) 39 SMR=1.05 (0.75, 1.44)
Hansen 2013 TCE (Urine TCA was 38 All:         SIR=1.31 (0.93, 1.80) ─ ─
















Benzene 45 RR=1.7 (1.0, 3.1)
Buhagen 2016 Train maintenance 6 SIR=0.9 (0.4, 2.0)
Incidence TCE

































































                     
          

















        
        
       
        
       












   
 
  
   


























RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Case-Control Studies
Santibañez 2010 Chlorinated Exposure intensity:
Incidence hydrocarbon solvents All pancreatic cancer:
161 cases (JEM) 1 “low” (≤0.83 ppm):  OR=0.9 (0.1, 7.8)
76 ductal adeno­ 5 “high” (>0.83 ppm): OR=2.0 (0.6, 6.4)
carcinoma Ductal adenocarcinoma:
455 controls 1 “low” (≤0.83 ppm):  OR=1.2 (0.1, 12.3)









hydrocarbons 279 OR=1.63 (1.32, 2.02








SMR = 1.1 (0.7, 1.5)
Exposure intensity    # cases
Little/no: SMR=1.2 (0.7, 2.0) 14
Med/high: SMR=0.8 (0.4, 1.5) 11
Lynge 2006 PCE (dry cleaning) Any exposure: Employment duration (yrs.)  # cases ─
Incidence 57 RR=1.27 (0.90, 1.80) 4 countries; 0-1: RR=2.14 (0.76, 6.06)  6
230 cases 32 RR=1.38 (0.87, 2.20) 2 countries 2-4: RR=1.38 (0.54, 3.50)  7
975 controls with most complete data on 5-9: RR=1.18 (0.62, 2.25) 14
1970-2001 exposure ≥10: RR=1.20 (0.72, 1.99) 23
Unk: RR=2.44 (0.90, 6.66)  7
Calvert 2011 PCE (dry cleaning) 22 All:           SMR = 1.51 (0.95, 2.29)







4 PCE-only: SMR = 0.82 (0.22, 2.10)
Selden 2011 Dry Cleaning & 34 All:        SIR=1.30 (0.90, 1.81)
Incidence Laundry Workers 10 Men:      SIR=1.48 (0.71, 2.72)



































































     
 




























































* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
** One included study did not report the number of exposed cases.
Ѱ Hierarchical Bayesian model combining information from studies that evaluated job titles only and information from a JEM . The number
of exposed cases was not reported.
€ This study was included in the Ojajarvi 2001meta-analysis but is listed here because of additional information on urine TCA.
RR: Risk Ratio
OR: Odds Ratio








                      
  
  










SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)
Urine TCA: urine levels of trichloroacetic acid, a metabolite of TCE.
Note: Christensen et al. 2013 had no cases of pancreatic cancer with “substantial” exposure to PCE or TCE and is therefore not included in 
the table.





   
     
  
  




    
   
  
 






      
   






   
    
     
 
 
Summary of NCI review of occupational exposures to chlorinated solvents and pancreatic cancer:
A review of the evidence for occupational exposures and pancreatic cancer by NCI (Andreotti G and
Silverman DT 2012) concluded: “Chlorinated hydrocarbon exposure is one of the most researched and 
established occupational risk factors for pancreatic cancer.” The review stated that, based on the meta-
analyses of studies published between 1969 and 1998 of 20 populations in Europe, North America, and 
Asia (Ojajarvi et al. 2001, 2007) and a recent study (Santibañez et al. 2010), the authors concluded that:
“…The strongest and most consistent findings linking occupational exposures with pancreatic cancer
risk to date are for chlorinated hydrocarbons and PAHs.”  The authors specifically mentioned that
pancreatic cancer was linked to TCE and PCE exposures as well as to dry cleaning and metal-related
work including metal degreasing.  
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR considered the results of an early meta-analysis
in the context of studies published after the meta-analysis was conducted. Our assessment of the 
epidemiological evidence considered some of the viewpoints associated with Hill: (1) temporal
relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and standardized mortality
ratio), (3) consistency of findings, (4) exposure-response relationship (although the relationship could be
non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  When considering the
magnitude of the effect estimate, an effect estimate was considered “near the null value” if ≤1.10 and 
“elevated” if >1.10.  Also considered were the effects of biases, in particular exposure misclassification, 
healthy worker effect, and confounding.
TCE
The meta-analysis by Ojajarvi et al. 2001 found a summary RR of 1.24 (95% CI: 0.79, 1.97) based on
five studies.  A much higher summary RR of 2.0 (95% CI: 1.2, 3.6) was found for metal degreasing
based on 6 studies (Ojajarvi et al. 2001). Eight cohort studies listed in the table were not included in the
Ojajarvi et al. 2001 and 2007 meta-analyses.  Of these studies, two observed elevated risks for TCE
exposure and pancreatic cancer only in female workers (Radican et al. 2008, Hansen et al. 2013). 
Another cohort study found an SIR close to the null (SIR=1.1, 95% CI: 0.9, 1.4) in males and no 
elevation in females (Raaschou-Nielsen et al. 2003).  Of the five other cohort studies, three observed no 
elevations in risk (Morgan et al. 1998; Lipworth et al. 2011; Buhagen et al. 2016), and two observed 
elevated risks among those in a lower exposure intensity or duration category but not in the higher
category, although these analyses were limited by small numbers.  
In the Camp Lejeune mortality studies, pancreatic cancer risk was elevated in the marine/Navy cohort





   
  







     
 
   















    
   
   
 
  
      
   
  







Conclusion: Although the meta-analysis found an elevated risk for TCE and pancreatic cancer, the
findings from subsequent studies have been mixed and not supportive of the meta-analysis. Therefore 
ATSDR concludes that there is below equipoise evidence for causation for TCE and pancreatic 
cancer.
PCE
The Ojajarvi et al. 2001 meta-analysis found an excess risk for dry cleaning and laundry worker studies
(sRR=1.4, 95% CI: 1.1, 2.4) similar to that observed in two other dry cleaning studies that were
published after the meta-analysis was conducted (Lynge et al. 2006 and Selden et al. 2011).  The 
Ojajarvi et al 2001 paper also reported the finding from the Anttila et al. 1995 cohort study of PCE-
exposed workers with exposure based on PCE blood measurements, (i.e., SIR of 3.08, 95% CI: 0.63,
8.99, based on three exposed cases). The Lipworth et al. 2011 cohort study of aircraft manufacturing
workers observed an SMR near the null, but healthy worker effect bias was possible (e.g., the SMR for
all cancers was 0.96, 95% CI: 0.89, 1.04) and exposures to PCE were much lower than those usually
experienced in the dry cleaning industry. 
In addition to the two dry cleaning studies published after the Ojajarvi et al. 2001 meta-analysis that
found elevated risks (i.e., Lynge et al. 2006 and Selden et al. 2011), two other dry cleaning studies had 
mixed findings.  In the Blair et al. 2003 cohort study, the SMR was near the null value (SMR=1.1, 95%
CI: 0.7, 1.5) and an elevated risk was observed only for those with “little/no” exposure intensity.  In the
Calvert et al. 2011 cohort study, an elevated SMR was observed for workers in the “PCE-plus” category
(i.e., workers who worked in a shop where PCE was the primary cleaning solvent, but also had a history
of employment in shops where the primary solvent in use could not be identified) but not for workers in 
the “PCE-only” category.  In this study, over 80% of the exposed pancreatic cancers were in the PCE-
plus category with only four pancreatic cancers in the PCE-only category.
The drinking water study at Cape Cod did not observe an excess of pancreatic cancer (Paulu et al. 1999).  
The Camp Lejeune mortality study of Marines observed an excess of pancreatic cancer in the 
comparison with Camp Pendleton Marines but no excess risk was found in the study of civilian workers
(Bove et al. 2014a, b). 
Conclusion:  Although there is some evidence of excess risk for pancreatic cancer from the meta-
analysis, the findings from the dry cleaning worker studies are not consistent. In addition, the findings
from the drinking water studies at Cape Cod and Camp Lejeune are not consistent.  There is no animal
data or mechanistic data to supplement the epidemiological evidence. Therefore, ATSDR concludes that






   
     
 







     
 
      
   
  
   
Benzene
Two studies have evaluated occupational benzene exposures and pancreatic cancer (Linet et al. 2015, 
Antwi et al. 2015). Both studies found similar elevated risks of 1.7 (95% CI: 1.0, 3.1) and 1.75 (95% CI:
1.29, 2.37).  However, the results of two studies are not sufficient to determine whether benzene
exposure is a risk factor for pancreatic cancer. Therefore, ATSDR concludes that there is below
equipoise evidence for causation for benzene and pancreatic cancer.
Vinyl Chloride
In the Ojajarvi et al.2001 meta-analysis, vinyl chloride had a summary RR of 1.17 (95% CI: 0.71, 1.91)
based on four mortality studies. Since then, a cohort study of vinyl chloride workers observed an 
elevated risk for pancreatic cancer with an SMR of 1.9 (95% CI: 0.95, 3.40) (Carreón et al. 2014).
However the epidemiological evidence is still too sparse to determine whether vinyl chloride is a risk
factor for pancreatic cancer.  Therefore, ATSDR concludes that there is below equipoise evidence for 
causation for vinyl chloride and pancreatic cancer.
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Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Cohort Studies
Axelson 1994** TCE (urine TCA) Any exposure: Years exposed    # cases Urine TCA (mg/L)   # cases
Incidence 26 SIR=1.25 (0.84, 1.84) <2: SIR=1.19 (0.39, 2.78) 5 <50:    SIR=1.30 (0.65, 2.33) 11
1,421 ≥2: SIR=1.27 (0.81, 1.94) 21 50-99: SIR=0.91 (0.11, 3.28) 2
1958-1987 ≥100:  SIR=2.40 (0.29, 8.67)  2
Anttila 1995** TCE (urine TCA) 13 SIR=1.38 (0.73, 2.35) Urine TCA (µmol/L)  # cases
Incidence <100  SIR=1.43 (0.62, 2.82) 8








21 SMR = 1.18 (0.73, 1.80) Cumulative exposure:
Low: RR= 1.72 (0.78, 3.80) 7 cases
High: RR=1.53 (0.85, 2.75) 14 cases







24 TCE Exposure duration (years)
<2:    Referent     23 cases
2-10:   0 cases
>10:    RR=2.15 (0.28, 16.6) 1 case
Intensity of exposure, 15 year lag
RR   # cases
“Light”:        1.04 (0.40, 2.70) 8






TCE (job title, plant air
monitoring & urine TCA
data)

















Cumulative exposure score (unit-yr):
0-5:   HR=1.03 (0.65, 1.62) 41 cases
5-25: HR=1.33 (0.82, 2.15) 32 cases
>25:  HR=1.31 (0.84, 2.06)   43 cases
Exposure Intensity (HR)     # cases
Low, intermittent: 1.22 (0.82, 1.82)   87
Low, continuous: 1.30 (0.85, 1.99)   60
Peak, infrequent:   1.02 (0.57, 1.86)   16


























     
                                      
                                 
  
     
  
  
                                      
                              
                         
                              
  







   
  
 











































          
  
 
     
                                              
        
                      
        
               
               
                                   
  
  
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Lipworth 2011 Aircraft manufacturing Any exposure: Years exposed (RRs):




PCE (JEM) 71 SMR = 0.92 (0.72, 1.16) <1:   0.80 (0.55, 1.16)
1-4:  1.17 (0.80, 1.70)
>4:   1.21 (0.84, 1.73)
42 0.87 (0.52, 1.45)
 39 1.09 (0.72, 1.66)










TCE (Urine TCA was
used to identify workers
ever exposed to TCE)













46 SIR=0.9 (0.7, 1.2)










Dry Cleaning & Laundry
Workers
(plant survey, work 
history)
82 SIR=0.95 (0.76, 1.18)
Case-Control Studies
Krishnadasan 2007 Aerospace/radiation Duration x intensity score
Incidence TCE (JEM) No Lag # cases 20-year lag¶ 
362 cases Low/moderate: OR=1.3 (0.8, 2.1) 90 OR=1.3 (0.8, 2.1)
1,805 controls
1988-1999


















     
 
 
     
 
   
 
   



























   
 
   
         
       
    






















    
 
 
          
            
 
            


























RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Christensen 2013 TCE 14 Any exposure: OR=1.3 (0.6, 2.8) 
Incidence 7 “Substantial”:  OR=1.1 (0.4, 3.1)
449 cases
533 controls PCE 9 Any exposure: OR=2.9 (0.8, 9.9)
1979-1985 9 “Substantial”:  OR=6.0 (1.2, 30)
Drinking Water Studies












vs. Camp Pendleton 18 SMR = 1.73 (1.02, 2.73)
HR = 1.23 (0.60, 2.49)
Any exposure (months)     # cases
1-3: OR=0.6 (0.1, 4.8)  1
4-6: OR=1.7 (0.4, 8.1)  2
7-12: OR=0.9 (0.2, 4.2)  2
>12: OR=0.7 (0.2, 2.1)  6





of 4 years or more. TCE:
Medium: 2.6 (0.3, 25)  3





HR = 1.17 (0.49, 2.82) PCE
Medium:  3.5 (0.4, 32) 4
High:        2.1 (0.2, 19) 5
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
** Included in the Morgan et al. 1998 meta-analysis.
*** The Morgan et al. 1998 conducted a meta-analysis that included its own study and three other studies.  The table reports both its study and 
its meta-analysis.
¶ The study did not provide the number of exposed cases for the 20-year exposure lag analysis.
RR: Risk Ratio
OR: Odds Ratio








                      
  
  
   
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
mSMR: Summary SMR obtained through a meta-analysis
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)








    
  





   
      
  
     
  
      
 
   
    
  
    
   
    
   
  
     







   
    
 
ATSDR Assessment: 
In the assessment of the evidence for causation, ATSDR considered the results of an early meta-analysis
in the context of studies published after the meta-analysis was conducted. Our assessment of the 
epidemiological evidence considered some of the viewpoints associated with Hill: (1) temporal
relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and standardized mortality
ratio), (3) consistency of findings, (4) exposure-response relationship (although the relationship could be
non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  When considering the
magnitude of the effect estimate, an effect estimate was considered “near the null value” if ≤1.10 and 
“elevated” if >1.10.  Also considered were the effects of biases, in particular exposure misclassification, 
healthy worker effect, and confounding.  Since prostate cancer is highly survivable, studies that
evaluated incidence were considered to have higher utility than studies that evaluated mortality.
TCE
Of the ten occupational cohort studies that evaluated TCE exposure and prostate cancer, four did not
observe an excess risk (Raaschou-Nielsen et al. 2003, Boice et al. 2006, Hansen et al. 2013 and Buhagen 
et al. 2016).  One study observed an excess risk of 1.20 (95% CI: 0.82, 1.76) that increased to 1.31 (95% 
CI: 0.84, 2.06) among those with high cumulative exposure score (Radican et al. 2008). Another cohort
study observed an SMR of 1.11 (95% CI: 0.93, 1.31) for any exposure to TCE and an SMR of 1.21 
(95% CI: 0.84, 1.73) for exposure duration of more than four years (Lipworth et al. 2011).  Morgan et al.
1998 observed elevated risks when cumulative exposure was evaluated but the trend was not monotonic.  
A meta-analysis of studies conducted by Morgan et al 1998, which included its own study and three
other cohort studies, obtained a summary SMR of 1.09 (95% CI: 0.87, 1.36). A case-control study
found a monotonic trend for an exposure metric that combined duration and intensity scores, with an OR
of 2.4 (95% CI: 1.3, 4.4) for high exposure and a 20-year exposure lag (Krishnadasan et al. 2007).  
Another case-control study obtained an OR of 1.1 (95% CI: 0.4, 3.1) among workers with “substantial”
exposure to TCE (Christensen et al. 2013).
Half of the occupational cohort studies evaluated prostate cancer mortality.  Prostate cancer is highly
survivable, with a 5-year survival percentage of nearly 99%.  Therefore, studies that evaluated prostate
cancer mortality were at a disadvantage, likely missing a majority of cases of the disease and impacting
the precision of the effect estimate (i.e., width of the 95% confidence interval). Although four of the
five occupational cohort mortality studies observed some increase in risk, in one study the increased risk 
was based on one exposed prostate cancer death (Ritz 1999) and the other three studies observed risks
between 1.1 and 1.2. The Camp Lejeune studies also evaluated prostate cancer mortality and obtained 
elevated hazard ratios when comparing the Camp Lejeune cohorts to the Camp Pendleton cohorts. For
the Camp Lejeune civilian workers, a majority of the prostate cancer deaths occurred among those with 
exposure durations of four years or more and risks were elevated among those with medium and high 
cumulative exposure although the trend was not monotonic. Among the seven studies that evaluated 
prostate cancer incidence, three studies did not observe an increased risk (Raaschou-Nielsen et al. 2003;













    
 
 
   
  
    
    
 
 
   








   
et al. 2013), and three observed an increased risk (Axelson et al. 1994; Anttila et al. 1995; and 
Krishnadasan et al. 2007).
Conclusion: ATSDR concludes that there is some evidence for a positive association between TCE and 
prostate cancer. However, the findings from the cohort and case-control studies are mixed with several 
studies finding no elevated risk.  Therefore, ATSDR concludes that there is below equipoise evidence 
for causation for TCE and prostate cancer.
PCE
No meta-analyses have been conducted for PCE and prostate cancer. Few studies have evaluated PCE
exposure and prostate cancer.  Two cohort studies of dry cleaning workers have observed no excess in 
risk (Blair et al. 2003; Selden et al. 2011).  A cohort mortality study of workers exposed to PCE in 
aircraft manufacturing also found no excess in risk (Lipworth et al. 2011). On the other hand, one case-
control study found a great excess in risk among those with “substantial” exposure to PCE (OR=6.0, 
95% CI: 1.2, 30) (Christensen et al. 2013).  Given the paucity of epidemiological studies and the
negative findings in the cohort studies, it is difficult to determine whether an association exists between
PCE and prostate cancer or whether there is evidence against an association. On the other hand, the high 
excess risk observed in the case-control study provides some evidence against a conclusion that PCE
does not cause prostate cancer.
Conclusion: ATSDR concludes that there is insufficient evidence to determine whether an association 
exists between PCE exposure and prostate cancer.  Therefore, ATSDR concludes that there is below
equipoise evidence for causation for PCE and prostate cancer.
Vinyl Chloride
One study evaluated vinyl chloride and prostate cancer and observed an SMR of 0.59 (95% CI: 0.16, 
1.51) based on 4 exposed cases. Since only one study has been conducted, there is insufficient evidence
to determine whether an association exists between vinyl chloride exposure and prostate cancer.  
Therefore, ATSDR concludes that there is below equipoise evidence for causation for vinyl chloride 
and prostate cancer.
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Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information








TCE (job title, plant air
monitoring & Urine TCA
data)







TCE (urine TCA was
used to identify workers
ever exposed to TCE)
2 SIR = 2.11 (0.26, 7.60)
Ruckart 2015 Camp Lejeune Modeled cumulative PCE (OR)  # cases
Incidence contaminated drinking Low:  1.05 (0.14, 5.14)  2 
71 cases water (modeled) High: 1.20 (0.16, 5.89)  2




Morgan 1998 Aerospace, TCE-exposed 16 SMR=0.75 (0.43, 1.22) Exposure Intensity: (SMR)  # cases
Mortality subcohort Low:  1.03 (0.51, 1.84) 11







TCE (job title, plant air
monitoring & Urine TCA
data)
145 SIR=1.1 (0.9, 1.2)
Chang 2003 Electronics factory 51 SMR=1.14 (0.85, 1.51) Employment duration (yrs)¶ 
Mortality Chlorinated organic ≤1:    SMR=1.08  31 cases
86,868 solvents (PCE and TCE) <1 - ≤5:  SMR=1.25 14 cases



















    
         
   
    

















    


























   
   
 
  
    
       
       
 
 
       
       
  
          




       















     
    
                                         
                                                                       
                                                  
                                                      






































solvents (PCE and TCE)
215 SIR = 1.19 (1.03, 1.36) Employment Duration (yrs.)   # cases
≤1: SIR=1.20 (1.01, 1.41)  140
1-5:     SIR=1.19 (0.90, 1.56)  54
>5-10: SIR=1.69 (1.02, 2.64)  19








HR = 1.23 (0.73, 2.06)
Cumulative exposure score (unit-yr):
0-5:   HR=1.57 (0.81, 3.04) 12 cases
5-25: HR=1.01 (0.31, 3.30) 3 cases
>25:  HR=1.05 (0.53, 2.07)  11 cases
Exposure Intensity  (HR)            # cases
Low, intermittent: 1.92 (1.08, 3.43)  18
Low, continuous: 1.71 (0.79, 3.71)  8
Peak, infrequent:   1.18 (0.36, 3.86)  3
Peak, frequent:      1.08 (0.57, 2.02)  14
Costantini 2009 Shoe factory Any exposure: Cumulative exposure (ppm-yr)  # cases
Incidence
679
Benzene (JEM) 24 SIR=1.20 (0.80, 1.79)
latency (years):
≤40:  SIR=1.16 (0.72, 1.86) 17
>40:  SIR=1.30 (0.62, 2.73) 7
1985-2000 10 <30: SIR=1.41 (0.76, 2.62)
14 ≥30: SIR=1.08 (0.64, 1.83)
Any exposure:
Mortality 12 SMR=1.08 (0.62, 1.91) ≤40:  SMR=0.96 (0.46, 2.02)  7
797 3 <30: SIR=0.59 (0.19, 1.81) >40:  SMR=1.31 (0.55, 3.15) 5
1950-2003 9 ≥30: SIR=1.51 (0.79, 2.90)
Lipworth 2011 Aircraft manufacturing Any exposure: Years exposed (RRs):




PCE (JEM) 12 SMR = 1.52 (0.78, 2.65) for PCE <1:    0.82 (0.34, 1.98)  6 1.40 (0.59, 3.30) 6
1-4:   0.31 (0.04, 2.32) 1 0.25 (0.03, 1.81) 1







TCE (urine TCA was
used to identify workers
ever exposed to TCE)





























                        
       










































      
         
          
          
 
           
           
 
           














    
    
 
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Dry Cleaning Workers Studies
Blair 2003 PCE (dry cleaning) 68 SMR = 1.0 (0.8, 1.3) Exposure intensity:    # cases
Mortality Little/no:   SMR=0.8 (0.6, 1.2) 30
4,049 Med/high: SMR=1.2 (0.8, 1.7) 29
1948-1993
Selden 2011 Dry Cleaning: 140 SIR=0.85 (0.72, 1.00)
Incidence PCE subcohort (plant
4,479 survey, work history)
1985-2006
Calvert 2011 PCE (dry cleaning) 28 All:           SMR=1.05 (0.70, 1.52)







18 PCE plus: SMR=1.05 (0.62, 1.66)
Case-Control Studies
Peplonska 2010 Benzene Any exposure: Duration of Exposure (yrs) # cases Exposure Intensity (mg/m3)     # cases
Incidence 115 OR=1.0 (0.8, 1.3) >0-5:   OR=1.1 (0.7, 1.7)  42 >0-1: OR=1.0 (0.7, 1.3)  92
2383 cases >5-10: OR=1.4 (0.7, 2.5)  25 >1:     OR=1.2 (0.7, 2.2)  23
2502 controls >10:    OR=0.8 (0.6, 1.2)  48 Cumulative Exposure
2000-2003 Low:  OR=1.0 (0.7, 1.5)  58
High: OR=1.0 (0.7, 1.4)  57 















   
 


































































































   
  
Reference, type of
















26 OR = 1.53 (0.84, 2.80) for
premenopausal women 




203 OR = 1.05 (0.69, 1.61)
12 OR = 1.47 (0.62, 3.45) for
premenopausal women 
25 OR = 0.94 (0.57, 1.54) for post-
menopausal women
Drinking Water Studies
Gallagher 2011 PCE in drinking water >90th percentile exposure and 13­
Incidence (modeled) year latency:
920 cases 37 OR=1.5 (0.9, 2.5)
1293 controls 13 OR=2.0 (0.8, 4.8) using LOESS
1983-1993 smoothing












10 SMR=0.51 (0.24, 0.94)
HR=0.93 (0.34, 2.50)












21 SMR=0.98 (0.61, 1.50)
















                      
  
   
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
¶ No confidence intervals were reported.
** The study reported results for “chlorinated solvents”, but in a footnote stated that exposure was to TCE.
*** Tables listing number of chlorinated solvent exposed cases may be in error.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
HR: Hazard Ratio
JEM: Job-exposure matrix
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)





   
 
  
    
 
  









     
    
     
 
  
    
   
  
    
 
   
     
      
    
  
   
 
 
     
  






    
  
    
  
   
ATSDR Assessment: 
ATSDR’s assessment of the epidemiological evidence considered some of the viewpoints associated
with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and 
standardized mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although 
the relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).
When considering the magnitude of the effect estimate, an effect estimate was considered “near the null
value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of biases, in particular
exposure misclassification, healthy worker effect, and confounding.  Since breast cancer is highly
survivable, studies that evaluated incidence were considered to have higher utility than studies that
evaluated mortality.  One study that evaluated possible susceptible populations (i.e., pre-menopausal vs
post-menopausal women) was also considered to have higher utility.
TCE
No meta-analyses have been conducted of TCE exposure and male or female breast cancer. Only three 
studies have been conducted that evaluated male breast cancer and TCE exposure.  The two cohort
studies (Raaschou-Nielsen et al. 2003 and Hansen et al. 2013) had two exposed cases each and
conflicting findings, and the Camp Lejeune case-control study observed an overall OR of 1.14 (95% CI:
0.65, 1.97) (Ruckart et al. 2015).
Of the five cohort studies that evaluated female breast cancer and TCE exposure, two did not observe an 
excess risk (Morgan et al. 1998 and Hansen et al. 2013), one observed an elevated risk only among those
workers exposed for more than 4 years (RR=1.47, 95% CI: 0.50, 4.32) (Lipworth et al. 2011) and two 
observed elevated risks in the range of 1.1 (95% CI: 0.9, 1.2, Raaschou-Nielsen et al. 2003)  and 1.2 
(95% CI: 0.7, 2.1, Radican et al. 2008).  One case-control study obtained an OR of 1.65 (95% CI: 1.04, 
2.62) for any TCE exposure which increased to 2.1 (95% CI: 1.2, 3.7) for those with exposure duration 
of at least 10 years (Oddone et al. 2014). Female breast cancer is highly survivable with a five-year
survival percentage of nearly 90%. It is likely that the three cohort mortality studies missed a majority
of breast cancer cases. Nevertheless, the findings from both the incidence and the mortality studies were
evenly mixed.  The Camp Lejeune mortality study of Marines did not observe an excess risk whereas the 
mortality study of civilian workers observed an excess risk of 1.21 (95% CI: 0.58, 2.51) when compared 
to civilian workers at Camp Pendleton (Bove et al. 2014a, b).
Conclusion: The epidemiological evidence for male breast cancer and TCE exposure is too sparse to 
determine whether an association exists. The results from the studies of female breast cancer and TCE
exposure are inconsistent. Therefore, ATSDR concludes that there is below equipoise evidence for 
causation for TCE and breast cancer.
PCE
No meta-analyses have been conducted for PCE and breast cancer. No occupational studies evaluated 
PCE exposure and male breast cancer. Three occupational cohort studies have evaluated dry cleaning
workers and female breast cancer.  One study of breast cancer incidence found no excess in risk (Selden 
et al. 2011).  One study of breast cancer mortality found an excess risk (SMR=1.2, 95% CI: 0.8, 1.7)
among those with medium or high exposure and no excess risk among those who worked at pick-up 




     
    
 
   
  
 




    
 
 
   
   
    
   






     
 
   
     
   
    
   
   









    
   
     
  
    
  
 
garments) and who were assigned as having “little/no exposure” (Blair et al. 2003). The third dry
cleaning study found a risk close to the null value (SMR=1.06, 95% CI: 0.51, 1.94)) (Calvert et al.
2011).  One cohort study of aircraft manufacturing workers observed an SMR of 1.52 (95% CI: 0.78, 
2.65) for any PCE exposure and a RR of 1.72 (95% CI: 0.53, 5.62) for those with more than 4 years of
exposure (Lipworth et al. 2011). 
In the Cape Cod drinking water study, exposure to PCE-contaminated drinking water resulted in an 
increased risk (OR=1.5, 95% CI: 0.9, 2.5) among those with the highest cumulative exposures
(Gallagher et al. 2011).
Animal and mechanistic information: Rats exposed by inhalation to PCE had an increased incidence 
of fibroadenoma of the mammary gland, although rats exposed by gavage did not have an increased
incidence (IARC 2014).
Conclusion: The results from the few cohort studies of female breast cancer and PCE exposure are 
mixed.  The findings from the Cape Cod drinking water study and the cohort study of aircraft
manufacturing workers provide some support for an association.  However, the overall evidence for PCE
and breast cancer is limited by the paucity of studies and the mixed findings in the dry cleaning worker
studies.  Therefore, ATSDR concludes that there is below equipoise evidence for causation for PCE
and breast cancer.
Chlorinated Solvents
Two occupational studies that evaluated chlorinated solvents as a group are included in the table for
completeness and provide only weak evidence for an association between female breast cancer and 
either TCE or PCE, separately or as a mixture. One cohort study (Chang et al. 2003, 2005) and one case-
control study (Glass et al. 2015) evaluated chlorinated solvents as a group and female breast cancer.
The cohort study evaluated a workforce likely exposed to both TCE and PCE and possibly other
solvents. The study found an SIR of 1.19 (95% CI: 1.03, 1.36) for any exposure, an SIR of 1.69 (95%
CI: 1.02, 2.64) for employment duration of >5-10 years, but the SIR for >10 years of employment was
below the null value (SIR=0.37, 95% CI: 0.04, 1.35, based on 2 exposed cases) (Chang et al. 2005).  For
breast cancer mortality, the cohort study observed an SMR of 1.14 (95% CI: 0.85, 1.51) for any
exposure and a monotonic trend in the SMRs for employment duration (SMR=1.32 for >5 years of
employment) (Chang et al. 2003). One case-control study found an excess risk exclusively among pre­
menopausal women (Glass et al. 2015).  This study indicated that the predominant chlorinated solvent
exposure among the women in the study was due to work as a dry cleaner.
Benzene
No meta-analyses have been conducted for benzene and breast cancer. Two occupational cohort studies
(Constantini et al. 2009, Linet et al. 2015) and two case- control studies (Peplonska et al. 2010, Glass et
al. 2015) have evaluated benzene exposure and breast cancer. One cohort study observed an SIR of 1.30 
(95% CI: 0.62, 2.7) in the high cumulative exposure group (Constantini et al. 2009), and the other
observed a RR of 1.2 (95% CI: 0.6, 2.5) for any exposure (Linet et al. 2015).  One case-control study





    
 
    
  
    
 
 
control study found no elevated risk among those with any benzene exposure but did observe elevated 
risks for those with higher exposure intensity (OR=1.2, 95% CI: 0.7, 2.2) (Peplonska et al. 2010).
Conclusion: The few studies that have been conducted of benzene exposure and breast cancer have
found excess risks.  However, the paucity of studies of benzene exposure and breast cancer leads





















    

























    
       
     
 
         
          






















   
                                                       
                          














    
 
 
                             
  
 
       




Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative exposure 
cancer data, total # (exposure exposed information








sRR = 1.08 (0.82, 1.42) for 3 PCE workers studies (2 case-control incidence studies, 1 cohort mortality study)











TCE (urine TCA) 5 SIR=0.82 (0.27, 1.90)
Morgan 1998 Aerospace Cumulative Exposure (SMR)     # cases
Mortality TCE subcohort 8 SMR=1.36 (0.59, 2.68) Low TCE:  0.51 (0.01, 2.83)  1
4,733 High TCE: 1.79 (0.72, 3.69)  7 
1950-1993 Cumulative & Peak Exposure (RR)   # cases
Peak (med/high): 1.41 (0.52, 3.81) 5
Low cumulative: 0.69 (0.09, 5.36)  1
High cumulative: 2.71 (1.10, 6.65) 7
Raaschou-Nielsen TCE (job title, plant Any exposure:











Cumulative exposure score (RRs)
Zero lag # cases  20 year lag # cases
Medium: 1.8 (0.6, 5.2)  19         1.8 (0.6, 5.1)       20










HR=1.05 (0.47, 2.35)  (males
only)
Cumulative exposure score (unit-yr):
0-5:  HR=0.96 (0.37, 2.51) 9 cases
5-25: HR=1.77 (0.70, 4.52) 10 cases
>25:  HR=0.65 (0.21, 1.98)   5 cases
Exposure Intensity  # cases
Low, intermittent HR=1.03 (0.44, 2.41)  17
Low, continuous  HR=1.32 (0.55, 3.18)   14
Peak, infrequent   HR=0.59 (0.12, 2.78) 2






























































































    
Reference, type of 
























Note: PCE 8hr TWA, mean=9.5 ppm,














SIR=1.21 (0.91, 1.58)  males



























































   
  
 
                                                                                    
          
                                 
               
          
            
                                   
                
 
            
                                        
              











   
 
   


















    




                  
            

















      
    
    
    
      
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative exposure 
cancer data, total # (exposure exposed information









JEM Females were not assessed for





Cumulative Exposure Indices: OR  (# cases):
Medium  High    Substantial
TCE (JEM)  Males:      1.1 (0.8,1.3) (154) 1.1 (0.9,1.4) (182)   1.3 (0.9,1.7) (68)
Females:      1.0 (0.6,1.7)   (21) 1.6 (1.0,2.5) (32)  0.6 (0.2,2.3) (3)
TCE (JTEM)  Males:  0.8 (0.6, 1.2)  (47) 1.3 (0.9,1.7)  (74)  1.8 (1.2,2.7) (36)
PCE (JEM)     Males:  1.1 (0.9,1.3) (162) 1.2 (1.0,1.5) (172)   1.4 (1.0,1.9) (71)
Females:       1.8 (1.0,3.0)  (21) 1.0 (0.6,1.9) (16)  0.7 (0.2,2.5) (3)
PCE (JTEM)   Males: 1.0 (0.7,1.5)   (37)  1.2 (0.8,1.7)  (47)   1.8 (1.1,3.1) (22)
Benzene (JEM)   Males:  1.1 (0.8,1.4)  (95)  0.9 (0.7,1.2) (70)    1.5 (1.0,2.1) (47)
Females:  1.2 (0.7,2.0) (21) 1.5 (0.9,2.8) (18)   1.4 (0.6,3.3) (8)
Benzene (JTEM) Males:  0.7 (0.5,1.0) (51) 1.0 (0.7,1.3) (71)   1.4 (0.9,2.1) (37)
Females:  0.4 (0.1,1.8)   (2) 0.4 (0.1,1.2)  (3)   0.8 (0.2,3.7)  (2)
Christensen 2013 TCE 10 Any exposure: OR=0.7 (0.3, 1.7)
Incidence 5 Substantial: OR=0.6 (0.2, 1.7)
484 cases
533 controls PCE 2 Any exposure: OR=0.5 (0.1, 3.0)
1979-1985 2 Substantial: OR=0.9 (0.1, 7.3)









Entering dry cleaning union:
<1960: SMR=1.1 (0.5, 2.0)  9 cases
≥1960: SMR=2.9 (0.6, 9.5) 3 cases
Duration in the dry cleaning union:
<4.4 years; SMR=2.1¶
≥4.4 years: SMR=0.9¶ 
Exposure Intensity:        # cases
Little/no: SMR=1.4 (0.4, 3.2) 5










RR=1.44 (1.1, 1.9) 4 countries
RR=1.69 (1.2, 2.4) 2 countries
with most complete data on
exposure
Duration of employment:
≤1 yr          OR=1.50 (0.57, 3.96)    6 cases
2-4 yrs       OR=2.39 (1.09, 5.22)   10 cases
5-9 yrs       OR=0.91 (0.52, 1.59)   17 cases
≥10 yrs      OR=1.57 (1.07, 2.29)   53 cases


























   
     



























   
 
 
             
             












































Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative exposure 
cancer data, total # (exposure exposed information
of subjects, follow- assessment) cases
up period
Calvert 2011*** Dry Cleaning 10 All:           SMR=1.81 (0.87, 3.33) 9 of 10 cases had duration of ≥5 years
Mortality (occupation, 0 PCE only: No cases and latency of ≥20 years (SMR=4.08 
1,704 industry surveys, 10 PCE plus: SMR=2.59 (1.24, 4.76) (2.13, 7.12)
618 PCE-only personal monitoring
1,086 PCE-plus data)
1940-2004
Selden 2011 Dry Cleaning and Any exposure
Incidence Laundry Workers: 38 All: SIR=0.92 (0.65, 1.26)
9,440 (plant survey, work 18 Men: SIR=0.86 (0.51, 1.36)








PCE in drinking 
water (modeled)
13 OR = 1.55 (0.74, 3.01) Note: High exposure (>90th
percentile) was in range of Camp
Lejeune drinking water levels.
Cumulative exposure:
Low:  OR=1.16 (0.48, 2.48)
High: OR=6.04 (1.32, 21.84)
       # cases
9
4












vs Camp Pendleton 11
SMR=0.84 (0.42, 1.51)
HR=0.76 (0.34, 1.71)


























































* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
Ѱ There were only 2 bladder cancer deaths among female workers.
** The study was included in the Vlaanderen et al. 2014 meta-analysis.  It is included in the table because of additional information on TCE
and benzene as well as information on exposure intensity.
*** The study was included in the Vlaanderen et al. 2014 meta-analysis.  It is included in the table because of information on exposure
duration and/or cumulative exposure.
¶ Median years in the union was 4.4.  The study did not provide confidence intervals or the number of bladder cancer deaths for this analysis.
JEM: job-exposure matrix
JTEM: job-task exposure matrix
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)










   
  
  
        




   
   
  
  
    
    




   








   
   
   
    
  
      
   






Summary of EPA and IARC reviews of PCE and bladder cancer:
EPA Toxicological Review of Tetrachloroethylene, 2012
EPA identified 32 epidemiological studies reporting data on bladder cancer and PCE exposure.  Its
review concluded: “In conclusion, the pattern of results from this collection of studies is consistent with 
an elevated risk for tetrachloroethylene of a relatively modest magnitude. The effect estimates from four
of the five studies with the relatively high quality exposure-assessment methodologies provide evidence
of an association, with relative risks of 1.44 to 4.03 (Calvert et al. , 2011; Lynge et al. , 2006; Blair et al.
, 2003; Pesch et al. , 2000b; Aschengrau et al. , 1993). …  Confounding by smoking is an unlikely
explanation for the findings….” (EPA 2012, pp. 4-100, 4-101).
A subsequent review article by EPA researchers who authored the toxicological review concluded: “The 
epidemiological evidence from cohort and case–control studies provides evidence of associations
between PCE exposure and bladder cancer, non-Hodgkin lymphoma, and multiple myeloma in adults. 
Of these, bladder cancer and non-Hodgkin lymphoma were considered to have the strongest databases
on the basis of the relative consistency of an observed association among studies with the higher quality
exposure measurement and indication of increasing risk with increasing exposure among the studies
using a cumulative exposure metric.” (Guyton KZ et al. 2014).  The review emphasized that the studies
of dry cleaning workers were useful since the workers “are unlikely to have been exposed to other
occupational bladder carcinogens.” (Guyton KZ et al. 2014).
“…PCE is characterized as “likely to be carcinogenic to humans” (U.S. EPA 2012). This
characterization is based on suggestive evidence of carcinogenicity in epidemiological studies and 
conclusive evidence that the administration of PCE, either by ingestion or by inhalation to sexually
mature rats and mice, increases tumor incidence.” (Guyton et al. 2014)
IARC Monograph 106 (IARC 2014)
In its assessment of the human data for the carcinogenicity of PCE, IARC focused on studies of dry
cleaners (i.e., not mixed with laundry workers) and studies that distinguished worker exposures to PCE
(IARC 2014).  IARC concluded: “All eight studies that evaluated employment in dry-cleaning showed 
positive associations with bladder cancer. ….  While positive associations with bladder cancer were
observed in several cohort and case-control studies, and smoking was adequately controlled for in the
majority, employment in dry-cleaning was in most cases the only indicator of exposure to 
tetrachloroethylene, the number of exposed cases was small, and support for an exposure-response
relationship was lacking.” (p. 326, IARC Monographs – 106, 2014).   It further concluded: “The bladder
has been identified as a target organ for tetrachloroethylene-induced carcinogenesis in humans; however
there are no mechanistic studies available to support this.  … There is limited evidence in humans for
the carcinogenicity of tetrachloroethylene. Positive associations have been observed for cancer of the 






   









     




     
   
 
    
    





    
   
 
  
    
  
 
      
   
 
   
 
    
  
  




In the assessment of the evidence for causation, ATSDR placed high weight on assessments conducted 
by EPA and IARC as well as the meta-analysis of PCE and bladder cancer. High weight was also given 
to studies that provided mechanistic information.  Our assessment of the epidemiological evidence
considered some of the viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the
effect estimate (e.g., risk ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, 
(4) exposure-response relationship (although the relationship could be non-linear or non-monotonic), 
and (5) biological plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an 
effect estimate was considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered 
were the effects of biases, in particular exposure misclassification, healthy worker effect, and
confounding. 
PCE
The ATSDR assessment of the evidence for causality for PCE and bladder cancer weighted strongly the
assessments by EPA and IARC and the meta-analysis conducted by Vlaanderen et al. 2014.  Subsequent
to the assessments by EPA (EPA 2012) and IARC (IARC 2014), an IARC workgroup comprising those 
who were authors of the IARC monograph as well as additional researchers conducted a meta-analysis
of PCE and bladder cancer focused on dry cleaning studies but also evaluating studies of other workers
exposed to PCE (Vlaanderen et al. 2014). The researchers reported that there was no evidence of
between-study heterogeneity or publication bias.
Seven studies of dry cleaning workers (3 cohort and 4 case-control) were included in the Vlaanderen et
al. 2014 meta-analysis with a total of 139 exposed cases.  The summary RR was 1.47 (95% CI: 1.16, 
1.85).  Among the case-control studies, all of which adjusted for smoking, the summary RR was 1.50 
(95% CI: 0.8, 2.84) which was similar to the summary RR among the cohort studies of 1.46 (95% CI:
1.14, 1.87), indicating that the cohort studies were unlikely to be biased by uncontrolled confounding by
smoking. 
Three key dry cleaning cohort studies conducted by NCI, NIOSH and Nordic researchers that were
included in the meta-analysis found positive associations.  The Nordic study (Lynge et al. 2006)
obtained RRs of 1.44 (1.07, 1.93) and 1.69 (1.18, 2.43) for all Nordic countries and analyses restricted to
Denmark and Norway, respectively. Denmark and Norway had the most complete information on 
employment with fewer than 2% of the workers being unclassified concerning employment in dry
cleaning compared to 35% unclassifiable among Swedish workers and 41% unclassifiable among
Finland workers. 
The NCI dry cleaning worker study (Blair et al. 2003) obtained an SMR of 1.3 (0.7, 2.4).  The NIOSH
dry cleaning worker study (Calvert et al. 2011) obtained an SMR of 2.59 (1.24, 4.76) for workers who 
worked in shops where PCE was the primary cleaning solvent but also worked in shops for which the
primary solvent was unidentified (but likely PCE).
These three key cohort studies of dry cleaning workers had some information on exposure-response
trends. The NCI study (Blair et al. 2003) found a slightly higher SMR for those with medium/high 
exposure (SMR=1.5, 95% CI: 0.6, 3.1) compared to those with little exposure (SMR=1.4, 95% CI: 0.4, 
3.2) with wide confidence intervals due to small numbers of cases in the two exposure categories. The





      
 
  
      
 
     
 















      
 
 




   
 
  
       
     
  
 
   
  
    
     
    
       
      
        
   
  
of PCE in US dry cleaning facilities by 1960 (Blair et al. 2003).  The NIOSH study (Calvert et al. 2011)
observed an elevated SMR for workers exposed for at least 5 years (SMR=4.08, 95% CI: 2.13, 7.12) but
no elevated SMR among those exposed for <5 years.  Finally, a study of Nordic dry cleaning workers
(Lynge et al. 2006) found elevated RRs for those with up to 1 year duration of employment (RR=1.50, 
95% CI: 0.57, 3.96), 2-4 years duration of employment (RR=2.39, 95% CI: 1.09, 5.22) and 10 or more
years duration of employment (RR=1.57, 95% CI: 1.07, 2.29) but not for those with 5-9 years duration 
of employment (RR=0.91, 95% CI: (0.52, 1.59).
The Vlaanderen et al. 2014 meta-analysis also evaluated one cohort study and two case-control studies
of PCE-exposed workers for a total of 463 exposed cases.  One case-control study (Christensen et al. 
2013) had only two cases with PCE exposure and is of low utility.  The cohort study (Lipworth et al.
2011) of aircraft manufacturing workers had 17 bladder cancer deaths exposed to PCE with an SMR of
0.84. NTP considered this study of relatively low utility because it did not provide information on 
exposure levels, the duration of exposure was likely short, and it did not evaluate an exposure-response 
trend (NTP 2015). From information provided in an earlier article about the exposure assessment of this
plant, the measured levels of PCE in the air during an 8 hour shift were considerably lower (i.e., 1/6th 
the level) than those typically found in dry cleaning establishments. The other case-control multicenter
study of the German population (Pesch et al. 2000) found monotonic exposure-response trends for
exposure indices based on duration, intensity and probability of exposure (using a job exposure matrix
and a job-task exposure matrix) for male workers. For “substantial exposure” using the exposure index
based on the job-task exposure matrix, the OR was 1.8 (95% CI: 1.1, 3.1).  (There were small numbers
of female cases in the high exposure category.)
Based on the findings in the German case-control study (Pesch et al. 2000) and the three dry cleaning
cohort studies, the authors of the meta-analysis concluded that there was some evidence of an exposure-
response trend: “Our meta-analysis demonstrates an increased risk of bladder cancer in dry cleaners,
reported in both cohort and case-control studies, and some evidence for an exposure-response
relationship. Although dry cleaners incur mixed exposures, tetrachloroethylene could be responsible for
the excess risk of bladder cancer because it is the primary solvent used and it is the only chemical
commonly used by dry cleaners that is currently identified as a potential bladder carcinogen.” 
(Vlaanderen et al. 2014).
The Camp Lejeune mortality studies provided an initial look at the disease situation among adults
exposed at the base (Bove et al. 2014a, b). The cohorts of Marines and civilian workers were too young
at the end of follow-up to effectively evaluate cancer mortality, especially bladder cancer. According to 
the American Cancer Society, bladder cancer occurs mainly in older people with the average age at the 
time of diagnosis of 73 years and about 90% diagnosed after the age of 55. However, the median ages at
the end of follow-up for Marines/Navy personnel and civilian workers at Camp Lejeune were 49 years
and 58 years, respectively, with most members of these cohorts under the age of 65 years at the end of
follow-up. Because of their young age at the end of follow-up, a strong healthy worker/veteran bias
would be expected, especially among Marines.  In the study of civilian workers, there were only two
cases of bladder cancer in the Camp Lejeune cohort and the SMR was 0.53 (95% CI: 0.06, 1.92)
indicating a strong healthy worker effect for that cancer (Bove et al. 2014b).  In the Camp Lejeune study 
of Marines and Navy personnel, there were 11 cases in the Camp Lejeune cohort with an SMR of 0.84
(95% CI: 0.42, 1.51) indicating a strong healthy veteran effect (Bove et al. 2014a). Other causes of
death occurring in the Camp Lejeune marine cohort also indicated a strong healthy veteran effect, for
example, all causes of death (SMR=0.83, 95% CI:0.81, 0.84) and all cancers (SMR=0.85, 95% CI: 0.85, 




   
     
   
 
  
    
  
     
  











   
   
 
   
     
  
    
 
     
      
   
     
     
   
       
    
    
  
  
   
 
    
   
    
  




























































































comprehensive evaluation of bladder cancer at Camp Lejeune should be based on incidence data rather
than mortality data. A future cancer incidence study of Marines/Navy personnel and civilian workers at
Camp Lejeune is underway. 
The study of PCE-contaminated drinking water in Cape Cod, MA and bladder cancer incidence found an 
elevated odds ratio (OR) and an exposure response trend (Aschengrau et al. 1993).  The odds ratio for
exposures >90th percentile was 6.04 (1.32, 21.84).  The PCE levels corresponding to the 90th percentile
were within the range estimated at Hadnot Point and Tarawa Terrace (Bove et al. 2014a).
Although there are animal data indicating that PCE causes neoplasms of the hematopoietic system, 
testes, kidney and brain, there are no animal data indicating that PCE causes bladder neoplasms.
Mechanistic information: Although there are no mechanistic data that provide strong evidence in 
support of a causal association between PCE and bladder cancer, there are studies suggesting that
workers exposed to chlorinated solvents who have certain genetic polymorphisms affecting a key
metabolic pathway for PCE are at increased risk of bladder cancer than those exposed to these solvents
who do not have these genotypes.  The metabolism of PCE takes place via two main pathways,
oxidation by cytochrome P450s and conjugation with glutathione (GSH) by glutathione S-transferases
(GSTs) (Guyton et al. 2014).  Some metabolites of the GSH conjugation pathway, e.g., 
trichlorovinylglutathione (TCVG) and S-trichlorovinyl-L-cysteine (TCVC), are genotoxic (Cristofori et
al. 2015). In the liver, the role of GSH is as an antioxidant and cytoprotective agent, whereas in the
kidney and to some extent in the bladder epithelium, GSH functions primarily in the bioactivation and 
subsequent cytotoxicity of PCE (IARC 2014; Matic et al. 2014). The amount of TCVG from PCE
produced in rat kidney is five-fold higher than the amount of dichlorovinylglutathione (DCVG) from
TCE, indicating the importance of the GSH conjugation pathway for PCE (IARC 2014). GST enzymes
play a role both in detoxification and antioxidant defense as well as bioactivation resulting in cytotoxic
metabolites. Among those GST enzymes present in uroepithelium, GSTM1 plays a key role in cellular
defense against free radicals whereas GSTT1 produces cytotoxic metabolites (Matic et al. 2014). 
Evidence from studies of workers exposed to chlorinated solvents suggested that there is effect
modification of the exposure-bladder cancer relationship produced by polymorphisms in the genes for
GSTM1 and GSTT1 enzymes (Simic et al. 2009; Matic et al. 2014).  Chlorinated solvent-exposed 
workers with a GSTM1-null genotype were at a higher risk of bladder cancer compared to exposed 
workers with an active GSTM1 genotype and to unexposed workers with either an active or null
GSTM1 genotype (Matic et al. 2014). On the other hand, chlorinated solvent-exposed workers with a
GSTT1-active genotype were at a higher risk of bladder cancer compared to exposed workers with a
GSTT1-null genotype and unexposed workers with either an active or null GSTT1 genotype (Matic et
al. 2014).  These findings suggest that lacking a fully functional GSTM1 gene and/or having a fully
functional GSTT1 gene enhances the risk of bladder cancer from chlorinated solvent exposure. It is
likely that those exposed to PCE who have a fully functional GSTT1 gene would have higher amounts
of the genotoxic metabolites TCVG and TCVC in the kidney and bladder than those who have a null
GSTT1 gene. And those exposed to PCE with a null GSTM1 gene would have a more difficult time
deactivating the reactive metabolites that result from PCE metabolism via the GSH conjugate pathway.
Conclusion: The Vlaanderen et al. 2014 meta-analysis concluded that there was an increased risk of
bladder cancer in the dry cleaners studies that could not be explained by confounding due to tobacco
smoking. PCE was the main exposure in the dry cleaners studies and the NCI study of dry cleaning
workers noted that the elevation in bladder cancer mortality risk coincided with the introduction of PCE
in US dry cleaning facilities by 1960 (Blair et al. 2003).  Although the meta-analysis found only a slight





   




   
  







        
    
   
   
    
    
 
   
    
      
    
 





   
 
       
  
limitations of these studies mentioned above. The meta-analysis is consistent with previous assessments 
by IARC (IARC 2014) and EPA (EPA 2012; Guyton et al. 2014) that found consistent, positive
associations between PCE occupational exposure and bladder cancer.  The Cape Cod, MA study of
PCE-contaminated drinking water also found positive associations with bladder cancer incidence and an 
exposure-response trend (Aschengrau et al. 1993).  At this time there are no animal data or mechanistic
data that definitely support the epidemiological findings, but ATSDR believes the epidemiological 
studies provide sufficient evidence for causation and are consistent with the mechanistic information
that certain genetic polymorphisms may enhance the production of genotoxic PCE metabolites in the 
bladder via the GSH conjugate pathway. Therefore, ATSDR has decided to adopt a different position 
from that currently held by EPA and IARC and conclude that there is sufficient evidence for causation
for PCE and bladder cancer. 
TCE
No meta-analyses have been conducted for TCE and bladder cancer. The epidemiological evidence 
provides only limited evidence of a positive association between TCE and bladder cancer. Of ten
occupational cohort studies, six did not observe an excess risk of bladder cancer.  Of the four remaining
cohort studies, one study observed an exposure-response trend for cumulative exposure (Zhao et al.
2005), one study found elevated risks among those most highly exposed but the trend was not
monotonic (Morgan et al. 1998), one study found elevated risks only among male workers (Hansen et al.
2013) and one study found elevated risks only among female workers (Raaschou-Nielsen et al. 2003). 
The Camp Lejeune mortality studies did not find increased risks for bladder cancer (Bove et al. 2014a, 
b).  Bladder cancer occurs mainly in older people and has a 5-year survival percentage of over 77%.
Because the Camp Lejeune cohorts were relatively young at the end of follow-up, few deaths due to
bladder cancer occurred. 
Conclusion: ATSDR concludes that there is below equipoise evidence for causation for TCE and
bladder cancer.
Vinyl Chloride and Benzene
Two studies evaluated benzene exposure and bladder cancer with mixed results.  One study evaluated 
vinyl chloride exposure and bladder cancer.  Given the paucity of epidemiological studies, there is
insufficient information to determine whether an association exists for either vinyl chloride or benzene
and bladder cancer. Therefore ATSDR concludes that for vinyl chloride and benzene there is below















     
   












          
              
             




















































   
                       
                                            
                                            












   
 
 
   










    
    
   
 
 
    
    
      
 
                    
             
          
         
 
                 
          
          


















Any solvents summary OR = 1.35 (1.09, 1.67) 16 studies
summary OR = 1.58 (1.23, 2.04) for 6 higher quality studies
─
Case-Control Studies
McDonnell 2003 Any solvents Any exposure to solvents: <10 years:         OR=1.2 (0.5, 2.7) 13 cases
Mortality 31 OR = 1.53 (0.81, 2.87) 10 - <20 years: OR=1.1 (0.4, 3.2) 6 cases
57 male cases 20 - <30 years:  OR=1.3 (0.3, 5.3) 3 cases















OR =   6.1 (1.2, 33)
OR = 10.5 (0.97, 113)
Duration of exposure, 1-tertile







Brouwer 2015 (JEM) Ever exposed (RR) Cumulative Exposure tertiles, (RR)
Mortality Aromatic solvents 95 Low: 0.84 (0.64, 1.10) Aromatic Solvents     # cases    Chlorinated Solvents      # cases
402 male cases** 13 High: 0.84 (0.45, 1.57) 1:  0.62 (0.40, 0.97)  27    1.00 (0.65, 1.54)  31
2098 male controls
Chlorinated solvents Ever exposed (RR)
2:  1.11 (0.76, 1.62)  42    1.05 (0.68, 1.61)   29
3:  0.82 (0.56, 1.21)  39    0.97 (0.60, 1.55)  26
46 Low: 1.09 (0.76, 1.56)
40 High: 0.93 (0.63, 1.35)
Van der Mark 2015 (JEM) Ever exposed (OR) Exposure duration (yrs.)      # cases Cumulative Exposure tertiles
Incidence Aromatic solvents 168 Low: 0.97 (0.73, 1.29) Aromatic solvents: Aromatic solvents # cases
444 cases 14 High: 0.82 (0.43, 1.58) 1-7:     OR=0.88 (0.61, 1.26)  57 1:  OR=0.89 (0.61, 1.28) 58
876 controls
Chlorinated solvents Ever exposed (RR)
8-24:   OR=0.91 (0.62, 1.34)  54
25-67: OR=1.26 (0.80, 1.97)  71
2:  OR=0.86 (0.58, 1.27)  52
3:  OR=1.33 (0.86, 2.05)    72
71 Low: 1.04 (0.74, 1.46)
37 High: 0.86 (0.55, 1.36) Chlorinated solvents:
1-7:     OR=0.65 (0.40, 1.06)  26
8-24:   OR=1.01 (0.65, 1.57)  38
25-67: OR=1.39 (0.88, 2.20) 44
Chlorinated solvents # cases
1:  OR=0.74 (0.46, 1.19)  27
2:  OR=1.09 (0.70, 1.69)  43






























   
 
 


























RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information














5 SMR = 2.19 (0.71, 5.11)
HR = 3.13 (0.76, 12.86)
The cases at Lejeune had at least
18 months of exposure
Four of five deaths had above the 
median cumulative exposure to TCE
and PCE
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted. 
** Due to small numbers of exposed female cases, the results for males are presented only in the table. (Note: The information on female 
exposed cases was provided in the journal article’s supplementary document. For any exposure (i.e., ever low or high exposed), the number of
exposed female cases and the odds ratios for aromatic solvents and chlorinated solvents were 7 cases, OR=0.74 (0.32, 1.70), and 5 cases, 
OR=0.48 (0.17, 1.33), respectively.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
HR: Hazard Ratio
95% CI: 95% Confidence Interval
JEM: Job-exposure matrix









   




   
   
 
     
 






     
   
   
  
        
  
   





    
     
  
  




The epidemiological evidence for TCE or PCE exposures and Parkinson disease is very limited because
few studies have been conducted.  On the other hand, there is mechanistic information based on animal
studies. Therefore, ATSDR’s assessment of the evidence for causation placed high weight on studies
and review articles that provided mechanistic information. High weight was also given to a well-
conducted twin study although the study was limited by a small number of exposed cases.
TCE and PCE
One study has evaluated TCE and PCE exposure and Parkinson disease; two studies have evaluated
chlorinated solvents and aromatic solvents separately, and several studies have evaluated any solvents.  
A meta-analysis evaluated 16 studies that evaluated any solvents and obtained a summary OR of 1.35 
that increased to 1.58 when the analysis was restricted to six higher quality studies (Pezzoli et al. 2013). 
The two studies of chlorinated and aromatic solvents had mixed findings (Brouwer et al. 2015 and Van 
der Mark et al. 2015).  The key study is the Goldman et al. 2012 twin study which found high elevations
in risk for both PCE and TCE with evidence of an exposure-response relationship for exposure duration 
and cumulative exposure.  This study used rigorous methods to ensure diagnostic accuracy and to assess
exposures.  The twin design had the advantage of controlling for potential confounders due to genetic
and shared environmental factors. A limitation was the small number of exposed cases which resulted in 
wide confidence intervals.
Parkinson disease mortality was evaluated in the Camp Lejeune mortality study of civilian workers and 
an elevated risks were observed when comparing these workers to the U.S. population (SMR=2.2, 95% 
CI: 0.7-5.1) and civilian workers at Camp Pendleton (RR=3.1, 95% CI: 0.8, 12.9).  Although limited by
the small number of deaths due to Parkinson disease, the study found that four of the five deaths
occurring among the Camp Lejeune workers had above the median cumulative exposure to TCE and 
PCE (Bove et al. 2014b). Parkinson disease mortality could not be evaluated in the Camp Lejeune
mortality study of Marines. 
There have been a few case reports of Parkinson disease and Parkinsonism among TCE-exposed 
workers that are described in a review article of TCE and Parkinson disease by Zaheer and Slevin 2011. 
Animal and mechanistic information:
TCE has been found to be a mitochondrial neurotoxin in animal studies, and mitochondrial dysfunctions
in substantia nigra dopamine neurons is considered to cause the disease (Gash et al. 2008; Zaheer and 
Slevin 2011). Studies in rats have shown that TCE exposure causes selective loss of dopaminergic
neurons in the substantia nigra pars compacta (SNpc), a pattern consistent with human pathological
staging of Parkinson disease (Goldman et al. 2011).  A systematic review of the toxicological and
epidemiological evidence made several observations: (1) it is uncertain whether inhalation of TCE can 
cause similar damage since the animal studies involved oral administration of TCE; (2) it is uncertain
whether TCE or its metabolites cause the damage to dopaminergic neurons in the SNpc; and (3) if a






     
   
 
 
     
     
  
    
    
  
    
  
      
   
   
     
 












TCE and PCE have some common metabolites (Lock et al. 2013).  The review concluded: “On balance, 
the convergence of toxicological and epidemiological research suggests a plausible association between 
TCE exposure and PD [Parkinson disease].” A recent report by the IOM echoes this conclusion:
“…Parkinson disease is a neurobehavioral effect that may result from exposure to TCE and/or PCE.”
(IOM 2015).
Conclusion: Positive associations have been observed for TCE and PCE and Parkinson disease in a
well-conducted twin study (Goldman et al. 2012). The Camp Lejeune study of civilian workers also 
found a positive association for Parkinson disease (Bove et al. 2014b).  Because only two studies have 
focused on TCE exposure (Goldman et al. 2012; Bove et al. 2014b), the epidemiological evidence for
causation for TCE and Parkinson disease is very limited. However, the findings from animal studies
indicating a plausible mechanism for TCE exposure and Parkinson disease that is relevant to humans
provides important supplemental evidence for causation. ATSDR concludes that the epidemiological
evidence for causality by itself is currently too weak to achieve equipoise and above.  However, given 
the strong supporting mechanistic evidence for TCE, ATSDR concludes that there is equipoise and 
above evidence for causation for TCE and Parkinson disease. 
For PCE, the epidemiological evidence is very limited and there is no available information on a
plausible mechanism as there is for TCE. However, this may change if a metabolite of TCE that is
common to PCE is found to be the agent causing damage to the dopaminergic neurons.  Given what is
presently known, ATSDR concludes that there is below equipoise evidence for causation for PCE and
Parkinson disease. 
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Person-years exposure to TCE:
<2.5: HR=1.99 (1.00, 3.97)
2.5-10: HR=1.52 (0.72, 3.21)
>10:  HR=2.05 (1.01, 4.17)
Person-years exposure to PCE:
<0.5: HR=1.79 (0.39, 8.11)
0.5-2.5: 0
>2.5:  HR=0.93 (0.12, 7.32)
Cumulative TCE exposure (unit-yrs)
<5:  HR=1.73 (0.86, 3.48)
5-25:  HR=2.48 (1.20, 5.15)
>25:   HR=1.65 (0.82, 3.35)
Jacob 2007 TCE Ever exposed to TCE:
Incidence 
269 (cohort with
6 RR = 2.5.(0.9, 6.5) for ESRD
High TCE cumulative exposure:
glomerulonephritis)
1994-2001
3 RR=2.7 (0.7, 10.1)
Lipworth 2011 Aircraft manufacturing Nephritis and nephrosis: ─




PCE (JEM) 28 SMR= 1.11 (0.74, 1.60)
Silver 2014 Microelectronics plant 56 Non-malignant chronic renal ─ Cumulative exposure (5 exposure-yrs)
Mortality TCE (JEM) disease HR=1.07 (0.70, 1.63)  for TCE
34,494 PCE (JEM) HR=0.94 (0.47, 1.86)  for PCE
1969-2009





Dry cleaning 13 SMR = 1.1 (0.6, 1.8) for chronic
nephritis
─ Exposure Intensity:  # cases
Little/no: SMR = 0.5 (0.0, 3.8) 2








   












    

















   




    
     
 
 
   
   
    
      
      
       
       
      
      
      
































































1,704 surveys, personal 4 SMR=1.62 (0.44, 4.16)   All
618 PCE-only monitoring data) 2 SMR = 2.60 (0.31, 9.39) PCE only
1,086 PCE-plus
1940-2004
2 SMR=1.18 (0.14, 4.27) PCE plus
Total ESRD:
30 SIR=1.34 (0.990, 1.91)
12 SIR = 1.30 (0.67, 2.26)   PCE only
18 SIR = 1.37 (0.81, 2.17)   PCE plus
Systemic ESRD:
27 SIR=1.55 (1.02, 2.25)  All
12 SIR=1.64 (0.85, 2.86)   PCE only
15 SIR=1.48 (0.83, 2.44)   PCE plus
Hypertensive ESRD
15 SIR=1.98 (1.11, 3.27)  All
8 SIR=2.66 (1.15, 5.23)   PCE only
































7 SMR=0.78 (0.34, 1.54)
HR=1.23 (0.39, 3.87)
3 deaths had exposure durations
of ≤6 months, and the other 4




























* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted. 
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)
ESRD: end stage renal disease.  The Radican et al. 2006 study defines ESRD as chronic renal failure that has advanced to the point that either













   
  
  




    
    
  











   
  
   
    
    
 
    
Summary of EPA and IOM reviews of TCE and PCE and kidney diseases:
The EPA toxicological review of TCE (EPA 2011) concluded that high levels of TCE exposure caused 
proximal tubule damage and increases in various biomarkers of kidney toxicity or ESRD including β2­
microglublin, total protein, NAG, and α1-microglobulin. Animal studies provide evidence that TCE exposure
causes renal toxicity in the form of cytomegaly and karyomegaly of the renal tubules. Studies of TCE
metabolites have demonstrated a potential role for DCVC, TCOH and TCA in TCE-induced kidney toxicity. 
EPA toxicological review of PCE (EPA 2012): “Taken together, the epidemiologic studies support an 
association between tetrachloroethylene and chronic kidney disease, as measured by urinary excretion of
renal proteins and ESRD incidence.”
IOM report, Review of VA Clinical Guidance for the Health Conditions Identified by the Camp 
Lejeune Legislation (IOM 2015), concluded: “While there is some evidence for increased mortality
from solvent-induced hypertensive end-stage renal disease (ESRD), the association between TCE and
PCE and chronic kidney disease is less clear, although there does appear to be an association between
exposures to high levels of these solvents and ESRD.”
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on the assessments
conducted by EPA including information provided by EPA on possible mechanism. Studies that 
evaluated kidney disease subgroupings (e.g., ESRD) were considered to have higher utility than studies
that combined all kidney diseases. Our assessment of the epidemiological evidence considered some of
the viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g.,
risk ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4) exposure-
response relationship (although the relationship could be non-linear or non-monotonic), and (5)
biological plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect 
estimate was considered “near the null value” if ≤1.10 and “elevated” if >1.10. Also considered were 
the effects of biases, in particular exposure misclassification, healthy worker effect, and confounding. 
TCE
Five cohort studies evaluated TCE exposure and kidney diseases. Three of these cohort studies obtained 
relative risk estimates ≥1.9 for TCE and kidney diseases (Boice et al. 2006; Radican et al. 2006; and 
Jacob et al. 2007). One cohort study found an elevated risk for nephritis and nephrosis (Boice et al.
2006); another found an elevated risk for glomerulonephritis (Jacob et al. 2007); and a third found an 
elevated risk for ESRD (Radican et al. 2006).  The other two cohort studies observed RRs of about 1.1 
(Lipworth et al. 2011; Silver et al. 2014). 
The Camp Lejeune mortality study of Marines did not observe an excess in all kidney diseases (HR=1.0, 
95% CI: 0.63, 1.63), but the mortality study of civilian workers did observe an elevated risk in 













     
    
 
   
    
     
      
        




   
   
  
   
  
      
   
 
   
    
    
 
EPA’s toxicological review of TCE noted that high occupational exposures to TCE caused damage to 
the proximal tubule.  Several studies of TCE workers found elevated excretion of urinary proteins
indicating tubule damage (EPA 2011).
Animal and mechanistic information: Evidence from animal studies indicates that TCE causes renal 
toxicity, and there is also evidence that TCE metabolites cause kidney toxicity.
Conclusion: Based on the evidence from epidemiological studies, occupational biomarker studies, and 
animal studies, ATSDR concludes that there is equipoise and above evidence for causation for TCE
and kidney diseases, in particular, ESRD.
PCE
No meta-analyses have been conducted for PCE and kidney disease. Two cohort studies of dry cleaning
workers found elevated risks for kidney disease (Blair et al. 2003; Calvert et al. 2011).  One study found 
an elevated risk for chronic nephritis among workers with medium to high exposures (Blair et al. 2003).  
The other dry cleaning worker study found elevated risks for the combined outcome, acute 
glomerulonephritis, nephrotic syndrome, and acute renal failure, systemic ESRD and hypertensive
ESRD among workers exposed to only PCE (Calvert et al. 2011). Three cohort studies evaluated
industrial workers exposed to PCE and kidney diseases. PCE exposures in these studies were likely
much lower than in the dry cleaning studies. Two of the cohort studies of PCE workers did not observe
elevated risks for kidney disease (Radican et al. 2006; Silver et al. 2014) and another study observed a
relative risk of 1.1 for nephritis and nephrosis (Lipworth et al. 2011). The findings in these three cohort
studies may be due to low PCE exposures. 
EPA’s toxicological review of PCE noted that occupational exposures to PCE caused damage to the
proximal tubule as measured by urinary excretion of renal proteins (EPA 2012). 
Animal and mechanistic information: Evidence from animal studies indicates that PCE causes renal
toxicity in the form of tubular toxicity.  This effect is potentially caused by PCE metabolites via the
GSH conjugation pathway.
Conclusion: The biomarker, animal and mechanistic evidence is similar in strength for PCE and TCE.  
However, the epidemiological evidence for PCE and kidney diseases is somewhat weaker than for TCE. 
Although the two dry cleaning worker cohort studies observed elevated risks, two cohort studies of
industrial workers exposed to PCE found no elevation in risk. It is likely that the discrepancy in the
epidemiological results is due to much lower PCE exposures in the industrial cohorts compared to the
dry cleaning cohorts. Therefore ATSDR considers the dry cleaning studies to be more informative than 
the industrial worker studies in evaluating the effects of PCE exposure, and views the evidence for
causality to be at least equipoise. ATSDR concludes that there is equipoise and above evidence for 
causation for PCE and kidney diseases, in particular, ESRD.
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cancer data, total # 
















TCE (Job title, plant air




SIR=1.7 (0.8, 3.0)  20 year lag
Duration of employment (yrs.)
<1:     SIR=1.7 (0.6, 3.6) 6 cases
1-4.9: SIR=1.9  (0.9, 3.6)  9 cases
≥5:     SIR=1.9 (0.8, 3.7)  8 cases
Higher exposed workers, exposure lag
period (years):
0-9:     no exposed cases
10-19: SIR=2.3 (0.9, 5.0)   6 cases
≥20:    SIR=1.6 (0.6, 3.2)   7 cases
Boice 2006€ Any TCE (job title, 3 SMR=0.88 (0.18, 2.58)
Mortality chemical use 
7,083 information)
1948-1999
Radican 2008 Aircraft maintenance Any TCE exposure: Cumulative exposure score (unit-yr) Intensity (Men only) (HR)          # cases
Mortality TCE (JEM) 17 HR=1.88 (0.61, 5.79) Men only:     # cases Low, intermittent: 1.92 (0.55, 6.73)  13
14,455 15 Men:        HR=1.66 (0.48, 5.74) 0-5:  HR=1.84 (0.48, 7.14)  7 Low, continuous:  0.98 (0.22, 4.41)  4
1953-2000 2 Women:   HR=2.81 (0.25, 31.1) 5-25: HR=1.33 (0.27, 6.59)  3 
>25:  HR=1.67 (0.40, 7.00)  5
Peak, infrequent:   2.15 (0.43, 10.7)  3
Peak, frequent:      1.59 (0.40, 6.41)  6
Lipworth 2011 Aircraft manufacturing Years exposed to TCE:   # cases              Years exposed to PCE: # cases




PCE (JEM) 24 SMR=1.13 (0.72, 1.68) 1-4  RR=0.62 (0.23, 1.63)  5  1-4  RR=1.30 (0.56, 3.02) 7










Men: SIR=1.30 (0.65, 2.32)
(1 case among women)
Lagtime (years) # cases
10:  SIR=1.20 (0.60, 2.14) 11
20:  SIR=1.46 (0.67, 2.78)  9
Urine TCA (mg/L) Ref: <5






Vinyl chloride 4 Any exposure:
SMR=1.12 (0.30, 2.86)
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Reference, type of 
cancer data, total # 



















Santibañez 2008 JEM Exposure level:      All esophageal cases    # cases     Squamous cell            # cases        Adenocarcinoma  # cases
Incidence Chlorinated solvents Low:    OR=1.05 (0.15, 7.17)  2  0     OR=4.92 (0.69, 34.7) 2
185 cases High:   OR=1.76 (0.40, 7.74)  6      OR=2.18 (0.41, 11.6)  5      OR=3.03 (0.28, 32.2) 1
285 controls
1995-1999 Aromatic solvents Low:    OR=1.33 (0.50, 3.53)  11      OR=1.63 (0.49, 5.43)  8      OR=2.27 (0.53, 9.63)  3
High:   OR=0.38 (0.06, 2.22)  2  0      OR=3.07 (0.53, 17.6)  2









OR=3.6 (0.5, 27.0) Squamous cell  (both cases had an exposure duration of 1-9 years and probable exposure to PCE) 
OR=1.1 (0.2, 5.7)   Adenocarcinoma (1 case each had exposure duration of 1-9 and ≥10 years. One case had probable 
exposure to PCE.)
Blair 2003 Dry cleaning 26 SMR=2.2 (1.5, 3.3) Exposure Level (SMR):   # cases
Mortality Little/no:         2.1 (0.9, 4.4)  7
5,369 Medium/high: 2.2 (1.2, 3.5)  16
1948-1993
Calvert 2011 Dry cleaning 16 SMR=2.44 (1.40, 3.97)    All ≥20 years since 1st employment,







10 SMR=2.32 (1.11, 4.27) PCE plus <5: SMR=2.16 (0.85, 4.54)  5 cases
≥5: SMR=4.78 (2.68, 7.91) 11 cases
Selden 2011 Dry Cleaning and Any exposure
Incidence Laundry Workers: 0 Men: ―




































   
   



















    
 
   
      
      









































cancer data, total # 







RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Drinking Water Studies














35 SMR=0.85 (0.59, 1.18)
HR=1.43 (0.85, 2.38)
Duration of exposure (months)
1-3:    OR=0.3 (0.0, 2.5)  1 case
4-6:  OR=1.9 (0.6, 5.8)  4 cases
7-12:  OR=1.5 (0.6, 3.9)  6 cases
>12:   OR=0.7 (0.3, 1.5)  10 cases











4 SMR=0.64 (0.18, 1.65)
HR=0.58 (0.15, 2.22)
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of
work/job histories obtained from interviews or plant records unless otherwise noted.
¥ There were no female cases of adenocarcinomas, so the results in the table are for male workers.
€ This study overlaps considerably with Zhao et al. 2005.  Although the Zhao study evaluated incidence, an important consideration given the
low survivability of esophageal cancer, the study unfortunately combined esophageal and stomach cancers so it is not include in the table.
Urine TCA: urine levels of trichloroacetic acid, a metabolite of TCE.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality




     
   
    
   
  
Note: Lynge et al. 2006 is omitted because a majority of the cases were unclassifiable on exposure status.  If all the unclassifiable were 
exposed, then RR=1.19 (0.67, 2.12).  If all the unclassifiable were unexposed, then RR=0.66 (0.30, 1.45). For those that could be classified as
dry cleaner workers, RR=0.76 (0.34, 1.69) based on 8 exposed cases. When the analysis was restricted to Denmark and Norway with no 
unclassifiable cases, the RR=0.91 (0.38, 2.20) among dry cleaning workers.














   
   
  
    
       
  
 
   
   
     
  
   
    
    
     
     
      
     
   
  
    
  
  
   
  




ATSDR’s assessment of the epidemiological evidence considered some of the viewpoints associated
with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and 
standardized mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although 
the relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  
When considering the magnitude of the effect estimate, an effect estimate was considered “near the null
value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of biases, in particular
exposure misclassification, healthy worker effect, and confounding. 
TCE
No meta-analyses were conducted of TCE exposure and esophageal cancer. Five cohort studies
evaluated TCE exposed workers and esophageal cancer.  None of these studies could adjust for smoking
or alcohol consumption although internal analyses were likely unaffected by confounding due to these 
risk factors. Three cohort studies of TCE exposed workers and esophageal cancer found elevated risks
(Raaschou-Nielsen et al. 2003, Radican et al. 2008, and Hansen et al. 2013). Relative risks for any
exposure to TCE in these three studies ranged from 1.3 to 1.8 (an RR of 2.8 was found for female
workers in the Radican et al. study based on 2 esophageal cancer deaths). A monotonic exposure-
response trend for duration of employment was found in the Raaschou-Nielsen et al. study. A non-
monotonic trend for cumulative exposure was observed in the Radican et al. 2008 study with the highest
RRs occurring for the lowest category of cumulative exposure and for low intermittent and peak
infrequent exposures.  The Hansen et al. 2013 study did not observe an exposure-response trend for
urine TCA but the analysis was limited by small numbers of exposed cases. Two cohort studies did not
find an excess risk (Boice et al. 2006; Lipworth et al. 2011).  One of these studies had only three
exposed esophageal cancer deaths (Boice et al. 2006).  Healthy worker effect bias was evident in the
other study with SMRs for all cancers and for esophageal cancer of 0.92 (95% CI: 0.86, 0.97) and 0.65 
(95% CI: 0.39, 1.01), respectively (Lipworth et al. 2011).
An elevated HR was observed in the Camp Lejeune mortality study of Marines and Navy personnel
(Bove et al. 2014a) but not in the study of civilian workers (Bove et al. 2014b). There were only four
esophageal cancer deaths among the civilian workers at Camp Lejeune.
Conclusion: The two cohort studies that did not observe an elevated risk had serious limitations
including small numbers of exposed cases (Boice et al. 2006) and healthy worker effect bias (Lipworth 
et al. 2011).  Of the three cohort studies that did observe elevated risks, only one study observed higher
risks associated with higher or longer exposures (Raaschou-Nielsen et al. 2003).  ATSDR concludes that
the epidemiological evidence for causality by itself is currently too weak to achieve equipoise and 
above.  Given the lack of supporting animal and/or mechanistic evidence, ATSDR concludes that there 








   
  
  
   
 
 
    
 
    







    
   
 
   
  




    
 
  






   
PCE
No meta-analyses were conducted of PCE exposure and esophageal cancer.  Five dry cleaning worker
studies and one study of aircraft manufacturing workers evaluated PCE exposure and esophageal cancer.
None of these studies could adjust for smoking or alcohol consumption although internal analyses were
likely unaffected by confounding due to these risk factors.     
Among the five dry cleaning studies, one did not observe an excess risk, but this study was seriously
limited because a majority of the esophageal cancer cases were unclassifiable on exposure status (Lynge
et al. 2006).  One study observed an elevated odds ratio for squamous cell esophageal cancer but was
based on only 2 exposed cases (OR=3.6, 95% CI: 0.5, 27) (Vaughan et al. 1997).  One study had no 
exposed male cases and an SIR of 1.33 (95% CI: 0.43, 3.10) based on five exposed female cases (Selden
and Ahlborg 2011).  Two studies observed elevated risks and were also able to evaluate exposure-
response trends (Blair et al. 2003; Calvert et al. 2011). In the Blair et al. 2003 study, an elevated risk
(SMR=2.2, 95% CI: 1.2, 3.5) among medium to high exposed workers was only slightly higher than the
risk for those with little or no exposure (SMR=2.1, 95% CI: 0.9, 4.4).  On the other hand, the Calvert et
al. 2011 study observed an elevated risk for workers exposed to PCE only (SMR=2.68, 95% CI: 0.98, 
5.83) and a monotonic exposure-response trend for employment duration.  
The cohort study of aircraft manufacturing workers obtained an SMR of 1.13 (95% CI: 0.72, 1.68).  In 
this study, the risk decreased with increasing duration of exposure so that an RR of 0.66 (95% CI: 0.22, 
1.96) was observed for those with five or more years of exposure (Lipworth et al. 2011). However, 
exposures to PCE in this study were likely much lower than in the dry cleaning worker studies.
Conclusion: Although several of the studies observed elevated risks, some were based on small
numbers of exposed cases and only one study observed an exposure-response trend. ATSDR concludes
that the epidemiological evidence for causality by itself is currently too weak to achieve equipoise and 
above. Given the lack of supporting animal and/or mechanistic evidence, ATSDR concludes that there is
below equipoise evidence for causation for PCE and esophageal cancer.
Benzene and vinyl chloride
One cohort study evaluated benzene and observed a RR of 1.6 (95% CI: 1.0, 2.5). One cohort study
evaluated vinyl chloride and observed an SMR of 1.12 (95% CI: 0.30, 2.86). Because only one study
each evaluated benzene and vinyl chloride, there was insufficient information to determine whether an 
association exists between these two chemicals and esophageal cancer.  Therefore ATSDR concludes
that there is below equipoise evidence for causation for benzene and vinyl chloride and esophageal
cancer.
Chlorinated/Aromatic Solvents
One case-control study evaluated chlorinated and aromatic solvents as a group.  For high level exposures








exposures to aromatic solvents, an elevated OR was observed only for adenocarcinoma (OR=3.07, 95%
CI: 0.53, 17.6).  This study was limited by small numbers of exposed cases, the collection of information

























    
   












    
              






























   
      
      












    
      






























Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information
of subjects, follow- cases
up period
Cohort Studies
Anttila 1995 TCE (urine TCA) Any exposure: Urine TCA (µmol/L):
Incidence 12 SIR=1.71 (0.88, 2.98) <100  SIR=2.34 (1.07, 4.44)   9 cases
3,089 TCE 100 +  SIR=0.85 (0.10, 3.07)   2 cases
1967-1992
Morgan 1998 Aerospace Any exposure to TCE: Cumulative Exposure (SMR) # cases
Mortality TCE subcohort 6 SMR=1.06 (0.39, 2.31) Low:  0.49 (0.01, 2.74)  1
4,733 High: 1.38 (0.45, 3.21)  5
1950-1993
Raaschou-Nielsen TCE (job title, plant air Any exposure:




data) 15 Women, SIR=1.1 (0.6, 1.8)
Chang 2003 Chlorinated organic Any exposure: Duration of Employment (years): women only € 
Mortality solvents 2 Men:       SMR=0.73 (0.08, 2.65) ≤1:     SMR=1.81 9 cases
86,868 13 Women:  SMR=1.67 (0.89, 2.85) 1-≤5:  SMR=1.01 2 cases
1985-1997 >5:     SMR=2.50    2 cases
Zhao 2005 Aerospace Cumulative exposure (RR)   # cases£ 
Incidence TCE (JEM) 28 Medium:  0.93 (0.58, 1.50)  28
6,044 13 High:        0.92 (0.49, 1.72)  13
1950-2001
Radican 2008 Aircraft maintenance Any exposure:
Mortality TCE (JEM) 9 HR=0.65 (0.22, 1.93)
14,455 8 Male: HR=0.64 (0.19, 2.12)
1953-2000
Lipworth 2011 Aircraft manufacturing 






























                
   
   
































   
 

































       
  
Reference, type of








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Hansen 2013 TCE (urine TCA was Any exposure:
Incidence used to identify workers 43 All:         SIR=1.06 (0.78, 1.43)














Buhagen 2016 Train maintenance 13 SIR=1.2 (0.7, 2.0)
Incidence TCE
997 males (union employment list)
1960-2010
Case-Control Study
Christensen 2013 TCE 13 Any: OR=1.8 (0.8, 4.0)
Incidence 3 Substantial: OR=0.7 (0.2, 2.6)
248 cases
533 controls PCE¥ 4 Any: OR=2.1 (0.5, 8.7)









Calvert 2011 Dry cleaning 7 All: SMR=1.26 (0.51, 2.59)






























































   
   
   




















   
 
    
   
  
   
Reference, type of








RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Selden 2011 Dry Cleaning & Laundry 38 SIR=0.83 (0.59, 1.14)











§ Ever exposed: (rectal cancer only)
OR=2.6 (0.8, 6.7) for 11 year latency
OR=3.1 (0.7, 10.9) for 13 year latency












vs. Camp Pendleton 24 SMR=0.81 (0.52, 1.21)
HR=1.60 (0.83, 3.07)
Duration of exposure (months)
1-3  OR=1.0 (0.2, 4.8)    2 cases
4-6  OR=0.7 (0.1, 5.9)    1 case
7-12  OR=0.8 (0.2, 3.6)    2 cases
>12  OR=1.1 (0.4, 2.6) 10 cases












4 SMR=1.06 (0.29, 2.72)
HR=1.65 (0.36, 7.44)
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of
work/job histories obtained from interviews or plant records unless otherwise noted. 
€ Although not stated in the text, the analysis of duration of employment appears to be limited to women. Among chlorinated solvent exposed
workers, there were only 2 rectal cancer deaths among men and 13 rectal cancer deaths among women.  The text stated that the analysis of
duration was limited to cancers with at least 3 deaths, and there are 13 rectal cancer deaths in the duration analysis, so it appears that this




    
      
 









                      
  
   








£ The study combined colon and rectal cancers and did not evaluate rectal cancers separately.
¥ The Christensen et al. 2013 study had 3 cases of rectal cancer with “substantial exposure” to TCE, and only 1 case with “substantial
exposure” to PCE.




SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)




















    
     
  
   
 
 
   
    
  
   
  
 
    
   
    
   









        
ATSDR Assessment
ATSDR’s assessment of the epidemiological evidence considered some of the viewpoints associated
with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and 
standardized mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although 
the relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  
When considering the magnitude of the effect estimate, an effect estimate was considered “near the null
value” if ≤1.10 and “elevated” if >1.10. Also considered were the effects of biases, in particular
exposure misclassification, healthy worker effect, and confounding. 
TCE
No meta-analyses have been conducted of TCE and rectal cancer. Eight cohort studies evaluated worker
exposure to TCE and rectal cancer.  Three of the cohort studies did not find an elevated risk (Zhao et al.
2005, Radican et al. 2008, Lipworth et al. 2011). Three cohort studies found risks near the null:
SMR=1.06, 95% CI: 0.39, 2.31 (Morgan et al. 1998), SIR=1.06, 95% CI: 0.78, 1.43 (Hansen et al.
2013), and SIR=1.1, 95% CI: 1.0, 1.4 for men and SIR=1.1, 95% CI: 0.6, 1.8 for women. Elevated risks
were observed in two studies: an SIR of 1.2 (95% CI: 0.7, 2.0) (Buhagen et al. 2016), and an SIR of 1.71 
(95% CI: 0.88, 2.98) (Anttila et al. 1995).  
Three of these cohort studies evaluated exposure-response trends. One study found no elevation in risk 
(Zhao et al. 2005). One study observed an elevated risk among those with lower urine TCA levels
(SIR=2.34, 95% CI: 1.07, 4.44) but not among those with higher urine TCA levels (SIR=0.85, 95% CI:
0.10, 3.07, based on 2 cases) (Anttila et al. 1995). And one study observed an elevated risk in the high 
cumulative exposure category (SMR=1.38, 95% CI: 0.45, 3.21) but had only 1 case in the low
cumulative exposure category (SMR=0.49, 95% CI: 0.01, 2.74).
One case-control study found an elevated risk for “any exposure” (OR=1.8, 95% CI: 0.8, 4.0) but not for
“substantial” exposure (OR=0.7, 95% CI: 0.2, 2.6), although the study was limited by a small number of
exposed cases who had “substantial” exposure to TCE (Christensen et al. 2013).  Both Camp Lejeune
mortality studies observed an excess rectal cancer when the Camp Lejeune cohorts were compared to
Camp Pendleton (Bove et al. 2014a, b). 
Conclusion: Based on the mixed findings in the epidemiological studies, ATSDR concludes that there is
below equipoise evidence for causation for TCE and rectal cancer. 
PCE
No meta-analyses have been conducted of PCE and rectal cancer. Three cohort studies evaluated dry




     
   
   
 
 
   
   
   
     
 
      





   




et al. 2011 had no rectal cancer deaths in the group of workers exposed only to PCE but did observe an
elevated risk (SMR=1.81, 95% CI: 0.73, 3.74) for workers who possibly worked with other solvents in 
addition to PCE. The Selden et al. 2011 study found no elevated risk.  None of these studies evaluated
exposure-response trends. 
A cohort study of aircraft manufacturing workers (Lipworth et al. 2011) did not find an elevated risk but
exposures to PCE in this study were low compared to the dry cleaning studies.  A case-control study
observed an elevated risk for any PCE exposure (OR=2.1, 95% CI: 0.5, 8.7) based on four exposed cases
but had only one case with “substantial” PCE exposure (Christensen et al. 2013).
The Cape Cod drinking water study evaluated colorectal cancers as a group but did report findings for
rectal cancer in the text of the article (Paulu et al. 1999). The study found an elevated risk for those ever
exposed to PCE-contaminated drinking water (OR=2.6, 95% CI: 0.8, 6.7, for 11-year latency period, and 
OR=3.1, 95% CI: 0.7, 10.9, for 13-year latency period). The number of rectal cancers evaluated were 
not provided in the text, but the confidence intervals for the odds ratio estimates were extremely wide
indicating a small number of exposed cases.  
Conclusion: The epidemiological evidence for an association between PCE exposure and rectal cancer
is weak. The findings of several of the studies were based on small numbers of exposed cases.  Of the
three studies with ≥10 exposed cases, the findings were conflicting (Blair et al. 2003, Selden et al. 2011, 
and Lipworth et al. 2011). Because of the weak epidemiological evidence, ATSDR concludes that there 

































                  
   












                 
   































     
      















 Brain (Central Nervous System) Cancer
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information




Vinyl chloride 68 SMR=1.26 (0.98, 1.62)  based on 5 
studies
Cohort Studies
Anttila 1995 TCE (Urine TCA) 9 SIR=1.09 (0.50, 2.07) Urine TCA (µmol/L):   # cases
Incidence PCE (blood PCE) 2 SIR=1.15 (0.14, 4.15) <100  SIR=1.52 (0.61, 3.13)  7
3,089 TCE 100 +  SIR=0.76 (0.09, 2.74)  2
849 PCE
1967-1992
Morgan 1998 Aerospace Any exposure: Cumulative exposure  # cases
Mortality TCE subcohort 4 SMR=0.55 (0.15, 1.40) Low:  SMR=0.73 (0.09, 2.64)  2










Raaschou-Nielsen TCE (job title, plant air Any TCE exposure:




data) 19 Women, SIR=1.1 (0.7, 1.7)
Zhao 2005 Aerospace  TCE (JEM) Cumulative exposure (RR)   # cases
Mortality Medium:  0.42 (0.12, 1.50)  3
6,044 mortality¥ High:        0.83 (0.23, 3.08)  3
1950-2001
Chang 2005 Electronics Factory, Any exposure:
Incidence chlorinated organic 2 Men:        SIR=0.40 (0.05, 1.46)




























    
    
  

















































   
 
 
   



































     
Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
cancer data, total # (exposure assessment) exposed exposure information









Men: HR=1.26 (0.43, 3.75)
Cumulative exposure score (unit-yr)
0-5:  HR=1.46 (0.44, 4.86) 8 cases
5-25: HR=1.74 (0.49, 6.16) 6 cases
>25:  HR=0.66 (0.15, 2.95)  3 cases
Exposure intensity (HR)    # cases
Low, intermittent: 0.92 (0.28, 2.98)  9
Low, continuous:  1.37 (0.42, 4.46)  9
Peak, infrequent:   3.00 (0.85, 10.6)  6
Peak, frequent:      0.88 (0.24, 3.26)  5
Lipworth 2011 Aircraft manufacturing 




PCE (JEM) 16 SMR=1.00 (0.57, 1.63)
Selden 2011 Dry Cleaning and Any exposure
Incidence Laundry Workers: 36 All: SIR=0.99 (0.69, 1.37)
9,440 (plant survey, work 9 Men: SIR=0.97 (0.44, 1.83)
1985-2006 history) 27 Women: SIR=1.00 (0.66, 1.45)
Hansen 2013 TCE (Urine TCA was Any Exposure:
Incidence used to identify workers 24 All:           SIR=0.79 (0.51, 1.17)




8 Women:  SIR=0.73 (0.31, 1.43)
Silver 2014 Microelectronics plant 55 Cumulative exposure (5 exposure-yr)
Mortality TCE (JEM) HR=0.01 (0.00, 24.6)











Buhagen 2016 Train maintenance 4 SIR=0.7 (0.3, 1.9)
Incidence TCE


































   
   
 
   
 
 
   
   
   
 











    
 
 













































































RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Case-Control Studies
Neta 2012 (JEM) Glioma ORs for exposure duration for ORs for cumulative exposure for
Incidence TCE (probable 11 OR=0.5 (0.3, 1.1)  All gliomas and PCE or TCE were ≤ gliomas and PCE or TCE were ≤ 1.0.
489 glioma cases exposure) 8 OR=0.4 (0.2, 1.0)  Men 1.0.
197 meningioma
cases
3 OR=1.0 (0.2, 4.3)  Women
Meningioma Duration of exposure for Cumulative exposure for meningioma
799 controls
1994-1998
6 OR=1.5 (0.4, 6.3)
Glioma
meningioma was not evaluated. was not evaluated.
PCE (probable 9 OR=0.7 (0.3, 1.6)   All
exposure) 6 OR=1.2 (0.4, 3.8)   Men
3 OR=0.5 (0.1, 1.7) Women
Meningioma
3 OR=0.3 (0.1, 1.7)
Ruder 2013 TCE 302 OR=0.74 (0.61, 0.90)  All ORs for cumulative exposure to PCE or
Incidence 221 OR=0.88 (0.69, 1.12)  Men TCE were <1.0
798 glioma cases 81 OR=0.57 (0.42, 0.79)  Women
1,175 controls
1995-1997 PCE 299 OR=0.75 (0.62, 0.91)  All
216 OR=0.81 (0.64, 1.04)  Men
83 OR=0.66 (0.48, 0.91)  Women
Drinking Water Studies







OR=1.0 (0.2, 2.9)  5 year latency













































     
 
   








                      
  
  














RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information












7 SMR=1.05 (0.42, 2.16)
HR=0.65 (0.21, 2.04)
* Exposures were occupational unless otherwise noted. Exposure assessments were based on expert review by industrial hygienists of
work/job histories obtained from interviews or plant records unless otherwise noted. 
¥ The findings for brain cancer incidence were based on 2 medium exposed and 1 high exposed case with RRs of 0.5.
¶ There were no brain cancer deaths among female workers.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)





















   
   
   
      
   
   
 
   
 
   
 
   




   
    
   
   
    
ATSDR Assessment
ATSDR’s assessment of the epidemiological evidence considered some of the viewpoints associated
with Hill: (1) temporal relationship, (2) magnitude of the effect estimate (e.g., risk ratio, odds ratio, and 
standardized mortality ratio), (3) consistency of findings, (4) exposure-response relationship (although 
the relationship could be non-linear or non-monotonic), and (5) biological plausibility (Hill 1965).  
When considering the magnitude of the effect estimate, an effect estimate was considered “near the null
value” if ≤1.10 and “elevated” if >1.10.  Also considered were the effects of biases, in particular
exposure misclassification, healthy worker effect, and confounding. Studies that evaluated brain cancer
sub-groupings were considered to have higher utility than studies that did not. A meta-analysis of vinyl
chloride and brain cancer was given high weight.
TCE
No meta-analyses have been conducted of TCE and brain cancer. Eleven studies evaluated TCE worker
exposure and brain cancer, nine cohort studies and two case-control studies.  Of these, six studies were
based on eleven cases or fewer resulting in extremely wide confidence intervals. The largest study, a 
case-control study of glioma, found no elevated risk (Ruder et al. 2013).  Another case-control study
found no elevated risk for glioma but an elevated risk for meningioma (OR=1.5, 95% CI: 0.4, 6.3) based
on six exposed cases (Neta et al. 2012).  Six of the nine cohort studies did not observe an elevated risk
(Morgan et al. 1995, Zhao et al. 2005, Lipworth et al. 2011, Hansen et al. 2013, Silver et al. 2014 and 
Buhagen et al. 2016). Of the three cohort studies that did observe an elevated risk, two observed SIRs
≤1.1 (Antilla et al. 1995; female workers only in the Raaschou-Nielsen et al. 2003 study).  The highest
elevation in risk was observed in the Radican et al. 2008 cohort study (RR=1.26, 95% CI: 0.43, 3.75).  
Both Camp Lejeune mortality studies did not observe an elevated risk (Bove et al. 2014a, b).
Conclusion: The evidence from the epidemiological studies could be interpreted as supporting a
position that TCE does not cause brain cancer. However, because a majority of the studies were based
on small numbers of exposed cases, ATSDR concludes that the evidence is too weak to conclude that
TCE does not cause brain cancer.  ATSDR’s conclusion is that there is insufficient evidence to
determine whether an association exists for TCE and brain cancer. Therefore, there is below equipoise 
evidence for causation for TCE and brain cancer.
PCE
No meta-analyses have been conducted of PCE and brain cancer. The epidemiological evidence for PCE
and brain cancer is weaker than that for TCE.  Of the six studies that evaluated PCE worker exposure
and brain cancer, four observed no elevated risk including a large case-control study.  One case-control
study observed an elevated risk for glioma among male workers probably exposed to PCE (OR = 1.2, 





     
 
    
  
 
    
   
 
      
  








   
   
   
   
    
     
 
 
    
  
       
   
        
based on 2 exposed cases found an SIR of 1.15 (95% CI: 0.14, 4.15) (Antilla et al. 1995).  Half of the six
studies had six or less exposed cases.
No excess risk for brain cancer was observed in the Cape Cod drinking water study (Paulu et al. 1999).
Animal and mechanistic information: PCE has been shown to cause brain gliomas in both sexes in 
rodent studies (EPA 2012).
Conclusion: The evidence from the epidemiological studies could be interpreted as supporting a
position that PCE does not cause brain cancer. However, because a majority of the studies were based
on small numbers of exposed cases, ATSDR concludes that the evidence is too weak to conclude that
PCE does not cause brain cancer. In addition, the positive findings in rodents provide evidence against a
conclusion that PCE does not cause brain cancer. Therefore ATSDR concludes that there is insufficient 
evidence to determine whether an association exists for PCE and brain cancer. Therefore, there is
below equipoise evidence for causation for PCE and brain cancer.
Vinyl Chloride
A meta-analysis obtained a summary SMR of 1.26 (95% CI: 0.98, 1.62) based on 5 studies with a total 
of 68 exposed brain cancer deaths. The authors stated that the excess in brain cancer deaths was mainly
due to the North American multicenter study which contributed 36 of the 68 deaths.  Fifteen of these
deaths came from one polymer production plant in Louisville, KY (Lewis et al. 2003a). When this plant
was analyzed separately, the SMR for brain cancer was 2.29 (95% CI: 1.29, 3.81), but the SMR for the
rest of the plants in the multicenter study was 1.12 (95% CI: 0.69, 1.71).  This indicated that the excess
mortality in the North American multicenter study, and the meta-analysis itself, was primarily due to the
Louisville plant. When the brain cancer deaths at the Louisville plant were reviewed, no association was
found for vinyl chloride exposure (Lewis et al. 2003b). Based on these analyses, ATSDR concludes that
there is below equipoise evidence for causation for vinyl chloride and brain cancer.
Benzene
One cohort study that evaluated brain cancer incidence and benzene exposure observed no excess. Since 
only one study has been conducted, ATSDR concludes that there is insufficient evidence to determine
whether an association exists for benzene and brain cancer. Therefore, there is below equipoise























           



























                                                                                            
                                     
                                
                        
                                                 
 
                          
                        











   
   
 
 
   
   
  


























   
   
 
   


















Reference, type of Exposure* # RR (SIR, SMR, OR) & 95% CI Exposure Duration Exposure intensity/cumulative
cancer data, total (exposure exposed information exposure information









Men: 2.46 (1.13, 5.38) 2 studies









Summary OR=2.07 (1.34, 3.17)  5 studies
Summary OR=2.03 (0.44, 9.27)  3 studies
Summary OR=1.02 (0.59, 1.75)  3 studies
Case-Control Studies
Nietert 1998¶+§ (JEM) Men   (OR)     # cases  Women # cases
178 cases TCE Any exposure£:   2.0 (0.8, 4.9) 19 0.7 (0.4, 1.3)  27
200 controls Max intensity:   3.3 (1.0, 10.3)      11 0.9 (0.3, 2.3)  8
1995-1997
Benzene
Cum. Intensity:  2.0 (0.7, 5.3)       12         1.2 (0.5, 2.6) 14
Max. Prob.: 5.1 ----­ 5     0.7 (0.2, 2.2)  6
Max intensity:  2.4 (0.8, 7.1)       10         1.1 (0.3, 3.9)  6
Cum. Intensity:  1.5 (0.6, 3.8)        13        2.0 (0.7, 5.5) 11
Max. Prob.   2.1 (0.7, 6.5) 9     1.3   --­ 5
Diot 2002¶+ TCE 13 OR=2.39 (1.04, 5.22)   All High Final cumulative exposure
80 cases 6 OR=2.10 (0.65, 6.75) Women TCE (all):
160 controls 7 OR=4.67 (0.99, 21.9)   Men OR=7.58 (1.54, 37.4)  7 cases
1998-2000
Aromatic solvents 11 OR=2.67 (1.06, 6.75)   All Aromatic solvents (all):
7 OR=2.48 (0.80, 7.70) Women OR=3.16 (0.87, 11.6) 6 cases
4 OR=3.62 (0.64, 20.4)    Men
Garabrant 2003¶+¥ TCE 8 OR=2.0 (0.8, 4.8) self-reported exposure
660  female cases 4 OR=1.9 (0.6, 6.6)  confirmed by expert review
2,227 female
controls PCE 7 OR=1.4 (0.6, 3.4) self-reported exposure
1980-1992 5 OR=1.1 (0.4, 2.9)  confirmed by expert review
Dry Cleaning work 31 OR=1.4 (0.9, 2.2) self-reported job
Benzene 13 OR=1.5 (0.8, 2.9) self-reported exposure
























   
   
 
 
   
   
  
  












   
 
    
    
    
    
       












     
     

































































OR=2.26 (0.95, 5.26)   All
OR=2.77 (0.80, 9.35)   Men
OR=1.36 (0.30, 5.04) Women
OR=8.17 (2.29, 36.5)   All
OR=2.05 (0.60, 19.2)   Men
OR=26.4 (3.45, 1183) Women
High Final cumulative exposure
TCE (all):
OR=3.63 (1.15, 12.1)  8 cases
High Final cumulative exposure
Aromatic solvents (all):
OR=7.40 (1.65, 45.3)  7 cases
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of
work/job histories obtained from interviews or plant records unless otherwise noted.
¶ Included in the Cooper et al. 2009 meta-analysis.
+ Included in the Zhao et al. 2016 meta-analysis for TCE.
¥ Included in the Zhao et al. 2016 meta-analysis for PCE and benzene.
§ Included in the Zhao et al. 2016 meta-analysis for benzene.
£ The Nietert et al. 1998 article did not report the analysis of any exposure to TCE.  The authors provided this analysis to the EPA for its
meta-analysis and is reported in Cooper et al. 2009.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HRs: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality
VOC: volatile organic compounds (i.e., TCE, PCE, 1,2-Dichloroethylene, vinyl chloride and benzene)
Note: The Nietert et al. 1998, Diot et al. 2002, and Marie et al. 2014 studies were included in the Zhao et al 2016 meta-analysis and are 
included in the table because they provide additional information on cumulative exposure and/or intensity of exposure.  The Garabrant et al.
2003 study also was included in the Zhao et al 2016 meta-analysis and is included in the table to distinguish results based on self-reported
exposures and results based on a review of the self-reported information by an expert in occupational/environmental exposure assessment




   
    

 
Note: the cluster investigation by Thompson and Pope 2002 and the study by Goldman 1996 are not included in the table because of serious




    
    




       
 












   
 
 
   
        





     
   
 
   
   
 
Summary of EPA Assessment of TCE and Scleroderma
“The human and animal studies of TCE and immune-related effects provide strong evidence for a role of
TCE in autoimmune disease…” “The relation between systemic autoimmune diseases, such as
scleroderma, and occupational exposure to TCE has been reported in several recent studies.”  “…The 
human data, at this time, do not allow for the determination of whether the difference in effect estimates
between men and women reflects the relatively low background risk of scleroderma in men, gender-
related differences in exposure prevalence or in the reliability of exposure assessment (Messing et al.,
2003), a gender-related difference in susceptibility to the effects of TCE, or chance.” (EPA 2011)
“Strong evidence, based on multiple human and experimental animal studies, that TCE exposure causes
autoimmune diseases, including scleroderma” (Chiu et al. 2013). 
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on the assessment
conducted by EPA.  High weight was also given to toxicological evidence from animal studies including
mechanism information.  The assessment also took special note of evidence from one epidemiological
study of a possible susceptible population. Our assessment of the epidemiological evidence considered
some of the viewpoints associated with Hill: (1) temporal relationship, (2) magnitude of the effect 
estimate (e.g., risk ratio, odds ratio, and standardized mortality ratio), (3) consistency of findings, (4)
exposure-response relationship (although the relationship could be non-linear or non-monotonic), and 
(5) biological plausibility (Hill 1965).  When considering the magnitude of the effect estimate, an effect
estimate was considered “near the null value” if ≤1.10 and “elevated” if >1.10.  Also considered were
the effects of biases, in particular exposure misclassification, healthy worker effect, and confounding. 
TCE
A recent meta-analysis of TCE and scleroderma included the four case-control studies listed in the table
(Nietert et al. 1998, Diot et al. 2002, Garabrant et al. 2003, and Marie et al. 2014) and an additional
cluster investigation in Ontario, Canada based on patients of a practice with a research interest in
scleroderma (Thompson and Pope, 2002).  The inclusion of the cluster investigation in the meta-analysis
was problematic for several reasons: (1) the focus of investigation was not on chemical exposures and 
the information on employment and workplace exposures was based entirely on self-report; (2) selection
bias was possible because the clinic’s catchment area for the scleroderma cases (the clinic specialized in
scleroderma research and cases were referred from  a large area) may have been different than the 
clinic’s catchment area for the controls who had other rheumatologic conditions; and (3) only about 3%
of the cases and controls reported any exposure to TCE either at home or the workplace. The cluster
investigation did not find an elevated risk for TCE.  On the other hand, inclusion of the cluster
investigation likely had little impact on the meta-analysis findings. The summary OR obtained by the




     
   
 
    
      






   
   














     
 
  
   
 
   
    
 
   
   
 
for men and women combined in the Marie et al. 2014 study (OR=2.26, 95% CI: 0.95, 5.26) and the
Diot et al. 2002 study (OR=2.39, 95% CI: 1.04, 5.22). 
In a previous meta-analysis conducted by EPA, which evaluated three studies listed in the table, the
pooled ORs for men and women were 2.46 (95% CI: 1.13, 5.38) and 1.22 (95% CI: 0.58, 2.57), 
respectively (Cooper et al. 2009). The EPA researchers attempted to explain the difference in the pooled
ORs for men and women: “The incidence of systemic sclerosis among men is very low (approximately 1
per 100,000 per year), and is approximately 10 times lower than the rate seen in women…. Thus, the
human data, at this time, do not allow for the determination of whether the difference in effect estimates
between men and women reflects the relatively low background risk of scleroderma in men, gender-
related differences in exposure prevalence or in the reliability of exposure assessment…, a gender-
related difference in susceptibility to the effects of TCE, or chance.” (pages 4-427 and 4-428, EPA
2011).  However, the difference in pooled ORs between men and women could also be partly explained
by the impact of the Nietert et al. 1998 study which supplied almost two-thirds of the exposed female 
cases in the Cooper et al. 2009 meta-analysis. The OR for women in the Nietert et al. study was 0.70.  
The ORs for TCE and scleroderma among women in three other case-control studies were 2.10 (95% 
CI: 0.65, 6.75) (Diot et al. 2002), 2.0 (95% CI: 0.8, 4.8) (Garabrant et al. 2003), and 1.36 (95% CI: 0.30, 
5.04) (Marie et al. 2014).  Pooling these three odds ratios would likely result in a pooled OR between 
1.7 and 2.0, still less than, but considerably closer to, the pooled OR for men observed in the EPA meta-
analysis. In summary, although the Cooper et al. 2009 meta-analysis observed gender differences in the
pooled ORs, much, if not most, of the difference is due to the impact of one study included in the meta-
analysis.
The Nietert et al. 1998 study used a generic job-exposure matrix (JEM) that linked occupational and 
industrial codes to the probability and intensity of specific solvent exposure. Generic JEMs are likely to 
result in much greater exposure misclassification bias than industry-specific or plant-specific JEMs.
Moreover, a generic JEM such as the one used in this study is likely insensitive to detect variations of
exposure among women and may overestimate their exposures.  These weaknesses in the use of a
generic JEM to assess solvent exposures in women workers were mentioned in the Nietert et al. 1998 
study. 
An interesting finding in the Nietert et al. 1998 study that was not incorporated in the Cooper et al. 2009 
meta-analysis or the Zhao et al. 2016 meta-analysis were the elevated ORs for both women and men
exposed to TCE who tested positive for the anti-Scl-70 antibody. (The Anti-Scl-70 antibody is
associated with diffuse forms of cutaneous involvement and severity of interstitial lung disease or
pulmonary fibrosis.) Among women who tested positive for the anti-Scl-70 antibody, the ORs for
maximum intensity, cumulative intensity, and maximum probability of exposure to TCE were 1.8, 4.0, 
and 2.2, respectively.  Among men who tested positive, the ORs for maximum intensity, cumulative 
intensity, and maximum probability of exposure to TCE were 4.8, 2.6 and 5.0, respectively (Nietert et al. 
1998).  (Note: the study did not provide confidence intervals for this analysis.) No trend for either men 
or women exposed to TCE was found for those who tested negative for the anti-Scl-70 antibody. This
suggests that men and women testing positive for this antibody may constitute a vulnerable




   
    
  
 
    
   
 
  
   
     
 
   
  
 
   
   
     
  
   
   
    
    
   
    
 
 
       
  
   
 
 
    
 
    
Two studies evaluated cumulative exposure to TCE and scleroderma.  Both the Diot et al. 2002 study
and the Marie et al. 2014 study found an increased risk among those with high cumulative exposure.  In 
the Nietert et al. 1998 study, an increased risk was found for men in the maximum exposure intensity
group as well as for men in the maximum probability of exposure group.  No increased risks were found 
for women in the Nietert et al. 1998 study except for cumulative intensity (OR=1.2, 95% CI: 0.5, 2.6).
In the Garabrant et al 2003 study, the exposure assessment based on self-reported exposures produced a
similar result as the exposure assessment based on expert review of the self-reported exposures.
Animal and mechanistic information: The EPA toxicological review of TCE summarized the animal 
evidence for TCE exposure and autoimmune effects in animal studies: “TCE treatment induces and
exacerbates autoimmune disease in genetically susceptible strains of mice, and has also been shown to
induce signs of autoimmune disease in a nongenetically predisposed strain. Although the mechanism for
this response is not fully understood, a number of studies have been conducted to examine this issue.
The primary conclusion to date is that metabolism of the TCE to its chloral or DCA metabolites is at 
least partially responsible for activating T-cells or altering T-cell regulation and survival associated with 
polyclonal disease in susceptible mice strains.” (4-424, EPA 2011)
Conclusion: Based on its review of the literature, EPA concluded that there is “Strong evidence, based 
on multiple human and experimental animal studies, that TCE exposure causes autoimmune diseases, 
including scleroderma” (Chiu 2013). ATSDR concurs with EPA’s assessment. It is our conclusion that
the epidemiological evidence, combined with the evidence from animal studies, provides support for a 
causal association between TCE exposure and scleroderma.  Although the observed gender differences
in the magnitude of the effect estimates adds some uncertainty, elevated risks have been observed in 
both women and men.  Moreover, both men and women who tested positive for the anti-Scl-70 antibody
and were exposed to TCE had elevated risks.  The identification of a possible susceptible population 
adds to the evidence for causality.  Although the combined human and animal evidence may not be
sufficient to conclude with certainty that a causal relationship exists, it is sufficiently strong to conclude
that the evidence for causality is above equipoise.  Therefore, ATSDR concludes that that there is
equipoise and above evidence for causation for TCE and systemic sclerosis/scleroderma.
PCE
The Zhao et al. 2016 meta-analysis obtained a summary OR of 2.03 (95% CI: 0.44, 9.27) for PCE and
scleroderma based on three studies. One of the studies was the cluster investigation mentioned above
that was based on patients of a rheumatology outpatient practice with a research interest in scleroderma 
(Thompson and Pope, 2002). This study had serious limitations mentioned above.  A second study was
also based on patients from a rheumatology practice and the exposure assessment was based primarily
on self-reports (Goldman 1996).  The author stated that there was no attempt at blinding the clinical
examinations of cases of scleroderma and controls of other connective tissue diseases. There were 33
scleroderma cases and 246 controls. Of the 33 cases, 30 were women and four of the women reported
employment in dry cleaning establishments compared to 2 women out of 210 female controls (OR and 





    
  
   
 
     
   







     
  
   
   
   
 




scleroderma cases that reported employment in dry cleaning establishments, 3 reported PCE exposure.  
Both controls that reported employment in dry cleaning also reported PCE exposure (OR and 95% CI 
calculated by ATSDR: OR=11.6, 95% CI: 1.6, 99).  No male cases of scleroderma reported employment
in dry cleaning or exposure to PCE. This study was severely limited by the number of exposed cases, an 
exposure assessment based on self-report, the possibility of information bias due to the lack of blinding, 
and the possibility of selection bias due to referrals to the practice.
In the Garabrant et al. 2003 study, an OR of 1.4 (95% CI: 0.6, 3.4) was obtained for women who self-
reported PCE exposure and a similar OR was observed for women who self-reported dry cleaning work
(OR=1.4, 95% CI: 0.9, 2.2).  The OR for PCE exposure declined to 1.1 (95% CI: 0.4, 2.9) after expert
review of the self-reported exposures.
Conclusion: Although three studies were included in a recent meta-analysis, only one study used 
appropriate methods and an expert review of exposures. Given the paucity of information, ATSDR
concludes that there is insufficient evidence to determine whether an association exists for PCE and
scleroderma.  Therefore, there is below equipoise evidence for causation for PCE and scleroderma.
Benzene
The Zhao et al. 2016 meta-analysis included three studies, Nietert et al. 1998, Garabrant et al. 2003, and 
the cluster investigation mentioned above (Thompson and Pope 2002) and obtained a summary odds
ratio near the null.  The cluster investigation had severe limitations for the reasons stated above. The
Nietert et al. 1998 study found elevated odds ratios for both sexes but much higher for men than for
women. The Garabrant et al. 2003 study included only female cases and did not find an excess risk after
expert review of the self-reported information on occupational exposures.
Conclusion: Given the paucity of epidemiological evidence and the lack of supporting animal or
mechanistic information, ATSDR concludes that the evidence is insufficient to determine whether an
association exists for benzene and scleroderma. Therefore ATSDR concludes that there is below



















































































   










    

 Major cardiac birth defects
Reference, type of







RR (SIR, SMR, OR) & 95% CI Exposure Duration information Exposure intensity/cumulative
exposure information
Gilboa 2012 Occupational exposure 69 TCE: 1.06 (0.77, 1.45), all heart
2,047 cases (JEM) defectsѰ 




Any chlorinated solvent exposure:
22 1.2 (0.8, 2.0), conotruncal heart
defects







74 PR** = 2.58 (2.0, 3.4) for first
trimester exposure
Bove 1995 Drinking water (sample
80,938 live births data)
75 towns in NJ TCE > 10 ppb 4 OR = 1.2 (0.5, 3.4)
1985-1988 PCE > 5 ppb 8 OR = 1.1 (0.6, 2.3)
Benzene > 0 ppb 5 OR = 1.8 (0.7, 4.3)
Masschusetts Dept











OR=0.40 (0.09, 1.35) ever exposed, Woburn as a whole (1975-1979)




























                              
 
                              


















   








                      
  
































































RR = 2.40 (1.00-5.77) major heart defects
RR = 4.91 (1.58-15.24), conotruncal heart defects
RR = 2.91 (0.73-+11.65) major heart defects
RR = 4.91 (0.69-34.90), conotruncal heart defects
* Exposures were occupational unless otherwise noted.  Exposure assessments were based on expert review by industrial hygienists of 
work/job histories obtained from interviews or plant records unless otherwise noted.
Ѱ Odds ratios and confidence intervals calculated by ATSDR from data provided in Table 1 of the article.
** Prevalence ratio calculated by Bove 2002.
RR: Risk Ratio
OR: Odds Ratio
SMR: Standardized Mortality Ratio
SIR: Standardized Incidence Ratio
95% CI: 95% Confidence Interval
sRR: Summary Risk Ratio
HR: Hazard Ratio
JEM: Job-exposure matrix
I: Incidence; M: mortality




   
 
 


















   
 
   
     
    




    
      
  
   
 
   
   
 
Summary of EPA Assessment of TCE and Cardiac Congenital Malformations
“Epidemiologic data provide some support for the possible relationship between maternal TCE exposure
and birth defects in offspring, in particular cardiac defects.” “…mechanistic studies, particularly based
on the avian studies…, provide additional support for TCE-induced fetal cardiac malformation, 
particularly with respect to defects involving septal and valvular morphogenesis.” “…The overall weight 
of evidence supports an effect of TCE on cardiac development.” (EPA 2011)
“Strong evidence, based on weakly suggestive epidemiologic studies, limited experimental animal
studies, and multiple mechanistic studies, that TCE causes fetal cardiac malformations; limited
experimental evidence that oxidative metabolites, such as TCA and/or DCA, cause similar effects.”
(Chiu et al. 2013)
ATSDR Assessment
In the assessment of the evidence for causation, ATSDR placed high weight on an assessment conducted 
by EPA as well as mechanistic information from animal studies. Our assessment of the epidemiological 
evidence considered some of the viewpoints associated with Hill: (1) temporal relationship, (2)
magnitude of the effect estimate (e.g., risk ratio, odds ratio, and standardized mortality ratio), (3)
consistency of findings, (4) exposure-response relationship (although the relationship could be non­
linear or non-monotonic), and (5) biological plausibility (Hill 1965).  When considering the magnitude
of the effect estimate, an effect estimate was considered “near the null value” if ≤1.10 and “elevated” if
>1.10.  Also considered were the effects of biases, in particular exposure misclassification, healthy
worker effect, and confounding. 
Few epidemiological studies have evaluated associations between cardiac defects and PCE, TCE, vinyl
chloride or benzene.  Nevertheless, two drinking water studies (Goldberg et al. 1990; Bove et al. 1995)
and a vapor intrusion study (Forand et al. 2012) observed elevated effect estimates for TCE and cardiac 
defects and provide support for an association. Strong evidence for causation is provided by the animal
and mechanistic studies. Animal studies suggest that prenatal exposure to TCE and its metabolites
results in increased numbers of congenital cardiac defects. Studies of pregnant rats found an exposure-
response relationship between exposure to TCE in drinking water and congenital heart defects in their
offspring (Dawson et al. 1990; Johnson et al. 2003). A study of chick embryos found that exposure to 
TCE when the heart was developing resulted in cardiac defects (Rufer at al. 2010). Based on the
combined evidence from human and animal studies, ATSDR concurs with EPA’s assessment that there 
is sufficient evidence for causation for TCE and cardiac defects.
For PCE, the epidemiological evidence is limited and there is no supporting animal or mechanistic
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Evaluation of possible confounding due to smoking and other risk factors for the studies 
listed in the tables
Study Smoking Other Risk Factors*
‘t Mannetje 2015 No information
Anttila 1995 No evident confounding for TCE: SIR < 1.0 for lung cancer
Aschengrau 1993 Smoking prevalence was similar for cases and controls SES, medical history
Axelson 1994 No evident confounding: SIR < 1.0 for lung cancer
Bassig 2015 Adjusted for smoking Alcohol, BMI, SES
Blair 2003 Confounding of up to 20% possible









Minimal confounding: RR=1.21 for COPD, other smoking-related
but not solvent-related diseases had RRs < 1.0 (Camp Lejeune vs 
Camp Pendleton)
SES, occupation
Brouwer 2015 Adjusted for smoking Physical activity, BMI
Buhagen 2016 No information.  SIR for lung cancer=1.2
Calvert 2011 Some evidence of potential confounding: SMR=1.33 for COPD
among “PCE only”; SMR=1.35 for lung cancer among “PCE plus”
Carreón 2014 Minimal confounding by smoking (<10%)
Chang 2003 No evident confounding: SIRs ≤1.0 for cancers of lung and larynx
Chang 2005 No evident confounding: SIRs < 1.0 for smoking-related cancers
Charbotel 2006 Adjusted for smoking BMI, coffee 
consumption, medical
history and treatments
Charbotel 2013 No confounding by smoking Sexual & gynecological
history, BMI, parity
Christensen 2013 Adjusted for smoking Alcohol, coffee, SES
Cocco 2010 N/A (case-control study of multiple myeloma and NHL) SES
Cocco 2013 N/A (case-control study of NHL) Study location
Cohn 1994 No information
Corbin 2011 Adjusted for smoking SES
Costantini 2008 No information SES
Costantini 2009 No information
Costas 2002 Adjusted for maternal smoking SES, breast-feeding
Feldman 2011 Adjusted for smoking SES
Gallagher 2011 No confounding observed after adjustment Medical history, family
history of breast cancer, 
pregnancy history
Gennaro 2008 No information
Gilboa 2012 Adjusted for smoking Folic acid supplement, 
SES
Glass 2015 No confounding due to smoking Alcohol, BMI, HRT, 
family history, parity,





   





   
 
 
     
   
 
   









    
    






   
   
   
     
     
   
   
  
 
   
  
 




   
 





    
 
 
   
 
  
   
   
    
Study Smoking Other Risk Factors* 
Gold 2011 N/A (case-control study of multiple myeloma, which is not related 
to smoking)
SES
Goldman 2012 Adjusted for smoking Hobby exposures, head 
injury (Twin study)
Hansen 2013 Confounding minimal: lung cancer SIR=1.08.  Urine TCA analysis 
is internal and not likely confounded by smoking
Hsieh 2011 No evident confounding: SMRs < 1.0 for lung cancer
Jacob 2007 No information Hypertension, baseline
proteinuria, SES
Krishnadasan 2007 No information (Smoking is not a strong risk factor for prostate
cancer.  A recent study¥ found an RR of 1.4 for prostate cancer






Linet 2015 Some evidence of potential confounding: RR=1.5 for lung cancer, 
but RRs < 1.0 for smoking-related bladder and oral cancers
Lipworth 2011 No evident confounding: SMRs < 1.0 for smoking-related cancers 
Lynge 2006 Adjusted for smoking Alcohol
Marie 2014 Adjusted for smoking
Marsh 2007 No adjustment for smoking. SMRs and RRs for lung cancer were 
substantially less than 1.0 indicating possible confounding that
would produce underestimates of the effects of vinyl chloride
Pay type (white/blue
collar)
Mattei 2014 Adjusted for smoking Asbestos, SES
McDonnell 2003 No information
Miligi 2006 No confounding was observed for smoking SES, disease history
Moore 2010 Smoking distribution was similar among cases and controls BMI, hypertension
Morgan 1998 Minimal cofounding: SMR=1.10 for lung cancer in TCE subgroup
Morton 2014 No information
Neta 2012 No information
Oddone 2014 Adjusted for smoking Alcohol, BMI, SES, 
pregnancy history
Paulu 1999 Adjusted for smoking SES, medical history
Peplonska 2010 No information SES and risk factors 
specific to breast cancer
Pesch 2000 Adjusted for smoking SES, study center
Raaschou-Nielsen
2003 
Some evidence of possible confounding: lung cancer SIRs=1.4 
males, 1.9 females (slightly lower SIRs for laryngeal cancer)
Radican 2006, 2008 No evident confounding: RR < 1.0 for lung cancer.  Internal
analyses unlikely to be confounded by smoking
Ruckart 2013 No confounding observed after adjustment SES, pregnancy factors, 
Vietnam experience
Ruckart 2015 Smoking is not a risk factor for male breast cancer Vietnam service,
diseases related to male 
breast cancer
Ruder 2013 No information SES
Saberi Hosnijeh 
2013
Adjusted for smoking alcohol
Santibañez 2008 Adjusted for smoking Alcohol, SES
Santibañez 2010 Adjusted for smoking Alcohol, SES




   
   
   






   
   
 
    
   
   
 
   
   
    
  
 
     
  
 




















Study Smoking Other Risk Factors* 
Schnatter 2012 Evaluated smoking with limited data and found none
Seidler 2007 Adjusted for smoking Alcohol
Selden 2011 Some evidence of potential confounding: SMR=1.32 for lung
cancer among dry cleaners + laundry workers (although excess risk
may be due to laundry workers rather than dry cleaning workers)
Silver 2014 No evident confounding: SMRs < 1.0 for smoking-related diseases
Stenehjem 2015 Adjusted for smoking Other benzene
exposures
Van der Mark 2015 Adjusted for smoking Coffee, SES
Vaughan 1997 Adjusted for smoking Alcohol, education
Vizcaya 2013 Adjusted for smoking SES, occ. exposure to 8 
lung carcinogens
Vlaanderen 2013 Internal analyses unlikely to be confounded by smoking
Weiderpass 2001 No confounding by smoking was found BMI, parity
Zhao 2005 Minimal confounding: RR=1.1 for lung cancer in high exposure
group; RR < 1.1 for lung cancer deaths.
* Risk factors in addition to age, sex, race/ethnicity, and calendar period that were either adjusted for or
were evaluated and found not be confounders.





















                              
                                          
                                      
  
 
                                
                                          
                                        
   
 
                                  
                                            











Camp LeJeune estimated monthly average contaminant concentrations tables for Tarawa Terrace
and Hadnot Point drinking water systems
Table 1a. Estimated Monthly Average Contaminant Concentrations in the Tarawa Terrace system, 1975 – 1985











Tetrachloroethylene 75.7 84.9 0 – 158.1 117 16
Trichloroethylene 3.1 3.5 0 – 6.6 11 0
Vinyl Chloride 5.6 6.2 0 – 12.3 117 0
1975 – 1979 (60 months)
Tetrachloroethylene 68.3 68.2 43.8 – 94.8 60 0
Trichloroethylene 2.8 2.9 1.7 – 3.9 0 0
Vinyl Chloride 5.2 5.5 2.6 – 7.3 60 0
January 1980 – January 1985 (61 months) * 
Tetrachloroethylene 96.1 95.5 0¥ – 158.1 57 16
Trichloroethylene 3.9 3.9 0¥ – 6.6 11 0
Vinyl Chloride 7.0 7.0 0¥ – 12.3 57 0
* Two contaminated wells were shut down in January 1985.  Estimated monthly average tetrachloroethylene levels from February through 
December 1985 were <4 µg/L



















                                  
                        
                                  
                                        
  
                                 
                       
                                 
                                            
  
 
                                 
                       
                                 




Table 1b. Estimated Monthly Average Contaminant Concentrations in the Hadnot Point system, 1975 – 1985











Tetrachloroethylene 15.7 15.4 0 – 38.7 111 0
Trichloroethylene 358.7 365.9 0 – 783.3 122 113
Vinyl Chloride 24.0 22.2 0 – 67.3 122 0
Benzene 5.4 4.6 0 – 12.2 63 0
1975 – 1979 
Tetrachloroethylene 12.2 12.0 1.4 – 24.1 53 0
Trichloroethylene 325.1 327.7 60.6 – 546.3 60 55
Vinyl Chloride 17.3 16.5 2.3 – 33.4 60 0
Benzene 3.5 3.4 0 – 5.8 4 0
January 1980 – February 1985* 
Tetrachloroethylene 21.5 21.4 2.2 – 38.7 58 0
Trichloroethylene 449.2 446.2 42.6 – 783.3 62 58
Vinyl Chloride 34.3 35.7 4.2 – 67.3 62 0
Benzene 7.6 7.6 1.6 – 12.2 59 0
* Contaminated wells were shut down after February 1985.  From March through December 1985, estimated monthly average levels of
trichloroethylene, tetrachloroethylene, and vinyl chloride were <1 µg/L, and benzene was <4 µg/L.
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